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In 2002, I accepted an invitation to Chair an
Inquiry into the issue of drug testing at work. I
felt that this was a hugely challenging and
timely project. There was a growing awareness
of the problems associated with drugs and
alcohol. The use of drug testing was expanding
in the criminal justice system and sports. There
had been a widespread and rapid increase in the
use of drug testing at work in the United States
over a relatively short period. There was
growing anecdotal evidence of an increase in
the numbers of organisations promoting drug-
testing services to British businesses. I was
aware that some people were starting to express
concerns that drug testing at work could
become an accepted part of life in Britain
without proper scrutiny of the evidence or
public debate.
Drug testing is a complex issue, which has
scientific, legal, ethical, social and economic
dimensions. It was clear from the beginning
that, if an Inquiry was to get to grips with all the
evidence and argument, it would need to be
conducted by a group of specialists from many
fields of expertise. It has been an enlightening
experience to have spent the past 18 months
working with leaders from the voluntary and
community sector, social policy specialists,
clinicians, academics, lawyers, trade unionists
and representatives from employers’ groups. I
would like to thank all of these Commissioners
for their contribution. I would particularly like
to thank Brian Pomeroy and Simon Deakin who
advised me beyond the call of duty.
I am immensely grateful to Yolande Burgin,
the Director of the Inquiry, without whom it
would not have taken place. She was
responsible for setting up and running the
Inquiry, gathering evidence, arranging for
hearings and stimulating our policy discussions.
We also owe a huge debt to Vanna De Rosas, the
Inquiry Co-ordinator, for providing the
Secretariat support, and to Marcus Roberts
without whom the report would not have been
written and published. DrugScope had the idea
in the first place and the Joseph Rowntree
Foundation provided the funding. Both these
organisations have been supportive without
being intrusive, ensuring that our work
remained independent of outside influence. I
would like to thank Frank Warburton and
Charlie Lloyd who gave me invaluable personal
support in the latter stages of our work, and
Roger Howard for all his encouragement and
support earlier on. I am also grateful to Harriet
Hall for advising me on the regulation of drug
testing. Finally, of course, I would like to thank
everybody who gave evidence to the Inquiry.
We have heard from employers and employees,
trade unions and business organisations,
insurers and police officers, occupational health
physicians and health and safety specialists,
natural and social scientists, lawyers,
philosophers and experts in every aspect of
drug-testing policy.
The Inquiry concludes that it is
inappropriate to drug test as a means of policing
the private behaviour of employees or
improving productivity. While drug testing has
a role in safety-critical industries it is no
substitute for investment in management
training and systems.
It has been a fascinating 18 months. This
Inquiry has, I believe, conducted the most
detailed investigation of this issue that has ever
been undertaken in Britain. I am delighted to be
writing the introduction to what I am confident




in the debate about drug testing at work. The
evidence that we have considered has often
resulted in controversy and debate among the
Commissioners, but this is a consensus report
with a substantive set of recommendations. We
hope it will clarify understanding and stimulate
a wider debate about a public policy issue that
could have profound implications for everyone




The Independent Inquiry on Drug Testing at
Work (IIDTW) was chaired by Ruth Evans,
former Director of the National Consumer
Council, with an independent Director, Yolande
Burgin. The Chair, Director and a group of 16
Commissioners have examined written and oral
evidence over an 18-month period.
Chapter 1  The background and context
The basics
The term ‘drug testing’ refers to the analysis of
biological material to detect drugs or their
metabolites in the body. Urine tests are most
common in the UK, but saliva, sweat and hair
can be tested. For alcohol, breath tests are most
common.
Drug testing at work takes a variety of
forms, including pre-employment testing,
random testing of employees and post-accident
testing.
The arguments for drug testing at work are
that there are benefits for safety, efficiency, an
organisation’s reputation and employee welfare.
The arguments are strongest with respect to
safety-critical occupations, where drug-induced
intoxication can increase the risk of accident.
The arguments against drug testing are that it
does not have the benefits that are claimed for
it, is excessively invasive, may damage relations
between employers and employees, and could
hamper the recruitment and retention of good
staff.
The science
Drug tests can detect if a drug has been used in
a given time period, but, generally, do not
directly measure the effects of drugs and alcohol
in the form of intoxication or impairment. They
may reveal that drugs were used weeks or
months previously, and cannot distinguish one-
off users from people with serious dependency
problems. Legally available drugs can produce a
positive test for illicit substances (e.g. codeine –
which is available in over-the-counter
painkillers – for opiates). Drug testing is not
infallible. But the science is sufficiently
sophisticated to enable employers to find out a
great deal of information about drug use among
staff and prospective staff. Tests may also reveal
other information, such as the use of
prescription drugs to treat medical conditions.
The law
Until recently, there has been little legal
constraint on the use of drug testing by
employers. But the situation is changing.
It is still unlikely that an employer would
face a legal challenge for refusing to employ an
applicant who tested positive for drugs or
refused a test. Similarly, an employment
tribunal would be unlikely to take the view that
an existing employee who had been sacked in
these circumstances was ‘unfairly dismissed’.
Provisions included in health and safety
laws may encourage employers in safety-critical
industries to drug test. Under Section 8 of the
Misuse of Drugs Act 1971, an employer who
knowingly permits drugs to be used in the
workplace could be vulnerable to prosecution.
An employer could also be liable to
prosecution under anti-discrimination laws for
targeting drug testing at a particular group or
for implementing drug testing in a
discriminatory way.
Two recent Acts place even tighter limits on
the scope for drug testing at work, although




The Human Rights Act 1998 incorporated
the European Convention on Human Rights
into domestic law. Article 8 states that ‘everyone
has the right to respect for his private and
family life, his home and his correspondence’.
The right to private life could have implications
for the legality of drug testing at work. Article 3
protects the individual from cruel and
degrading treatment, but this article is unlikely
to be triggered in any but the most exceptional
circumstances.
The Data Protection Act 1998 places limits on
the processing of personal data. Recent
guidance from the Information Commissioner –
responsible for implementation of data
protection laws – states that ‘other than in most
safety critical areas, regular drug testing is
unlikely to be justified unless there is a
reasonable suspicion of drug use that has an
impact on safety’.
New laws are limiting the room for
managerial manoeuvre on drug testing, but it is
not yet clear how the courts will interprete the
relevant human rights instruments or the data
protection legislation.
The ethics
Drug testing at work may be difficult to
reconcile with fundamental social and political
values.
There is a presumption in liberal-democratic
societies against invasion of private life unless
this is necessary to protect others from harm.
While drug use is illegal, it would be a
departure from social norms to empower
employers to actively investigate whether staff
are acting illegally outside work.
Employees have a responsibility to turn up
in a fit state to work, but employers cannot
expect people to live in such a way as to be
maximally productive at work. Performance,
after all, can be affected by a whole range of
factors that are not the legitimate concern of
employers, including late nights and child-care
responsibilities, stress, fatigue, anxiety and
bereavement.
The social issues
The use of illicit drugs is increasingly
widespread in modern Britain. Employers need
to take this into account in developing their
policies.
There is anecdotal evidence to suggest that
the demands of some work environments can
contribute to drug and alcohol problems.
Employment policies need to address the causes
of drug and alcohol use – for example, by
promoting a sensible work–life balance.
If people are excluded from work as a result
of their drug and alcohol use, this will result in
loss of income, difficulty in obtaining future
employment and significant costs in social
benefits.
Chapter 2  The evidence: trends and
trajectories
Extent of drug testing in Britain
The use of drug testing by employers is
increasing in the UK.
A survey of businesses by the Chartered
Management Institute in 2003 found 16 per cent
were randomly testing and 14 per cent were
screening as part of their recruitment processes.
A MORI poll was conducted on behalf of the
IIDTW in 2003. Over 200 companies were
surveyed, of which 4 per cent conducted drug
tests and 9 per cent said they were likely to
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introduce tests in the next year. Seventy-eight
per cent said they would be more likely to test if
they believed that drug or alcohol use was
affecting performance or productivity.
The CBI also distributed a questionnaire to
its Health and Safety Panel on behalf of the
IIDTW. There were 50 responses from
approximately 100 members. Nearly one-third
(30 per cent) of companies tested their staff for
drugs and alcohol. A further 12 per cent
intended to introduce drug testing in the near
future (but only one company was planning to
alcohol test).
Overall numbers might seem comparatively
low on the MORI findings, but this is
misleading. Even if only 4 per cent of businesses
are drug testing, this affects hundreds of
thousands of employees. If the 9 per cent of
businesses that told MORI that they were likely
to introduce drug testing in the next year were
to do so, this would treble the proportion of UK
businesses testing over a 12-month period.
Pressures for expansion
The IIDTW concludes that a major expansion of
drug testing at work, while far from inevitable,
is a genuine possibility. The North American
experience shows how rapidly drug testing at
work can expand. There is evidence that
increasing numbers of British employers are
identifying drug and alcohol use as a problem
for them, including many companies outside of
the safety-critical sector. There are commercial
incentives for expansion for organisations
offering drug and alcohol services. Over the
past 15 years, drug testing has grown into a
multi-billion-dollar industry in the United
States.
Chapter 3  The evidence: costs and benefits
Drug testing and safety-critical environments
Overall, the IIDTW was able to find no
conclusive evidence for a link between drug use
and workplace accidents, except for alcohol. A
literature review conducted by the Health and
Safety Executive reports that ‘five studies have
found some association between drug use and
work place accidents, whereas seven others
have found little or no evidence’.
The evidence is inconclusive.
Aside from this the IIDTW makes four key
points about drug use and safety at work.
First, it is unacceptable for employees in
safety-critical roles to be intoxicated at work.
There are also legitimate grounds for concern
about drug and alcohol use in other professions
where there are issues of public confidence, and
a reasonable expectation of high levels of
probity, such as the police and prison services.
Second, safety concerns do not neatly map
onto wider perceptions of the relative
harmfulness, legality or acceptability of
different substances (for example, alcohol may
be a greater safety threat than cannabis or
cocaine).
Third, intoxication will be a risk factor in
safety-critical environments, but it is not the
only source of risk, and should not receive
disproportionate attention and investment
(other risk factors include noise, dirty
equipment and machinery, conflicts at work and
sleeping problems).
Fourth, while drug testing may have a role in
some industries, it is no substitute for good
management and, where reliable – and
otherwise acceptable – methods are available, it
will generally be preferable to test staff in
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safety-critical occupations directly for
impairment (fitness for work) rather than to
conduct drug tests.
The message from industry
The IIDTW heard evidence from nuclear
generation, coal mining, quarrying, electricity
supply and distribution, water supply and
distribution, the underground railway system,
aerospace, engineering, bus and coach
operators, caterers, telecommunications, the
entertainment industry and financial services.
Four key messages emerged from the oral
evidence to the IIDTW from organisations
working in safety-critical industries.
First, the majority of employers who gave
evidence did not believe that drug misuse was a
serious or widespread problem for them.
Second, employers in safety-critical
industries stressed the importance of
implementing drug testing in a fair and
transparent way.
Third, employers said that, even in safety-
critical environments, drug testing could be
divisive and counterproductive if it was
clumsily handled.
Fourth, a number of employers emphasised
the need for welfare and support services for
staff with alcohol and drug problems.
Drug testing, productivity and performance
Employers have a legitimate interest in staff
performance. But a range of questions arise
about the extent to which employers should be
involved in regulating the private lives of
employees. The research evidence is not
supportive of drug testing as a means of
enhancing performance.
• Absenteeism: there is some evidence that a
weak relationship exists between drug use
and absenteeism, but it is inconclusive.
• Turnover: there is some evidence that illicit
drug users are more likely to leave a job
or to be dismissed, but it is inconclusive.
• Performance and productivity: the evidence
concerning the relationship between drug
use and performance has been variously
described as ‘conflicting’, ‘insufficient’
and ‘inconclusive’. The common
assumption that drug and alcohol use has
a major impact on productivity and
performance at work is not conclusively
supported by the evidence.
• Reputation: the impact of drug use among
employees on a company’s reputation is
almost impossible to assess.
The evidence does not provide much
support for alarmist claims about the impact of
drug use on absenteeism, turnover, productivity
or reputation. Nor has it been demonstrated that
drug testing has a significant deterrent effect, or
is the most appropriate way of identifying and
engaging with staff whose drug use is affecting
their work.
The costs of drug testing
There is a lack of reliable data on the cost-
effectiveness of drug testing. There are three
principal costs.
First, there are the financial costs of drug
testing.
Second, there is the impact on staff morale
and workplace relationships. A number of
businesses told the IIDTW that drug testing had
damaged relations with employees.
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Third, there are recruitment and human
resource costs. The exclusion of illicit drug users
from jobs may constitute a substantial cost for
organisations. Most recreational drug users are
otherwise responsible people who do not have
serious drug problems and have scarce skills to
offer to employers.
The Inquiry identified some less obvious
costs. For example, it heard some evidence that
testing could prevent staff in safety-critical
industries from reporting minor incidents,
increasing the risk of serious accident later.
Chapter 4  Conclusions and
recommendations
Drug testing at work is a complex topic and
often defies common assumptions and
preconceptions. Some of the conclusions and
recommendations of the IIDTW are summarised
below.
1 It is important to keep matters in
perspective. Overall, the evidence does not
suggest that drug and alcohol use is having
a serious and widespread impact on the
workplace. The IIDTW recommends that
further research is undertaken on the impact
of drug and alcohol use on performance and
safety at work.
2 The IIDTW concludes that employers have
a legitimate interest in drug and alcohol use
among their employees in a restricted set of
circumstances only. These circumstances are
where:
• employees are engaging in illegal
activities in the workplace
• employees are actually intoxicated in
work hours
• drug or alcohol use is (otherwise)
having a demonstrable impact on
employees’ performance that goes
beyond a threshold of acceptability
• the nature of the work is such that any
responsible employer would be
expected to take all reasonable steps to
minimise the risk of accident
• the nature of the work is such that the
public is entitled to expect a higher than
average standard of behaviour from
employees and/or there is a risk of
corruption (for example, in the police or
prison service).
3 The IIDTW concludes that employers have
no direct interest in the private behaviour of
employees and prospective employees, and
that investigation of an employee’s private
life simply for its own sake is an invasion of
personal liberty.
4 The legality of different drugs is not directly
relevant to their impact in the workplace, as
the recently published draft code from the
Information Commissioner (who oversees
the implementation of the Data Protection
Act 1998) states, drug testing should only
ever be used to ‘detect impairment at work
rather than illegal use of substances in a
worker’s private life’.
5 The IIDTW does not accept the argument
that drug testing is a private, contractual
matter between employers and employees.
Not only is there an inequality in bargaining
positions, but a significant expansion in
drug testing could have profound economic
and social implications for society at large.
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6 The IIDTW believes that the legal position
on drug testing at work is somewhat
confusing, largely because there is no direct
legislation and important legal questions
hinge on interpretation of a whole range of
legal provisions in health and safety,
employment, human rights and data
protection law. The IIDTW calls on the
Government to produce clear and definitive
guidance on the legal and other issues
around drug testing, and to finance a major
communication initiative to ensure that this
information is available to all employers
and employees.
7 The present accreditation mechanism covers
only a small part of the drug-testing
industry, with many companies not subject
to accreditation. The results of drug tests
can have a profound impact on the rights of
individuals. Substandard laboratories and
procedures are not acceptable. The IIDTW
concludes that a more rigorous system of
accreditation is needed. If an effective
system of self-regulation is not developed
by the industry within the next three years,
the Government should act to introduce a
legal requirement to ensure that all
companies providing drug-testing services
are operating to the very highest standards.
8 The IIDTW believes that there is a useful
role for drug testing in safety-critical
industries. However, direct testing of
impairment is better suited to health and
safety purposes than drug testing, which is
an indirect and unreliable measure of
impairment. With the development of more
effective forms of impairment testing, the
case for drug testing in safety-critical
industries would become much weaker.
9 The key to the successful implementation of
a drug and alcohol policy is that it is
conceived as a component of health and
welfare policy and not – at least, not
primarily – as a disciplinary matter. A drug
and alcohol policy will be effective only if it
is negotiated with and accepted by staff
across the organisation. The IIDTW
concludes that drug testing at work should
not be introduced in the absence of proper
consultation and involvement of trade
unions and/or other staff representatives.
10 The IIDTW found that drug testing, while it
can have a useful role in some industries, is
no substitute for good management
practice.
One of the strongest themes to emerge from
the evidence heard by the IIDTW over an 18-
month period is that good all-round
management is the most effective method for
achieving higher productivity, enhanced safety,
low absentee rates, low staff turnover and a
reliable and responsible workforce. For the
majority of businesses, investment in
management training and systems is likely to
have a more beneficial impact on safety,
performance and productivity than the
introduction of drug testing at work.
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REPORT OF THE INDEPENDENT INQUIRY
INTO DRUG TESTING AT WORK

3Are there reliable ways of testing people for
drugs use? Is it appropriate for employers to
test staff for drugs or alcohol? If so, in what
circumstances? Should applicants be turned
down for jobs on the basis of a positive test?
What is the law relating to drug testing? What is
the extent of drug testing in the UK at present,
and how is that projected to change? Do British
industries have sufficiently rigorous alcohol and
drug policies to ensure that the public is not
exposed to an unacceptable level of risk? What
is testing expected to accomplish? Is it
successful in that aim? In what circumstances, if
any, should an employer discipline or dismiss
staff for using drugs and alcohol? Does business
have a legitimate interest in what people do in
their own time? Where staff develop substance
misuse problems, do employers have a
responsibility to offer help? What is the law?
These are important questions that raise
complex issues. But they have received
surprisingly little detailed attention or
independent analysis in the UK. The aim of this
report from the Independent Inquiry on Drug
Testing at Work (IIDTW) is to fill this gap. It
provides a detailed and impartial review of the
arguments around drug testing at work and
seeks to put the whole issue into perspective at
a time when private drug-testing companies are
looking to expand.
The IIDTW’s report is concerned with both
illicit drugs and alcohol, and, unless otherwise
stated, the term ‘drug testing’ should be taken
to encompass alcohol testing too.
An important issue
The issue of drug testing at work is beginning to
gain a much higher profile. The growing
political concern was evinced by the publication
of a report from the All-Party Parliamentary
Drug Misuse Group (APDMG), Drug Testing on
Trial, in July 2003. This report concluded that ‘at
present there is no real consensus or clarity
about what the aim of drug testing in the
workplace is or should be’. The APDMG
concluded by welcoming the work of the
IIDTW, commenting on the need for an ‘in-
depth review of this whole issue’.
There are a number of reasons for the rise in
political and public interest in drug testing in
the workplace.
First, there is growing public and political
awareness of the extent of drug and alcohol use
in contemporary Britain. The British Crime
Survey 2002–03 found that 12 per cent of 16 to 59
year olds had used illicit drugs in the previous
year and that 3 per cent had used Class A drugs.
The figures were substantially higher for people
in their late teens and early twenties; 50 per cent
of 16 to 29 year olds had used drugs at some
time, over a quarter (28 per cent) of 16 to 24 year
olds had used an illicit drug in the last year and
8 per cent said that they had used Class A
substances in the last year (Condon and Smith,
2003). A Home Office study, published in
December 2003, found that 79 per cent of young
club-goers had used drugs at some time
(Deehan and Saville, 2003). Another recent
Home Office research report concludes, on the
basis of an analysis of the findings of the Youth
Lifestyles Survey, that over a third (39 per cent) of
18 to 24 year olds can be classified as binge
drinkers.1
Second, while the public debate about drug
and alcohol misuse has tended to focus on the
link with crime, disorder and anti-social
behaviour, it is a reasonable extrapolation from
Introduction
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what we know about the prevalence of drug
misuse and problem drinking that it will affect
significant numbers of people at work – as well
as many others who are in training and
education or are available for work. Drugs
impact on the lives of the socially included as
well as the socially excluded. For example, a
recent research study by Howard Parker and
colleagues at Manchester University concludes
that there is increasing use of Class A substances
among ‘primarily educated, employed young
citizens with otherwise conforming profiles …
[who] … see their substance misuse as de-
stressing, chilling out activity, whereby
intoxicated weekends and going out to “get out
of it” is the antidote to the working week’.2
Third, it is generally assumed that the use of
psycho-active substances could, in some
circumstances, affect the productivity and
performance of people at work, and, in some
industries, could result in accidents and
mortalities. A number of striking claims have
recently been made about the costs of alcohol
and drug use at work. A report from the
National Treatment Agency claims that the cost
to industry from illegal drug use is £800 million
each year. And the Government’s Alcohol Harm
Reduction Strategy for England (Prime Minister’s
Strategy Unit, 2004) says that ‘alcohol misuse
among employees costs up to £6.4 billion in lost
productivity through increased absenteeism,
unemployment and premature death’. Such
claims may appear to strengthen the case for
drug testing at work. But it is unclear how some
of these figures are arrived at, how reliable they
are and what difference, if any, drug and alcohol
testing would make.
Fourth, there is greater public awareness and
concern about drug testing, as its use in other
areas of social life has expanded in recent years –
particularly in sport, but also within the criminal
justice system.3 There have been proposals to
introduce drug testing in the police force.4 More
recently, the level of public and political interest
in, and concern about, drug testing was shown
by the response to the Prime Minister, Tony
Blair’s, comments in an interview with the News
of the World in February 2004, in which he
appeared to offer some encouragement to the use
of drug testing in schools. Before this, the
expansion of drug testing by police, prisons and
other criminal justice agencies had already begun
to raise important public policy questions, which
are equally relevant to the issue of drug testing at
work. For example, questions about the balance
between public interest and individual rights, the
responsibility to provide support and treatment,
the relation between drug and alcohol use and
drug and alcohol dependency, and the deterrent
effect of drug-testing regimes. Some similar
issues were raised by recent cases involving high-
profile sports people, including the tennis player
Greg Rusedski and the footballer Rio Ferdinand.
These cases have also raised public awareness of
the technical issues about the reliability of drug
tests, which would be of much wider concern if
the use of drug tests by employers was
significantly extended.
Fifth, there is concern about the increasingly
sophisticated marketing of drug testing by
commercial organisations. The technology of
drug testing is not well understood. The
companies that produce this equipment and
conduct tests have a business interest in
promoting testing to employers and opening up
new markets. But it is important that an
independent assessment of the value and limits
of drug testing in the work place is available to
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inform wider discussion of an issue that touches
on serious matters.
Sixth, there has been anecdotal evidence for
an increase of drug testing in some high-profile
firms, particularly in the financial sector, where
there are no obvious health or safety justifications
for testing. In the past, other than in the rail
industry, routine drug testing was introduced
into the UK by North American firms insisting
that their subsidiaries, or those doing business
with them, institute drug testing. Since the mid-
1980s, drug testing in the United States has
grown exponentially into a multi-billion-dollar
industry, thus showing how rapidly a pervasive
drug-testing culture can take root.
A complex issue
The issue of drug testing at work raises a wide
range of important questions. In a crowded and
confused legislative framework where case law
is mixed, there has been no strong guidance to
date. This is a complex, multi-faceted issue with
a number of aspects that cut across traditional
disciplinary and organisational boundaries – for
example, it has scientific, legal, ethical and
economic dimensions, and it is an area of
concern for a number of government
departments, notably the Home Office,
Department of Health and Department of Trade
and Industry. That is why the APDMG’s report
stressed the need for an ‘in-depth review’.
Five key dimensions are examined in this
report.
1 The science: how do the various forms of
drug testing work? What can they detect
and what can’t they detect? How reliable
are the results?
2 The ethics: how is the balance to be struck
between promoting the public good and
respecting individual rights? Where do the
legitimate interests of employers end and
the private lives of individuals begin? What
responsibilities do employers have, if any, to
promote the health and welfare of the
people who work for them? Do employers
have a role in policing the activities of their
staff outside work time, and especially
where they are acting illegally? What about
the responsibility of employees to be in a fit
and proper state to work? How do these
questions relate to other impairment-
producing factors such as stress, fatigue,
anxiety and bereavement?
3 The law: what is the current legal position on
drug testing? What are the legal
requirements on employers in storing and
processing test results? Are there any
circumstances in which an employee who
was dismissed following a drugs test could
claim that this constituted ‘unfair
dismissal’? What forms of consent are
required and what are the implications for
the drafting of contracts of employment?
What about human rights? What about data
protection?
4 The social dimension: is it the role of
employers to address drug use in society?
To what extent, if any, can the demands of
the modern workplace contribute to drug
and alcohol problems? What, if anything,
should employers do about informing and
educating their workforce about drugs and
alcohol? What, if anything, is the role of the
employer in minimising social exclusion?
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5 The business case: is drug testing worth the
investment? Is drug testing an effective tool
in performance management and
measurement? Does it help to reduce
absenteeism? Does it affect accidents at
work? What are the human resource costs to
businesses of refusing employment to
promising candidates who fail drug tests?
What is the effect on workplace
performance? What is the effect on
relationships at work? What are the costs of
dismissing staff for drug or alcohol use? Is it
cost-effective for businesses to help staff
with problems to access treatment and
support services? Is there evidence that
testing deters drug use?
The answers to these questions will not
always be clear and unambiguous. The term
‘drug testing at work’ does not refer to a single
homogeneous issue, but designates a range of
different practices that vary depending on:
• the form of drug testing
• the point at which drug testing takes
place
• the rationale for drug testing
• which drugs are being tested for
• who is being tested
• the type of work that is involved.
The purpose and scope of the Inquiry
Background
The IIDTW is the first Inquiry of its kind in the
UK. Its remit is to address the spectrum of
complex and far-reaching issues surrounding
drug testing in the workplace. The lack of
detailed analysis of this subject – and concerns
about the pace of technological change and its
commercial exploitation – prompted the
formation of the Inquiry in 2002. It was facilitated
by DrugScope and funded by the Joseph
Rowntree Foundation and the Network of
European Foundations (NEF). Throughout its
work, the IIDTW has rigorously examined these
controversial issues, while maintaining its
independence from all interest groups, including
the facilitator and funders. It has striven to
remain wholly impartial throughout its inquiry.
Aims
The aims of the Inquiry were to examine:
• the nature and extent of workplace drug
testing
• the science of testing
• the consequences and implications of
drug testing in the workplace
• the legal and statutory framework, and
• to reach conclusions and make
recommendations.
Underlying this whole prospectus was a
fundamental concern about the lack of good
practice, evidence or professional consensus to
assist employers in their decisions on whether,
how and in what circumstances they should test
for drugs and the lack of any ‘accepted
protocols relating to testing in the workplace’.
The IIDTW’s work was guided from the
outset by two clear principles.
• That the Inquiry, while rigorously
examining the issues, would at all times
remain impartial, and maintain its
independence from all interest groups.
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• That the Inquiry would work to be open
and transparent in all of its endeavours,
while protecting the privacy of individuals
where necessary. In incidences where
sources were kept confidential, those
sources would be thoroughly checked. The
IIDTW has sought verification for all
quotations.
Methodology
The IIDTW has considered both written and
oral evidence.
1 Literature reviews: the IIDTW began by
identifying and scrutinising the existing
evidence on drug testing at work and
commissioned a series of literature reviews.
Reviews were conducted by Ross Coomber,
Principal Lecturer in Sociology at the
University of Plymouth; Peter Francis,
Natalia Hanley and David Wray of the
Sociology and Criminology Division,
Northumbria University; and the Inquiry
benefited from the pre-existing work of
Johanna Beswick and colleagues at the
Health and Safety Laboratory.
2 Expert advice: the IIDTW’s deliberations were
informed by a number of specially prepared
written submissions from experts – including
Commissioners – on the science, sociology,
ethics and law of drug testing. It heard
extensive evidence from a wide range of
individuals and agencies – including
employees and employers, trade unions and
business organisations, drug-testing
companies and regulatory authorities,
scientific experts, lawyers, philosophers and
social scientists. The Inquiry has been reliant
on the advice it has received from lawyers on
some difficult legal issues. A report was
commissioned by the IIDTW from Gillian
Ferguson of the Matrix Research Panel at
Matrix Chambers. The Inquiry also received
expert legal opinion from Michael Ford, a
leading barrister with expertise on drug
testing. In addition, the Commissioners
benefited from the evidence provided by a
number of leading legal practitioners
working in England and Wales.
3 Polls and research: the IIDTW was responsible
for initiating new research that has helped to
fill in some of the gaps in the available
evidence base. In particular, the Inquiry
commissioned a MORI poll on employers’
attitudes to drug and alcohol policy in
general, and drug testing in particular.
Questionnaires were also distributed on the
Inquiry’s behalf by the Confederation of
British Industry (CBI), the Federation of
Small Businesses (FSB) and the Trades Union
Congress (TUC). The clubbers’ magazine
Mixmag included questions on behalf of the
Inquiry in its annual drugs survey and the
IIDTW further benefited from new research
on drug testing in the UK published by the
Chartered Management Institute.
4 Hearings: the IIDTW heard oral evidence
from a wide spectrum of organisations,
including employers, drug-testing providers
and representatives from the relevant
statutory and regulatory bodies. The IIDTW
also spoke to a number of employees about
their experiences of drug and alcohol use.5
5 Round-table discussions: the IIDTW set up a
number of round-table discussions. A
Health Round Table at the Royal College of
Practitioners was attended by people
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working across the National Health Service;
a round-table discussion for Occupational
Health and Human Resources Practitioners
took place at the London Chamber of
Commerce; and a Round Table discussion
on the legal and ethical issues was the
subject of the Industrial Law Society’s
Plenary Session on 12 September 2003.
Conclusion
Drug testing at work, then, is a complex issue,
and this 18-month Inquiry has heard evidence
from experts across a wide range of disciplines,
as well as employers, employees and the
industries supplying drug-testing equipment and
services. But the questions that the issue of drug
testing at work raises are not simply technical
ones that can be left to the relevant experts.
Ultimately, this issue raises some profound
questions for all of us: questions about the
rapidly changing nature of work and leisure in
the modern world; questions about health and
welfare in the workplace; questions about the
balance between corporate responsibilities and
individual privacy; questions about risk, risk
management and the ‘nanny state’; questions
about responsible behaviour at work; questions
about stress in the workplace; and questions
about the relationship between market
imperatives and the development of humane
and effective approaches to drug and alcohol
misuse among staff where this is a genuine
concern for organisations.
The IIDTW believes that these are important
issues. This report reaches definite conclusions
and puts forward specific recommendations. It
is intended that it should also provide a clear
introduction to the issues, an accessible and
comprehensive survey of the evidence and a
detailed evaluation of the case for and against
drug testing at work.
The remainder of the report is divided into
four chapters.
Chapter 1 answers the obvious questions
‘what is drug testing?’ and ‘how does it operate
in the workplace?’. It outlines the principal
arguments for and against testing at work. It then
examines the scientific issues, the relevant legal
instruments (including the Human Rights Act
1998 and the Data Protection Act 1998), the ethics
of drug testing and the wider social implications.
The following two chapters review the
evidence that has been presented to the IIDTW
over the 18 months that is has been sitting, both
in its oral hearings and in the form of written
submissions.
Chapter 2 is concerned with the prevalence
of drug use in modern Britain, the attitudes of
employers and employees, the extent of drug
testing in the workplace and the potential for
future expansion. It presents fresh evidence on
employers’ attitudes to drug testing, notably the
results of a MORI poll and a CBI survey, both
conducted on behalf of the IIDTW.
Chapter 3 reviews the evidence on the costs
and benefits of drug testing, with particular
attention to: health and safety issues,
absenteeism and staff turnover, performance
and productivity, and the reputations of
organisations. It also assesses the costs to
organisations of drug testing, including not only
the financial investment but also the potential
damage to industrial relations and the possible
recruitment and human resource costs.
Finally, Chapter 4 of the report summarises
the IIDTW’s conclusions and sets out the
Commissioners’ recommendations.
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the specific findings and recommendations of
the IIDTW that follow. It examines the broader
context for the debate about drug testing in the
UK and looks at some of the key issues in
greater detail. It is particularly concerned to set
out the broader scientific, ethical, legal and
social issues.1
1.1 ‘Drug testing at work’? The basics
1.1.1 What is drug testing?
The term ‘drug testing’ refers to the analysis of
biological material to detect the presence or
absence of drugs and/or their metabolites
within the human body. Metabolites are the
substances into which drugs, including alcohol,
are converted by the human body. The presence
of metabolites shows that the relevant
substances have been used in the recent past.
The commonest form of testing for illicit
drugs is the analysis of urine samples. For
alcohol, breath tests are more common, and
these are often followed up by blood tests for
confirmation. In addition, oral fluid, hair and
sweat can be tested.
1.1.2 Drug testing in the workplace
The term ‘drug testing at work’ refers to all kinds
of employment-related drug testing. The principal
forms of testing at work are identified below.
1 Pre-employment testing (also often referred to
as ‘screening’): this is testing conducted as
part of the screening and selection process
for job applicants.
2 Routine medicals: drug testing as part of
routine medicals for staff, usually as part of
a pre-employment process.
3 Transfer testing: testing when employees
move to a new job within a company or are
promoted.
4 Mandatory random testing: where employees
are required to submit to tests as a matter or
course, either regularly or irregularly.
Typically, National Insurance numbers are
used to generate a random sample of a pre-
agreed percentage of the workforce.
5 Post-accident testing: testing may take place
as part of the procedure for investigating
and dealing with workplace accidents.
6 ‘For cause’ testing: employees are tested
where an employer or manager believes
that there is reasonable suspicion of drug
use at work.
7 Post-treatment or follow-up testing: this covers
the testing of employees who are known to
have used drugs, including those who have
previously tested positive and may be in
treatment.
8 Voluntary testing: employees volunteer to be
tested.
These eight forms of testing are not
exhaustive of all the possibilities, and they may
be used either independently or in a whole
variety of different combinations. Drug-testing
regimes within the workplace can also vary in
other ways – for example, depending on
whether employees are or are not given notice
that random drug tests will be conducted on a
particular date. Or, to take another example, an
organisation may decide to drug test only those
staff who could pose a significant safety risk, or
it may test all staff – or, at least, a random cross-
section of staff. In some organisations, everyone
1 The background and context
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may be tested from senior management
downwards.
1.1.3 Why test?
There are four fundamental reasons for drug
testing at work.
1 Safety: there is concern that an individual
who is impaired by alcohol or drugs is an
increased safety risk to him or herself, co-
workers and/or the public. This may be of
particular concern where employees have
safety-critical functions. This is true, for
example, of air traffic controllers, train
drivers, ambulance drivers, pilots, bus
drivers, miners and quarry workers.
2 Organisational efficiency: it is believed that
the use of alcohol and drugs can be a cause
of low productivity, absenteeism and high
staff turnover. It is further assumed that
drug testing can reduce the number of
working days that are lost through staff
absence, increase productivity and reduce
the costs of recruiting and training new
employees.
3 Reputational risk: some employers are
concerned about the damage that they
believe can be caused to the reputations of
their organisation as a result of alcohol and
drug use among their workforce. The use of
illegal drugs by employees will be a
particularly sensitive issue in some
professions, such as the police force and the
prison service.2
4 Employee welfare: it has been suggested that
drug testing can help to improve the health
and welfare of the workforce by deterring
drug use and by helping to identify staff
who have problems. These individuals can
be encouraged to seek help by their
employers and supported in their efforts to
address their substance misuse problems.
It is not only existing employees who are
drug tested. Potential employees may be asked
to take drug tests as a part of the recruitment
processes of organisations. It is believed that
such pre-employment testing (or ‘screening’)
can help to ensure that staff whose drug use
could compromise safety or performance or the
employer’s reputation are not being recruited.
In addition to these rationales for drug
testing at work, some employers may simply be
reluctant to take on job applicants or to retain in
employment people who have taken illegal
drugs, regardless of whether or not this affects
their capacity to do the job in question. Some
employers may see themselves as having a
quasi-policing role with respect to the
workforce, and view drug testing as a means of
discouraging socially unacceptable and illegal
forms of behaviour. Finally, a stigma can attach
to people who have a history of drug and/or
alcohol problems, including those in treatment,
and this may affect employers’ attitudes.
1.1.4 Against drug testing
Aside from doubts that drug testing has the
benefits that are claimed, there are several
arguments against drug testing at work.
1 What is being identified? It is suggested that,
as a drug test does not identify impairment,
but merely the presence of metabolites that
indicate past use, this is not useful or
appropriate information for an employer.
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2 Breakdown of trust: a workforce, believing
itself to be under surveillance, may no
longer trust the employer and withdraw
goodwill.
3 Inability to recruit qualified people or the loss of
key staff: it is suggested that some people
might prefer not to work for employers who
test for drugs. In addition, it is argued that,
by dismissing an employee after a positive
drug test, a member of staff, in whom a
long-term investment might have been
made, is lost to the organisation.
1.1.5 The key questions
It is actually misleading to talk about the issue of
drug testing at work. The reality is that the
pertinent arguments will vary significantly
depending on what type of drug testing is
under consideration and for what purpose. For
example, the use of random drug tests as a
means of detecting and deterring the use of
drugs or alcohol on a building site or at a quarry
will raise different questions to the use of pre-
employment screening to exclude prospective
employees because of a general reluctance to
offer employment to candidates who have used
illicit drugs in the past. Similarly, the
information that someone is intoxicated at work
has a different significance for employers than
the information that someone may have used
drugs at some time in the past few months. In
short, there are a whole range of issues involved
in ‘drug testing at work’ depending on the type
of testing, the purpose of testing and the context
for testing.
Drug testing: what happens?
For the most part, the companies that gave
evidence to the Inquiry and carried out
drug testing did so by taking urine
samples. At the pre-employment screening
stage, the most common approach was to
use a presumptive test kit (for example, a
dipstick) and make a decision about a job
applicant based on this result. Testing may
be part of the general medical examination
that is carried out as part of the
recruitment process and people may be
offered a job pending the result from the
laboratory.
When existing employees are tested, the
companies that gave evidence to the
IIDTW either, as a first step, used a
presumptive testing kit and, as a follow-
up, sent the sample to a testing laboratory
for confirmation or else they sent samples
directly to a testing laboratory. Typically, a
laboratory or testing agency will be
contracted to perform this task and will
collect two samples: the first is analysed by
the laboratory, the other is frozen. If the
veracity of the first result is challenged
then the frozen sample can be sent to
another laboratory.
Some companies set aside a specific room
where people were required to give a
sample. If this is a toilet, then taps may be
sealed and something may be added to the
water to avoid tampering with the sample.
Other companies will send people to a
medical centre or hospital to have a
sample taken. The IIDTW heard of
(continued overleaf)
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intoxicated at work. In addition, ability to
perform at work may be negatively affected by
the after-effects of drugs and alcohol – including
hangovers and the ‘come down’ experience that
can follow the use of illicit drugs, as well as
experience of withdrawal symptoms.
Nonetheless, the issues are not entirely
straightforward. Three points in particular
should be noted.
1 Different drugs have different effects. Some
drugs may be used in the belief that they
enhance performance. For example,
amphetamines may reduce fatigue in the
short term and enable people to ‘keep
going’ (for example, there is evidence of
their use among long-distance lorry drivers
and by the armed forces in specific
circumstances).
2 The grounds for concern about drug use at
work do not neatly map on to the legal–
illegal distinction. Alcohol may impair
performance at work to the same – or even a
greater degree – than cocaine or
amphetamines. Many prescription and
over-the-counter drugs have side effects.
Licit drugs can be a source of impairment
too.4
3 People who are undergoing treatment for
drug use may be prescribed substitutes,
such as methadone, which may show up in
drug tests, and could impact on
performance.
While the general reasons for worrying
about the impact of drug use at work are
straightforward, there are some complexities.
Different psycho-active substances (licit and
illicit) will have different effects and there is
incidents of people being asked to strip
down before giving their sample, but this
is rare. Nor is it normal for someone to be
present to supervise the production of
samples, although this is common practice
in the army.
The result of a drug test is legally
defensible only if it can be proven that a
correct chain of custody procedure3 has
been followed in sending the sample to the
laboratory, to ensure that it could not have
been tampered with or mixed up with
another sample.
1.2 How do drugs affect people at work?
The science
Why should employers be concerned if people
are actually turning up for work under the
influence of drugs?
Drug use can affect the individual’s capacity
to perform a whole range of work-related tasks
and functions.
The obvious example is drink driving.
Where people are driving under the influence of
alcohol, this impacts on their perception, motor
skills, decision making, attitudes to risk and so
forth. Similarly, people put themselves and
others at risk when they drive or operate
machinery at work under the influence of
alcohol or other, illicit, drugs with similar
psycho-active properties.
Where an individual is under the influence
of alcohol or drugs, this may affect productivity
and the capacity to deal with colleagues and the
public.
So, in one sense, the answer to this question
is obvious: it is a bad thing if people are
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much that is unknown about the impact of
psycho-active substances on productivity and
safety at work.
1.3 Does it work? The science
To begin with, it is necessary to address some
obvious practical questions about drug tests.
How are they carried out? Has a ‘chain of
custody’ (ensuring that a sample is intact and
could not have been tampered with – see note 3,
this chapter) been strictly adhered to? Do drug
tests work? How reliable are test results? What
do they tell us? What don’t they tell us? The
answers to these questions will, of course, vary
depending on the kind of testing that is under
consideration.
1.3.1 What drug tests do
Drug tests can indicate whether a drug or
metabolite is present in the body of the subject.
A drug test will generally reveal only the
presence or absence of the particular substance
that is being tested for. It will be possible to
detect whether a drug has been used over a
limited time period only. This ‘detection period’
will vary depending on the nature of the
substance that is being tested for and the type of
testing.
1.3.2 What drug tests don’t do
For the most part, drug tests can indicate only
that a drug or its metabolite is present, and
cannot provide a direct measure of impairment
or intoxication. The main exception to this rule
is breath tests for alcohol. By contrast, other
forms of testing pick up different information.
The testing of human hair for the presence of
cocaine or heroin may reveal the presence of
drugs that were taken months – or even years –
previously, while failing to pick up evidence of
use over the previous few days.
Drug tests are not a reliable indicator of
levels of intoxication and impairment. For the
most part, a drug test will not prove that its
subject was intoxicated at a particular time, nor
provide a reliable guide to the degree of
impairment that exists where drugs are used.
Another limitation of most drug testing is that it
provides little information on an individual’s
pattern of drug use – that is, whether he or she
is an addict, a regular user, irregular user or
one-off user.
1.3.3 How reliable are the results? Cut-off
levels
Testing equipment can be sensitive enough to
detect very low levels of substances that have
found their way into the body other than
through illicit drug use. In other words, drug
tests may be too sensitive. The use of over-the-
counter drugs can produce a positive test for
illicit substances – for example, the use of
codeine (which is available in over-the-counter
painkillers) can result in a positive test for
opiates.
This problem has led to some bitter
controversies about the reliability of positive
test results for sports personalities and there is
presently a debate about appropriate ‘cut-off’
points for recording a positive or negative
reading in the workplace.5
One way to deal with this problem is to
identify cut-off points so that detection of low
concentrations of substances are not recorded as
a positive result for the purposes of determining
whether the subject has used an illicit drug.
But this is not unproblematic.
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If cut-off points are set too high, then the
concentration levels of opiates within the body
will fall rapidly below the cut-off level
following consumption, and the ‘window of
opportunity’ for getting a positive test for a
drug like heroin will be extremely narrow.
If the cut-off is high, someone who tests
positive for an opiate on Tuesday may test
negative by Wednesday. On the second day,
there will still be significant traces of opiates in
the body, but they may fall short of an
excessively high cut-off point.
An interesting, and related, point is that
surprisingly little is known about the impact on
behaviour of given quantities of drugs. Thus, A.C.
Grayling – a Commissioner on the Inquiry –
comments in his evidence that many of the ethical
issues concerning drug testing would be clearer ‘if
medical evidence suggests that some residual
trace of a given substance marks a limit below
which no adverse affects can be expected’. But, in
fact, the science in this area is underdeveloped.
The precise relationship between the levels of
drugs present in the human body and the impact
on behaviour is not well understood, and will
vary a great deal depending on the substance. This
was confirmed for the IIDTW by a witness from
the drug-testing company Tricho-Tech, who
explained that ‘the level of drugs present can be
measured in external agents like saliva, urine, hair
and blood. But we cannot measure the quantity
that needs to be present in the brain to induce a
particular status. The relation between the level in
percentage of a certain drug and its effect is
therefore not clear’. Indeed, the effective doses of
different drugs can vary by several hundred or
thousand fold, so that the level of detection that is
set for one drug may be wholly unsuitable for
another.
1.3.4 How reliable are the results? More on
false positives
The term ‘false positive’ is used to describe a
situation in which someone tests positive for a
drug, but has not consumed that drug over the
relevant time period.
As indicated in the previous section, there
are a number of potential sources of ‘false
positive’ results.
1 The cut-off concentration levels are too low: for
example, someone who has eaten a bread
roll sprinkled with poppy seeds tests
positive for heroin.
2 The subject of the test has consumed licit drugs
that invalidate the result: over-the-counter or
prescribed drugs may produce positive
results for illicit drugs. For example,
occasional users of the American version of
a Vicks Nasal Inhaler have tested positive
for amphetamines or methamphetamines.6
3 Passive consumption: as the debate about
passive smoking has highlighted, a positive
test could, in theory, result from the passive
inhalation of substances. For example,
somebody who has recently been in a room
where cannabis has been smoked could, in
theory, test positive for cannabis.
Of course, the possibility of false positives does
not invalidate drug tests, although it does mean
that their results need to be treated with a degree
of caution. It should be noted that these problems
are by no means unique to drug testing, but are
equally applicable to other forms of screening – for
example, for cancer and other diseases – which are
not infallible either. The issues that drug testing
raises can be illuminated by considering the wider
debate on the science and ethics of screening.
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In recent years, better scientific knowledge
and improvements in testing techniques and
protocols have significantly reduced the
likelihood of ‘false positive’ results.
Where an initial oral fluid or urine test
shows up positive in a cup or vial by a change
in colour, it is now widely recognised that such
positive test results need to be followed up by a
full, more costly laboratory test in order to be
relied upon. There may be an alternative – and
‘innocent’ – explanation for the presence of an
illicit drug. This may emerge only after review
of a pre-test interview, in which subjects are
asked whether they have taken any over-the-
counter or prescribed medications. There are
documented cases of people giving wildly
improbable explanations for the presence of
drugs in their bodies, which have turned out on
further examination to be true.
1.3.5 How reliable are the results? False
negatives
The term ‘false negative’ is used to refer to a
situation in which someone tests negative for a
particular drug, but has in fact consumed that
drug in the relevant time period of concern to
the tester.
For the most part, the causes of ‘false
negatives’ are simply the corollaries of ‘false
positives’.
1 If cut-off concentration levels are set too low
in order to deal with false positives, this will
result in positive results being dismissed as
unreliable in some cases where the subject
has consumed illicit drugs.
2 The ‘window of opportunity’ for detecting
drugs in the human body will vary
depending on the type of test, the particular
substance that is being tested for and the
level at which the relevant cut-off has been
set. For example, heroin will leave the body
much more quickly than cannabis and a
urine test for cocaine or heroin will be
reliable for a period of two to three days,
whereas a hair test may be able to detect
these drugs in the human body over a
period of several months (see Table 1).
3 There are masking agents and adulterants
that can be used to corrupt test results.
Increasingly, these substances may be tested
for as well as the drugs themselves.
The results of drug tests need to be treated
with some caution, as testing procedures are
fallible. It is also important to be clear what
particular drug tests can and cannot do. A test
that can reveal the presence of heroin that was
taken by one person months previously may not
detect that another subject was actually on
heroin at the time the test was taken. Another
type of test may pick this up, but will not be
able to detect that the subject used cocaine or
heroin a few days earlier. It is important to be
aware of these limitations.
But, at the same time, drug-testing methods
and technologies are getting increasingly
sophisticated. For the most part, and within
these limitations, it is possible to be reasonably
confident about test results, so long as the
proper procedures are followed. But the
detection of drugs or their metabolites in the
human body will often tell us little or nothing of
value about impairment or the impact on
performance. It is another question, of course,
whether ‘tests work’ in the sense that they are
an effective means to the ends of employers,
including reducing accidents, cutting
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Table 1  Drug testing, detection times and reliability
Type of test Urine Saliva Sweat Blood Hair
24 hours Up to 1 week to
Detection time 2/3 days 24 hours to 2/3 days 31 hours 18 months
Drug/drug type Drug detection times
Alcohol 6 hours to 1 day
Amphetamines 1 to 4 days
Benzodiazepines Short-term therapeutic use: 3 days
Long-term chronic use: 4 to 6 weeks
Cocaine 2 to 5 days
LSD 1 to 4 days
Marijuana Casual use: up to 7 days. Chronic use: up to 30 days or longer
MDMA 1 to 4 days
Mescaline 1 to 4 days
Methadone 1 to 7 days
Methamphetamines 1 to 4 days
Nicotine 1 to 2 days
Opiates (including heroin) 1 to 4 days
Propoxyphene 1 to 7 days
Psilocybin (Mushrooms) 1 to 3 days
Steroids (Anabolic) Oral: 2 to 3 weeks. Injected: 1 to 3 months. Nandrolone: up to
9 months
Tricyclic Antidepressants 1 to 9 days
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absenteeism, increasing productivity and
enhancing the reputation of the organisation.
These important issues will be examined in
detail later in this report, when the principal
findings of the IIDTW are set out and discussed.
1.4 The law
Drug-testing technologies are not infallible.
However, it is possible, within strict limits, to
find out a great deal about people’s alcohol and
drug use by testing. It can be done, but should it
be done? Is it permissible for employers to drug
test their staff – and, if so, in what circumstances?
Is it ever encouraged or required? What are the
rights and responsibilities of employers and
employees in this area? The answers to these
sorts of questions will vary significantly
depending, for example, on whether testing is
about safety and performance at work or
behaviour outside the workplace that has no
demonstrable implications in terms of
impairment at work.
To summarise, there are a number of aspects
of drug testing that raise ethical and legal issues.
In particular:
• employees taking illicit drugs are
engaging in an illegal activity
• employers have health and safety
responsibilities to their employees and to
the public at large
• employees may lose their livelihoods, face
other disciplinary action or be stigmatised
where they test positive for drugs
• testing may be perceived as a violation of
the integrity and privacy of the individual,
particularly in the absence of consent
• drug testing can reveal sensitive
information about people that should not
be used in inappropriate ways.
This section takes a close look at the legal
status of drug testing in the UK, while the
following section discusses the wider ethical
questions.7
1.4.1 An emerging issue for jurisprudence
In his evidence to the IIDTW, leading barrister
Michael Ford explained that drug testing at
work had been ‘a matter for unconstrained
management prerogative’ for years, but that this
‘is now less so’. So what has changed? Of most
significance, two landmark pieces of legislation
were passed by the UK Parliament in 1998: the
Human Rights Act and the Data Protection Act.
Both have considerable potential relevance to
the legality or otherwise of different forms of
drug testing.
However, as a number of witnesses to the
IIDTW stressed, the precise significance of these
legal instruments is unclear. As Michael Ford
explains ‘there has been little case law on the
Human Rights Act and the Data Protection Act
in relation to the issue of drug testing … quite
how extensive an incursion the legislation will
make into management prerogative in this area
remains a matter of considerable uncertainty’.
He proceeds to note that any discussion of the
law on drug testing is bound to ‘venture into
uncharted territory’.
What is clear is that drug testing raises
fundamental issues for law and ethics. As
Gillian Ferguson, from Matrix Chambers,
explains in her evidence to the IIDTW, this is a
legally and ethically controversial area, which is
likely to generate many future cases for the
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consideration of employment tribunals and law
courts because of the tensions between the
interests of employers and employees. ‘From an
employer’s perspective’, she comments, ‘key
reasons for testing include compliance with
health and safety laws, enhanced productivity
and the promotion of public confidence.
Standing in potential conflict with these are the
employees’ interests in privacy, dignity and
bodily integrity.’
This is a controversial area of law.
1.4.2 ‘Unconstrained managerial prerogative’
Leaving aside anti-discrimination provisions (see
below), UK employment law has had little to say
about drug testing at work. To paraphrase
Michael Ford, the reality is that employers have
been able to do pretty well as they choose.
1 Pre-employment
Outside of anti-discrimination law, an employer
is highly unlikely to be open to legal challenge
for refusing to employ a candidate who tests
positive for drugs, or who refuses to take a test,
or who has lost a job in the past because of an
alcohol or drug problem. This has traditionally
been treated as a matter of freedom of contract –
if the employer chooses not to enter into an
agreement with a prospective employee, for
whatever reason, then that is, literally, his or her
business.
2 Assault and consent
Employers cannot physically compel their staff
to submit to drug tests. An employer who
attempted to take, say, hair or blood by force
would be committing a crime. In practice,
however, this legal prohibition on assault will
place little or no restriction on the employer’s
ability to drug test staff and/or potential
employees. For the most part, potential
employees will consent to drug testing if they
know that the alternative is to be no work or a
damaged career. Subsequently, if refusal to take
a test is treated as a positive result, an employee
has little real choice.
In organisations that do testing, it is common
for employers to make it an express term of
contract that an employee submit to a drug test
if required. In addition, there is an implied
condition in employment contracts that an
employer will not act in ways that will damage
relationships of trust without good reason.8 The
IIDTW was advised that ‘so long as an
employer can point to some possible reason for
justifying drug testing of an employee – which
might simply be the effect on its reputation if its
employees are known to be taking drugs –
testing is unlikely to breach the implied term’.
Employers cannot force anyone to take a
drug test, but, under employment law, they can
refuse to employ anybody who says ‘no’. And
they can treat refusal to submit in the same way
as they would treat a positive test.
3 Dismissal
Generally speaking, employers have wide
discretion, as a matter of contract, to determine
what kind of matters will result in disciplinary
action and what the sanctions will be. However,
if an employer sacks somebody, this brings
another area of employment law into play.
Employees, so long as they have been in their
current jobs for at least 12 months, are protected
against ‘unfair dismissal’ by the Employment
Rights Act 1996.9
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Legal experts told the IIDTW that it was
highly unlikely that an employment tribunal
would feel that a dismissal was unfair if there
was evidence that drug or alcohol use affected
performance at work – and particularly not if
there were health and safety considerations.
For a dismissal in these circumstances to be
judged ‘fair’, however, it will probably be
necessary to demonstrate some link between an
employee’s drug and alcohol consumption and
their work. The IIDTW heard that employment
tribunals have tended in the past to accept
whatever employers have told them about what
will and will not affect work. It has been
common for tribunals to accept justifications for
dismissal that gesture towards some general
and rather vague claims about the adverse
effects of drug use on the organisation’s
reputation. But this may be starting to change.
leading barrister Michael Ford told the IIDTW
‘it is probably true that tribunals nowadays
increasingly tend to expect some stronger links
between drugs and performance at work’ and
are not so ready to settle for ‘vague claims’
about reputation.
Employers may also run into trouble if
proper procedures have not been followed in
cases resulting in the dismissal of staff. An
employment tribunal may want to know, for
example, whether employees were warned of
the consequences of drug use and whether the
employer followed its own internal rules in the
case in question.10
Unfair dismissal cases
Racal Services v. Flockhart EAT 701/00
The Employment Appeal Tribunal ruled
that the dismissal of a safety-critical
trackside worker who tested positive for
cannabis had been ‘fair’, and this was the
only conclusion open to an employment
tribunal. In addition, on-duty
consumption of drugs or present
impairment is likely to constitute a
legitimate ground for dismissal even when
there are not these kinds of safety
considerations.
Mathewson v. R.B. Wilson Dental Laboratory
[1998] IRLR 512
A dental technician purchased some
cannabis during his lunch hour for his
personal use and was arrested and later
fined. He admitted the offence to his
employers immediately and was
summarily dismissed. There was no
suggestion that the employee took
cannabis while at work. The tribunal held
that nevertheless his dismissal was fair
because it fell within the band of
reasonable responses and this decision was
upheld on appeal. Relevant considerations
included the skilled work performed by
the employee and the possible influence
on younger members of staff.
Booth v. Southampton Airport Ltd, EAT Case
NO 39214/81, IDS Brief, December 2002
An air traffic controller was dismissed for
off-duty cannabis use. This was held to be
a fair dismissal even though there was no
(continued overleaf)
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4 References
Where an employee is dismissed for failing a
drugs test, it may be very difficult to get another
job. An employer who had dismissed an
employee for a positive drug test would be likely
to pass this information on to a prospective new
employer – not least because failing to provide
this information could leave the previous
employer open to legal action if drug or alcohol
use by the employee subsequently led to serious
problems in the new job.11
1.4.3 The responsibilities of employers
Is there anything that employers are legally
required to do about drugs at work? After all, if
they fail to take effective action to prevent their
employees working under the influence of
alcohol or drugs then this could result in
accident and mortality.
Three key legal instruments are of relevance
here.
1 The Health and Safety at Work Act 1974:
employers have a duty to protect their
employees’ health, safety and welfare in the
workplace. They are also legally responsible
for the welfare of third parties.12
2 The Management of Health and Safety at Work
Regulations 1999: these regulations oblige
employers to conduct assessments of health
and safety risk to their employees and third
parties.13
3 The Transport and Works Act 1992: it is a
criminal offence for certain workers –
including drivers and conductors on buses
or trains – to work under the influence of
alcohol or drugs.14 Under these
circumstances, if the employer has not
exercised ‘due diligence’ in ensuring that
the employee is not under the influence of
alcohol or drugs, he or she is also guilty of a
criminal offence. The avoidance of criminal
liability, alongside the obvious safety
concerns, has led many to introduce drug-
testing programmes.15
Although these legal instruments do not
expressly require employers in the relevant
safety-critical industries to have drug-testing
programmes, they have provided them with an
incentive to do so.
The issue of drug testing is moving up the
health and safety agenda in a society where
problematic forms of alcohol and drug use are
increasing among the working population. The
Health and Safety Executive (HSE) has
identified drug misuse as an important
workplace issue. In a recent guidance
document, Drug Misuse at Work, the HSE
concludes that drug testing is a sensitive area,
evidence it affected his work in any way.
The employer justified the dismissal by
referring to the importance of preserving
public confidence in the service.
Norfolk v. Bernard [1979] IRLR 220
A drama teacher was dismissed following
his conviction for the possession and
cultivation of cannabis. In the absence of
any evidence that the drug conviction or
drug use had affected or would affect his
work or the employer’s reputation, an
employment tribunal found that the
dismissal was unfair and this decision was
subsequently upheld by the Employment
Appeals Tribunal.
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and will be embraced by staff only as part of a
wider occupational health strategy that has
clearly been designed to minimise risk (Health
and Safety Executive, 1999).
There is no direct legal requirement for
employers to test employees (or prospective
employees). In so far as drug testing is currently
one means of meeting a legal obligation in the
UK, it is because of health and safety law.
There is a qualification to this, however.
Illicit drugs are illegal. In certain circumstances,
employers who knowingly allow drugs to be
used on their premises may be vulnerable to
prosecution under Section 8 of the Misuse of
Drugs Act 1971.
1.4.4 Legal protection for employees
Employees are entitled to protection of their
health and safety at work. This is the basis of a
strong argument for drug and alcohol testing.
But people may also need legal protection to
ensure they are not subjected to workplace
procedures that violate their rights, invade
privacy without good reason or are
insufficiently respectful of their dignity as
human beings. People cannot be physically
compelled to submit to drug tests, as this would
constitute criminal assault. But what other legal
protections apply to drug testing at work?
1 Discrimination
An employer should not target alcohol or drug
testing disproportionately at, say, young black
men – or, indeed, at young men. It is also
important to ensure that the way that drug
testing is actually conducted takes proper
account of ethnic, cultural and religious
differences and sensibilities. Employers who
discriminate against job applicants, staff or
contract workers on the basis of race, sex or
disability (or, indeed, because they are members
of trade unions) are likely to face action under
anti-discrimination legislation.16
These laws also place limits on what
employers can do with the information that is
obtained from a drug test. For example, a test
may (incidentally) reveal that somebody is taking
prescription medication.17 An employer would
be in breach of discrimination law if he or she
declined to offer a job applicant employment on
these grounds – or discriminated in other ways,
such as turning someone down for a promotion
or an internal transfer. This area of law may
receive greater attention as prescription drugs
containing cannabis become available for the
treatment of some disabilities.
It might be argued that an alcoholic or
someone with a drug dependency is ‘disabled’.
This is not the legal position. The Disability
Discrimination (Meaning of Disability)
Regulations 1996 state that dependency on
drugs and alcohol is not a ‘disability’ for the
purposes of the Disability Discrimination Act
1995. There is a significant exception to this,
however. Where someone has developed a
mental health problem as a result of taking
prescribed drugs, or undergoing medical




Individuals are entitled to a private life, outside
of the workplace.
This right is recognised by the European
Convention on Human Rights (ECHR), which
was incorporated into domestic law by the
Human Rights Act 1998.
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Article 8 of the ECHR declares that
‘everyone has the right to respect for his private
and family life, his home and his
correspondence’.
This protects bodily integrity and requires
free and informed consent to drug testing.19 Of
course, it is unlikely that any employer would
physically force someone to take a drug test.
However, bodily integrity would also be
violated if a blood or other sample was taken
under another pretext and subsequently used
for drug-testing purposes without the consent
of the individual.
Other than this, the IIDTW was told that the
impact of both human rights and data
protection legisation was still a matter of
‘considerable uncertainty’.20
What can be said with confidence is that
Article 8 could have implications for the way the
law deals with drug testing at work. Leading
barrister Michael Ford told the IIDTW that ‘in
view of changing attitudes to drug use and the
growing evidence of widespread use of
recreational drugs, it is plausible that in future
drug use may be seen as an aspect of private
life’.
However, even if drug use did come to be
seen as an essentially private matter, the right to
private life could still be overridden under
Article 8 ‘in the interests of national security,
public safety or the economic well-being of the
country, for the prevention of disorder or crime,
for the protection of health or morals, or for the
protection of the rights and freedoms of others’.
This is another significant hurdle to Article 8
being invoked to limit the power of
employers.21
With this in mind, Michael Ford comments
in his evidence to the IIDTW that the indications
are that ‘courts and tribunals will be slow in
departing from their traditional approach, in
which the right to private life in the context of
work relationship has hardly figured at all’. He
adds, however, that ‘the long term trend is less
clear’.22
There is a further, and very significant,
restriction.
Under the Human Rights Act 1998, the rights
contained in the ECHR can be invoked directly
only against a ‘public authority’. The
applicability of the right to privacy will depend
not only on correct interpretation of Article 8,
but also on whether or not the employer in
question is a ‘public authority’.23
Pressure from the labour movement
In the longer term, a range of external factors
are likely to have a significant impact on the
interpretation of Article 8. For example,
organisations that represent the interests of the
workforce will want to influence the
development of drug testing at work, notably
the trade union movement – as, of course, will
employers’ bodies.
The International Labour Organization (ILO)
adopted a set of guiding principles on alcohol
and drug testing in the workplace in the early
1990s.24 These principles could influence the
way that Article 8 is interpreted by tribunals
and courts in the UK, particularly given the role
that British trade unions play in representing
employees in unfair dismissal – and other
relevant – cases.
Where an employer is testing, the ILO
guidelines state that:
• there should be a formal written policy on
testing
23
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• methods of testing should be of the
highest quality and reliability
• the objective of testing should be clearly
defined and articulated
• it must be clearly demonstrated that
testing can reasonably be expected to
achieve its intended goals
• the substances to be tested for should be
identified
• the test results should be kept
confidential.
The Guidance states that ‘workers should
have the right to make informed decisions about
whether or not to comply with requests for
testing’. It continues:
Rights of workers to privacy and confidentiality,
autonomy and fairness, and integrity of their
bodies must be respected, in harmony with
national and international laws and jurisprudence,
norms and values. Employees who refuse to be
tested should not be presumed to be drug or
alcohol users. The need for testing should be
evaluated with regard to the nature of the jobs
involved. With some jobs, the privacy issues may
be determined to outweigh the need to test.
The substantive issues raised by this
statement of principle are discussed elsewhere
in this report. It should be noted here only that
the development of drug-testing policy, and the
interpretation of Article 8, is not only a matter
for dispassionate deliberation in the law courts.
This is an area where there is a potential for
divergence between the interests of employers
and employees, and some of the key issues are
open to political contestation. It is against this
background that the relevant human rights
instruments will be interpreted and
implemented.
Data protection
Drug testing is a means of obtaining
information. This information can be used in a
variety of ways.
The Data Protection Act 1998 – which itself
draws on Article 8 of the ECHR – sets out a
series of legal requirements for obtaining,
recording, processing, holding, using or
disclosing information.
The first three data-processing principles are
of particular significance to drug testing at
work. They are:
1 personal data must be processed fairly and
lawfully
2 personal data must only be processed for a
specified lawful purpose
3 personal data must be adequate, relevant
and not excessive in relation to the purpose
for which it was processed.
The experts who advised the IIDTW felt that
these principles placed real constraints on the
scope of employers. Gillian Ferguson, of Matrix
Chambers, argued that ‘Data Protection Act
compliant drug testing will have to be carefully
tailored to specific purposes … unreasoned and
unnecessary testing will not be acceptable’.
Michael Ford agreed: ‘plainly, the application of
these principles will have a significant effect on
drug testing by employers: in general terms
employers will have to be much clearer as to the
purpose of drug testing and be able to justify
that testing in the light of how it affects their
workers and their right to respect for private
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life’. He added that ‘it may also prove difficult
for them to rely on blanket “consents” obtained
through clauses written into contracts of
employment to which individuals have little
choice but to agree’.
In addition, the Data Protection Act places
strict controls on the handling of sensitive data
obtained from a drug test – such as the
information that the subject has committed a
criminal offence by using an illicit substance or
is taking a prescription drug.
To summarise: employment law appears to
strongly favour the employer. However, it
appears that other emerging areas of law are
starting to provide a counterbalance to
‘unconstrained managerial prerogative’, notably
the Human Rights Act and the Data Protection
Act. However, this all remains uncharted – and
politically contested – territory. It is not yet clear
precisely how the courts will interprete Article 8
or the data protection legislation.
More pressure for a health and safety focus?
The precise application of the data protection
principles to drug testing will depend on what
is and what is not considered to be a good
reason for processing this information. Here, as
elsewhere, there are indications that the
acceptability of testing may hinge on whether it
has a legitimate health and safety purpose.
The impact of the Data Protection Act on
employment practice has so far been limited,
perhaps because its full implications have not
yet become clear to employers. To date, there
has been very little litigation, in part because
there is not much scope for it.25
The issue has recently been clarified with the
publication in November 2003 by the
Information Commissioner of the consultation
draft of Part 4 of the Employment Practices Data
Protection Code (this document is on the
Information Commissioner’s website at
www.informationcommissioner.gov.uk).
According to the draft Code, the legitimacy of
drug testing depends on showing that there are
health and safety concerns and providing
evidence of real (not assumed) impairment of
performance; it also casts doubt on the
legitimacy of the practice of random testing in
all but safety-critical industries. Thus it suggests
that ‘the collection of information through drug
and alcohol testing is unlikely to be justified
unless it is for health and safety reasons’26 and
recommends that employers should ‘confine
testing to those workers whose activities
actually have a significant impact on the health
and safety of others’.27 Even in safety-critical
industries, ‘workers in different jobs will pose
different safety risks’, so that ‘[t]esting of all
workers in a business will not be justified if in
fact it is only workers engaged in particular
activities that pose a risk’.28
The Code recommends that the purpose of
testing should be to ‘detect impairment at work
rather than illegal use of substances in a
worker’s private life’. Testing for illegal use
may, however, be justified, according to the
Code, where such use would ‘breach the
worker’s contract of employment, conditions of
employment or disciplinary rules, and cause
substantial damage to the employer’s business,
e.g. by seriously undermining public confidence
in the integrity of a law enforcement agency’.29
The Supplementary Guidance issued along
with the Code urges employers to ‘[t]ake
particular care when carrying out an assessment
of whether drug testing is justified on health
and safety grounds’, and to bear in mind that
‘other than in the most safety-critical areas,
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regular drug testing is unlikely to be justified
unless there is reasonable suspicion of drug use
that has an impact on safety’.30 It suggests that
employers should employ drug testing only if it
provides significantly better evidence of a
health and safety danger than the available
alternatives, such as tests of cognitive ability,
and recommends that employers should
therefore use tests that are designed to detect
recent exposure.31
Such a health and safety emphasis is
common to many jurisdictions. In Canada, for
example, workplace drug testing constitutes a
‘bona fide occupational requirement’ only if it is
conducted for a purpose that is ‘rationally
connected to the performance of the job’. Or,
again, France directly authorises alcohol testing
only of employees who are employed in
particular safety-sensitive positions. Similarly,
drug testing is permitted in the Netherlands if
there is a major risk to the safety of the
employee, co-workers or third parties. The
United States may seem to provide an exception
to this general rule. However, while extensive
drug testing in the United States was initially
motivated by concerns about crime and
productivity, the justificatory emphasis has
since shifted to health and safety.
Data protection: quality assurance and procedural
matters relating to tests
The Information Commissioner’s draft
guidelines referred to in the previous
paragraphs also advise employers that they
must justify and communicate the criteria on
which those to be tested are selected. Covert
testing should not be used. Drug and alcohol
testing should be of sufficient quality to support
decisions made on the basis of the tests and
should be conducted and interpreted by a
person suitably qualified and competent in the
field of drug testing.
A note on consent
If the legitimacy of drug testing is increasingly
thought to depend on the purpose for which it
is conducted, then this implies that less
importance is attached to the issue of consent.
Of course, to test someone without their
consent is against the law, so consent is legally
significant in this respect. But, if a drug test
serves no legitimate purpose, then the consent
of the employee is not obviously going to be
sufficient to legitimise it. Thus, in the conclusion
to her research paper, Gillian Ferguson of
Matrix Chambers comments that ‘employee
consent is increasingly regarded [by the law] as
a spurious basis on which to conduct tests’. This
is because it is recognised that there is a
substantial inequality in bargaining power
between employees and employers – and
between job applicants and prospective
employers. Bluntly, it is hard to say no.
3 Dignity
Even where drug testing is permitted,
encouraged or required by the law, there could
still be a possible legal challenge if the way it
was conducted was inappropriate. In particular,
Article 3 of the ECHR protects the individual
from cruel and degrading treatment. For
example, the courts have held that a lack of
privacy in prison toilet facilities can contribute
to ‘degrading treatment’ of prisoners.
This article might be invoked if testing was
conducted in a particularly brutal and
insensitive manner. For example, a
representative of Amicus, the UK’s largest
manufacturing trade union, told the IIDTW of
one case in which a bald staff member was
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required to provide a sample for a hair test. He
was told that a sample – approximately the size
of a pencil in circumference – would be taken
from his underarm hair or pubic hair. When he
declined to take the test, he was dismissed for
refusing to comply with a ‘reasonable request’.32
This sort of practice is a matter for some
concern. But it would probably be overstating
the case to say that it constituted degrading
treatment for the purposes of Article 3.
The lawyer’s evidence
The IIDTW wrote to 136 lawyers across
England and Wales who specialised in
employment law, inviting them to give
evidence. The majority did not believe
they had much to contribute to the
IIDTW’s inquiry, as, significantly, they had
not been involved in cases where alcohol
or drug testing was an issue. None of the
lawyers who the Commissioners spoke to
felt that alcohol and drug use in the
workplace was a significant problem for
the businesses that they represented.
A lawyer from a leading firm of UK
solicitors, who mainly represents
corporate and multi-national clients from
the United States, reported that 20 per cent
of these clients did some form of drug
testing, and numbers were increasing. He
told the IIDTW that some employers are
aware that cannabis metabolises slowly
and can show up in a test long after it has
ceased to impact on performance, but that
there is still a tendency to deal with all
drug use as a disciplinary matter. For
many companies, a positive test will result
in dismissal in the absence of any evidence
of an effect on performance. This witness
expressed concerns that a minority of
managers might be tempted to abuse drug
testing to ‘manage out’ unwanted
employees. He also commented:
I have known one company that had a ‘snorting
room’ in the City. People turn a blind eye with
regard to drugs and alcohol – but also with a
range of other behaviours – because they don’t
want to lose a key employee … someone who
can make a lot of money.
A representative from Thompsons
Solicitors – the largest firm of trade union
solicitors in the country – had a number of
concerns about the legal status of drug
testing. He commented that an
Employment Tribunal is likely to consider
dismissal for drug use as being within the
‘band of reasonable responses’ to ‘gross
misconduct’. He believed that this gave
employers too much latitude to act in a
discriminatory way, and he argued that a
positive drug test should not be a
justification for dismissal in the absence of
evidence of impaired performance.
Random drug testing for an entire
workforce could seldom if ever be
justified, he thought, and there should be
safeguards where staff are tested – for
example, committing organisations to
support the rehabilitation of staff with
drug or alcohol problems.
A partner in a large regional practice,
which is the solicitor for a number of
safety-critical industries, reported that the
(continued) (continued)
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personal choice and private life. Indeed,
‘toleration’ has been defined as ‘the deliberate
choice not to prohibit, hinder or interfere with
conduct of which one disapproves, where one
has both the requisite power and the
knowledge’.35
Perhaps the best known statement of this
principle is found in J.S. Mill’s Essay on Liberty
(1859). Mill writes that:
… the only purpose for which power can be
rightfully exercised over any member of a civilised
community, against his will, is to prevent harm to
others. His own good, either physical or moral, is
not a sufficient warrant.
It can be argued that the state is sometimes
justified in acting, paternalistically, to protect
individuals from the harmful consequences of
their own actions. This is epitomised, for
example, in the UK’s drug laws. Nonetheless,
there is, in general, a strong presumption against
interfering with individual freedom, which can
usually be overridden only by demonstrating
that this is necessary to protect others from harm.
In his evidence to the IIDTW, the
philosopher A.C. Grayling – a Commissioner for
the Inquiry – argued that liberal societies accord
a special moral weight to the rights and
freedoms of individuals, but that these freedoms
can be limited where third parties are affected
or harmed. He comments, therefore, that:
… there is surely widespread agreement that
[drug] use by people whose work affects the
well-being, and even lives, of others must be a
matter of special interest. No one would wish to
be a passenger in an aeroplane flown by
someone drunk or in a state of heroin-induced
euphoria.
most common reason for introducing
testing was pressure from a parent or
partner company in the United States. She
reported that almost all US companies
want drug testing introduced if they are to
do business with organisations in the
United Kingdom and claimed that all
Fortune 500 companies33 have pre-
employment tests and random testing. She
commented on the problems that small
and medium-sized companies can have in
developing the infrastructure to enable
them to drug test and the general
reluctance of employers in the UK to
‘police society’. It was her view that the
firm’s client base was cutting back on drug
testing – primarily because of the expense
– and that, for the most part, businesses in
the UK do not see alcohol and drugs as a
big problem for them.
1.5 More on the rights and wrongs of
drug testing: ethics
Discussion of the legal position on drug testing
directs our attention to some of the broader
moral questions. It is helpful to identify five
issues in particular.
1.5.1 Private life, public life
A distinction between the public sphere and
private sphere has been fundamental for liberal
societies like the UK.34 For a society that is
committed to the values of toleration and
autonomy, the mere fact that an action is
disapproved of – or is harmful to the individual
involved – does not, in itself, provide a
compelling justification for interference with
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A.C. Grayling adds that employers are also
justified in requiring their employees not to turn
up for work in a condition where their
intoxication, while not a threat to safety, is ‘an
embarrassment or a nuisance’ (say, affecting an
assistant in a retail outlet). In such cases, A.C.
Grayling concludes that ‘for cause’ testing may
be justified, but that random testing ‘is, by the
principle, unethical’. There are, A.C. Grayling
argues, no grounds at all for workplace testing
in all those cases where an individual’s use of
psychotropic substances affects nobody else. In
such cases, drug testing at work offends against
some of the fundamental principles that
undergird a liberal-democratic society.
1.5.2 Privacy, liberty and law enforcement
If employees or prospective employees are taking
cannabis or cocaine, then they are committing a
criminal offence. On the face of it, this would
seem to be of considerable importance to the
arguments for and against drug testing at work.
On closer inspection, however, it is of doubtful
relevance. Of course, employers can have a
legitimate interest in knowing whether the
people who work for them have broken the law
(hence the arrangements for disclosure of
criminal records), but this is a different matter
from permitting employers to test as a means of
actively investigating employees and potential
employees.
Nobody seriously argues that organisations
should be granted the power to search the
houses of job applicants, or to monitor the bank
transactions of their staff, or to acquire stop and
search powers. It is doubtful that there are
better reasons why employers should have
drug-testing powers simply as a means to check
that employees are not breaking the law.
Furthermore, while employers do have an
interest in activities of staff that impact on their
capacity to work, there is no general obligation
on employees to order their leisure time in such
a way as to maximise productivity at work. It
would be inappropriate for employers to have a
say in what time their staff went to bed or the
amount of exercise they get on weekends,
although this could significantly affect
performance. The fact that, say, having a drink
in the evening can affect productivity the next
day is not – in and of itself – sufficient to
demonstrate that employers can legitimately
concern themselves with the out-of work
activities of the people who work for them.
In his evidence, A.C. Grayling comments
that:
… random testing which uncovers the subject’s
own-time private activities introduces a
questionable grey area. Principally, it raises
questions about the degree to which, in the
absence of express agreement and definition, an
employer can exercise influence over employees’
private lives. Since these are a fundamental
individual privilege, only the most careful mutual
arrangements between individuals and those who
employ them in safety-critical situations can be
regarded as ethically sound.
A.C. Grayling proceeds to argue that, in all
other employment situations, ‘there can be no
justification for invasion of privacy by an
employer of this or any cognate kind’.
1.5.3 Purposes and outcomes
Implicit in much of the evidence presented to the
IIDTW was an acceptance that drug testing at
work did constitute an invasion of privacy and
that there needs to be a compelling reason for
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overriding this right. Many witnesses felt that the
case for drug testing was strongest where the
employer’s purpose was to promote health and
safety, or was about enhancing staff performance
in some other way. But, it might be thought, what
ultimately matters is not the motivations of
employers, but the outcomes of drug-testing
regimes. If drug tests do not improve safety or
enhance performance, then the case for testing is
weakened significantly. Does drug testing
actually achieve its objectives? Is it an effective
measure of impairment? Does it deter people
from using drugs and alcohol at work? Does
drug testing reduce absenteeism or increase
productivity? These issues are examined in detail
elsewhere in this report.
Even where there are good arguments for
drug testing at work, there will also be ethical
questions about the type of testing that is used.
As a general principle, there is a clear case for
saying that employers should adopt the least
invasive drug-testing regime that is consistent
with realising their ends. While drug testing
will rarely – if ever – constitute ‘degrading’
treatment in the sense required to invoke Article
3 of the ECHR, it may be experienced as
humiliating, uncomfortable or embarrassing.
1.5.4 Fairness
Testing should not be discriminatory. This is not
simply a matter of avoiding discrimination on
the basis of gender, race or disability, but also of
making sure that no employee is ever ‘selected’
for testing without good reason. This effectively
means that workplace drug testing – if it is not
voluntary – should either be ‘for cause’, ‘post-
accident’ or random, and within a transparent
and agreed policy.
It is also important that any disciplinary
action taken against workers who test positive is
fair and proportionate. There is the wider moral
issue of whether an employee who is found to
have a serious drug problem should be
disciplined (for example, suspended or
dismissed) or helped. To discipline staff simply
for use of illicit drugs might be seen to constitute
an arrogation of a law-enforcement role by the
employer. This would imply that any
disciplinary action should be focused on the
consequences of impairment for performance at
work rather than the consumption of a drug as
such – otherwise loss of employment would
effectively act as a sort of quasi-judicial sanction
for breaking the criminal law.36
But nor should the responsibilities of
employees be neglected. Society takes a dim
view of people who drive under the influence of
alcohol. It is also wrong for people to turn up at
work in a state of intoxification that makes them
unfit for their work and that might put their
colleagues or members of the public at risk.
1.5.5 Welfare
It is increasingly accepted that employers have a
wider responsibility for the welfare of their staff
than simply to protect them from accident and
injury at work. Generally, employers would be
thought to have ethical obligations, alongside
any legal responsibilities, to deal in a sensitive
and appropriate way with staff who, for
example, develop significant health or mental
health problems. In part, this is because
depriving employees of work is likely to
exacerbate such problems as people become
increasingly reliant on workplace relationships
for support and structure in their lives. Similar
considerations will apply to staff with drug and
alcohol dependency problems.
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It is also arguable that employers have an
ethical responsibility to ensure that the
pressures of work are not so excessive as to
increase significantly the chances that staff will
turn to damaging forms of alcohol or drug use –
for example, by ensuring work loads do not
become unmanageable and by taking firm
action to tackle bullying at work.
1.6 Social problems and social
responsibilities
The issue of drug testing at work also needs to
be placed in a wider social context. Work has a
broad social significance. For many people, it is
a source not only of income but also – and
increasingly – of self-esteem, a structured life
and social support and friendship networks.
This means that the way that employers
approach drug testing at work has wide
repercussions for society as a whole. For
example, if organisations refuse work to
anybody with a history of drug or alcohol
dependency – including people who are in, or
have recently completed, treatment – then this
will tend to exacerbate social exclusion.
Similarly, if staff who fail drug tests are
dismissed, then this could, in some cases,
precipitate a downward spiral of exclusion and
substance misuse.
There are obvious and strict limits to the
extent that society can reasonably expect
employers to shoulder responsibility for social
problems. But it is important that these wider
issues are not ignored in the debate about drug
testing at work.
1.6.1 Drugs and social exclusion
Excluding people who use drugs from work
will have a number of negative outcomes. These
include:
• loss of income for individuals and their
families
• potential exclusion from future
employment
• potential loss of home and family
relationships
• creating a net drain on, rather than a net
contribution to, society.
1.6.2 The pressures of work
People do not develop alcohol and drug
problems independently of everything else that is
happening and it is important to be aware of the
wider causes and contexts of problematic
substance use. The problematic use of psycho-
active substances can be a response to the
problems of daily life. The workplace itself
contributes to these pressures. There is a growing
body of anecdotal evidence that the demands of
work are greater than ever before, and that some
people come to depend on alcohol and drugs as a
way of dealing with these pressures.
The IIDTW heard from a number of
employees who said that their drug or alcohol
use was, in part, an antidote to the demands of
the workplace. For example, one management
consultant in his mid-twenties told the Inquiry
about his experiences of working for an
international consultancy firm. He explained that
‘people worked incredibly hard and very long
hours ... the whole environment was pressure …
big stress – big pressure’. A woman in her late-
twenties, working in telecommunications,
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claimed that ‘in a time-deprived, working life,
smoking cannabis is crucial to me to cope with
the workload and hours’. It would be a mistake
to attach too much significance to the remarks of
one or two witnesses to the Inquiry, but these
comments are suggestive and resonate with the
experience of many. At the very least, it is evident
that employment policies should ideally address
the causes of problematic drug and alcohol use –
for example, by recognising the need for a
sensible work–life balance.
1.7 Conclusion
The issue of drug testing at work raises
important questions about the legal obligations
of employers and their wider social
responsibilities. Most employers recognise that
these sorts of considerations are a source of
significant constraints on their employment
policies. But their first concern must be for the
efficiency of their organisations. When
employers are developing drug and alcohol
policies, they are – quite rightly – interested in
the costs and benefits to them. A number of the
points made in this detailed discussion of the
scientific, legal, ethical and social issues raised
by drug testing also have business implications,
and will impact on the efficiency and
productivity of organisations.
For example, there are the human resource
costs of refusing employment to talented
people, or of dismissing highly trained staff, for
what may be a one-off or recreational and non-
problematic drug experience. Particularly in a
culture where experimental drug use is
widespread, an ill-considered drug-testing
regime may also have a negative impact on
industrial relations if there is no clear rationale
for testing. In addition, employers could be
vulnerable to legal challenge, notably under the
Data Protection Act.
How do employers hope that they will
benefit from investment in drug testing and
would any benefits offset these costs? In safety-
critical industries, this is about health and safety
obligations and a desire to reduce the incidence
of accident, injury and mortality. Elsewhere,
they may believe that testing can improve
efficiency and productivity. The IIDTW has
talked to many British employers about their
attitudes to drug testing, and has conducted a
thorough review of all the evidence on safety,
productivity, reputation and efficiency. This
evidence is examined in Chapter 3 of this report,
which also takes a more detailed view of the
costs. First, however, it is necessary to say more
about the extent of drug testing at work in
contemporary Britain.
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Many people have had no direct experience of
drug or alcohol testing in their working lives,
and may doubt that this is a significant problem
for them or a particularly salient issue for public
debate. Is drug and alcohol use at work a major
problem? How widespread is drug testing? Are
there good reasons to think that drug testing is
becoming more widespread in Britain, or is likely
to become so in the foreseeable future? This
chapter addresses these questions and, in
particular, asks whether there are genuine
grounds for concern about alcohol and drug use
at work or about the use of drug testing in the
UK. It also presents new evidence commissioned
by the IIDTW, including the results of a MORI
poll.
2.1 Drugs and alcohol at work – is there a
problem?
2.1.1 Prevalence and cultural change
In an article in the magazine Safer Society, Peter
Martin, Chief Executive of the charity
Addaction, recently commented that ‘there has
been a massive social change in the last 20 to 30
years, with drug use more commonplace than
ever before … we have to direct our strategy to
recognise that we are living with a drug
culture’.1 As noted earlier, Howard Parker and
his colleagues at Manchester University have
recently concluded that employed young people
are no longer ‘maturing out’ of binge drinking
and recreational drug use in their mid-twenties.
On the contrary, a growing number of young
adults view ‘substance use as a de-stressing –
chilling out – activity, whereby intoxicating
weekends and going out to “get out of it” is the
antidote to the working week’.2 The
Government’s Alcohol Harm Reduction Strategy
for England, published in March 2004 (Prime
Minister’s Strategy Unit, 2004), confirms that
binge drinking is widespread among the
working population.
The use of psycho-active substances is
widespread in British society, as is confirmed by
the official data on prevalence. This is not to
condone the use of illicit drugs. But it is
something that employers need to take into
account in developing drug and alcohol policies.
A business that refuses to employ anyone who
tests positive for drugs will exclude large
numbers of talented and otherwise law-abiding
young people. Moreover, where recreational
drug use is widespread, it may be seen as unfair
if a few staff each year face disciplinary action as
a result of random drug tests. In addition, while
recreational drug use is widespread in
contemporary Britain, it is young people at the
margins of society who are the most likely to
have experience of drugs, particularly Class A
drugs.3 If a history of drug use were to become a
major barrier to employment, then this would
impact disproportionately on some of the most
disadvantaged young people.
2.1.2 The impact on work
Over a third of respondents to the British Crime
Survey 2002–2003 reported that they had used
an illicit drug.  More than a quarter of 16 to 24
year olds said that they had done so in the
previous year. These are striking findings. But
do they show that drug misuse is having a
significant impact in the workplace and should
therefore be a matter of serious concern to
employers?
This is certainly the message that is coming
from some leading providers of drug-testing
services. In a presentation to the IIDTW, Altrix
2 The evidence: trends and trajectories
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placed a great deal of emphasis on the scale of
the drug problem in the UK, telling the Inquiry
that its message to employers was that they
could no longer ignore evidence for a high
prevalence of illicit drug use.4
Studies like the British Crime Survey are of
limited value in assessing the real impact of
drugs in the workplace. It does not follow
because somebody has used an illicit drug at
some time in their lives – or in the previous year
or month – that this will have had a discernible
impact on their work. After all, for most people
who experiment with illicit drug use, this is no
more than a brief adolescent flirtation, which is
anyway indulged outside of work hours.
What is relevant is not so much general
prevalence data as finer-grained research that
can show the extent to which alcohol and drug
use is directly impacting on performance at work
in the UK – for example, evidence on
intoxication at work or the relation to
absenteeism. In fact, the available research, such
as it is, tends to show only that some employers
perceive alcohol and drug use to be a significant
problem.
Employers’ perceptions will not be
groundless, of course, and this sort of research is
illuminating. For example, UK-based research
conducted by Alcohol Concern, DrugScope and
Personnel Today concludes that the majority of
employers do view alcohol and drug use as a
major cause of absenteeism. Indeed, around
one-third of employers questioned for this 2001
survey said that they would actively consider
introducing drug testing because of concerns
about the impact of drug and alcohol use in the
workplace.5 Similarly, research conducted by
the Chartered Management Institute in 2003
concludes that there is a widespread perception
among employers that alcohol and drug use has
increased and that this is a source of problems
for their organisations.6
As Ross Coomber, Professor of Sociology at
the University of Plymouth, concludes in his
literature review for the IIDTW:
… the evidence for clear-cut deleterious effects
of drug use on business is equivocal. What is less
so is the belief by the business sector of the
harm that drug use, and alcohol consumption in
particular, causes to British industry.
This is not to say that there is no direct
evidence of drug and alcohol use impacting on
performance at work. Evidence to the IIDTW
suggests that some sectors of industry have
higher levels of substance use than others.7
Two small-scale surveys, conducted for the
IIDTW, suggest that drug and alcohol use is
having an impact. Of nearly 250 respondents to
a questionnaire in the Trade Union Congress’s
(TUC’s) online magazine, Hazards:
• 71 per cent said that they or someone they
knew had worked under the influence of
drugs or drink
• 58 per cent felt that they or someone they
knew had performed less effectively
because of drugs or drink.8
In 2003, the IIDTW also placed a range of
questions on drug use at work in a survey of
drug use (‘The world’s biggest drug survey’)
that appeared in MixMag, which describes itself
as ‘the world’s biggest clubbing and dance
music magazine’. Of 1,134 respondents, 22.9 per
cent said consumption of alcohol had made a
difference to their performance at work, 63.9 per
cent said that illicit drugs had done so.
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Both the TUC and MixMag surveys were
based on small, self-selecting samples, whose
responses to other questions suggest that they
were not representative of the working
population as a whole. But these findings are
interesting nonetheless.
It would be difficult for an organisation to
justify investment in a drug-testing programme
on the basis of evidence that a minority of staff
are sometimes less productive at work because
they have a hangover, or that there are a
handful of absences each year due to illicit drug
use. There are also questions about the
effectiveness of drug testing as a means of
deterring drug and alcohol use, and reducing
absenteeism. These are examined in detail in the
next chapter of this report.
But, first, it is necessary to say more about
the extensiveness of drug testing in the
workplace in modern Britain and to identify
some of the pressures that could potentially
drive future expansion.
Drugs and alcohol at work: personal
testimonies
The IIDTW was unable to talk to large
numbers of employees. However, the
commissioners felt it was important to hear
the voices of some employees in the course
of the Inquiry. Their evidence is anecdotal,
and there is no reason to assume that their
experiences are typical. But this testimony
was greatly appreciated by the
Commissioners. It provides an insight into
what is happening in some workplaces and
adds some texture to the research data. (All
names have been changed to protect the
identities of witnesses.)
James
James is a management consultant in his
mid-twenties. Asked about the use of
drugs in a City environment, he said:
… from my experience, dope is mainstream,
although it is still a minority who take drugs.
People are aware who’s using various drugs – out
of 20 friends from work, about five or six take
drugs. But they all perform at work. It shouldn’t
be about drugs, but about whether they perform.
I have friends in banking, where it’s mainly coke. I
have never seen heroin. I have seen it at parties
… people in suits doing lines of coke.
Ian
Ian has worked for London Underground
for five-and-a-half years. In the past, he
has drunk heavily at work and used drugs.
He is now undergoing treatment for drug
and alcohol abuse. Did he think that his
alcohol and drug use had an impact on his
performance? ‘I tended to work hard to
cover up’, he said, ‘maybe sometimes my
reactions were not as good as they could
be … [but] it never impacted on my
performance, that was never called into
question, but my attendance suffered. I
would take the odd day off after a heavy
session – probably not more than eight or
nine days over four years.’
John
John is a relatively high-profile chef in a
well-known restaurant. He told the Inquiry
that, in kitchens, ‘it seems socially acceptable
to take Class A drugs – cocaine, ecstasy and
ketamine – although they [i.e. young people]
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America. It also ignores the evidence that
enthusiasm for testing at work may already be
on the wane on the other side of the Atlantic.
This said, the exponential growth of drug
testing in the United States does show how
rapidly this practice can take root and expand.
Drug testing has already migrated beyond the
workplace into many North American schools,
and has done so to such an extent that it has
been claimed that it is now ‘nearly a universal
experience for American youth’ (Caulkins et al.,
2002). Home-testing kits are also widely
available. Public opinion polls in the United
States indicate that there is widespread support
for drug-testing programmes. There are
indications that this momentum is gathering
pace in the UK too. At the end of February 2004,
for example, Tony Blair announced plans to
empower head teachers to drug test children in
schools in the UK.
It has been claimed by some commentators
that drug testing at work is much more
widespread in the UK than in most other
European countries. In 2001, Dr Alain Verstraete
– from the Laboratory of Clinical Biology-
Toxicology at Ghent University Hospital,
Belgium – and Dr Anya Pierce – from Beaumont
Hospital, Dublin, Ireland – estimated that
anywhere between 220,000 and 330,000 drug
tests are carried out in Britain each year – 35 per
cent in prisons, 40 per cent in the military and 25
per cent by employers. They also report that
these tests are being handled by two major
laboratories and three smaller ones operating
across the UK (Verstraete and Pierce, 2001). A
study published by the Chartered Management
Institute in 2003, Managing the Effects of Drug and
Alcohol in the Workplace, found that 16 per cent of
all organisations made use of random testing and
Janine
A successful young woman in her late-
twenties told the IIDTW:
I can’t fall asleep until an impractically late hour
which would decrease my performance at work
the next day. Smoking [cannabis] shortens the de-
stress process … smoking is crucial to me to
cope with all the workload and hours.
2.2 Drug testing at work: prevalence and
employers’ attitudes
How widespread is workplace drug testing in
the UK?
Is there any evidence that organisations that
are not currently testing are likely to introduce
programmes in the future?
2.2.1 The background
Over the past 25 years, there has been a massive
expansion of drug testing in the United States.
The Reagan administration promoted the use of
drug testing in the mid-1980s as part of its ‘war
on drugs’ crusade, legally requiring federal
employers to test their staff.9 By the mid-1990s,
testing had spread to become ‘common
organisational practise’ in North America.10 In
Europe, it has been a different story. In part, this
is because concern about drugs at work has
tended to focus more on health and welfare, and
testing in the workplace has not generally been
viewed as a crime-reduction measure.
It has been argued that, in terms of the extent
of drug testing at work, Europe lags behind the
United States by some ten to 15 years.11 But, in
the view of the IIDTW, this wrongly assumes
that there is some sort of inevitability that
Europe will take the same path as North
36
Drugs testing in the workplace
14 per cent of pre-employment testing as part of
their recruitment process. This rose to 59 per cent
for the uniformed and emergency services, and
53 per cent in transport industries.12 This study
was based on self-completion questionnaires that
were sent out to a nationally representative
sample of 4,000 CMI members in September
2002. This sample was drawn from all
management levels, sectors and sizes of
organisation. The CMI received 670 completed
questionnaires, a response rate of 17 per cent.
Ross Coomber concludes, in his literature
review for the IIDTW, that ‘drug testing may be
(slowly) on the increase in the UK’ (and ‘this
appears to be coinciding with a period where
drug testing in the United States has shown
slight declines’).
As the findings of the Chartered Management
Institute survey suggest, drug testing in the UK
has been overwhelmingly concentrated in safety-
critical industries. This largely reflects the legal
requirements of the Transport and Works Act
1992, and employers’ concerns about their health
and safety responsibilities. The IIDTW spoke to a
large number of organisations running drug-
testing programmes; the overwhelming majority
did so for health and safety reasons (see box).
A sample of the evidence from British
companies testing for drugs and alcohol
The Inquiry heard evidence from a
number of British companies that use drug
testing. They are predominantly in the
‘safety-critical’ category.
• British Energy is testing pre-
employment, ‘for cause’ and on an
unannounced random basis.
• UK Coal is testing at pre-employment
stage and intends to introduce testing
post-incident.
• Foster Yeoman – a large quarrying
business – is testing pre-employment,
‘for cause’, post-accident, random and
‘follow up’ (i.e. after an employee has
requested help).
• Seaboard plc is testing pre-employment
and ‘for cause’, and safety-critical staff
are tested post-incident.
• Southern Water is testing pre-
employment and ‘for cause’.
• Transco retains the right to screen
applicants pre-employment, but has
never done so in practice.
• London Underground tests pre-
employment, on promotion and where
an employee is transferred from one
area to another, and randomly for
safety-critical roles.
• Rolls-Royce plc tests pre-employment and
‘for cause’, and conducts random testing
if required for the Federal Aviation
Authority or Ministry of Defence.
• The United Kingdom Atomic Energy
Authority tests pre-employment, ‘for
cause’ and random.
• Stagecoach – the bus and coach operators
– tests both pre-employment and at
random.
• BT tests only people working trackside
on the railways, before they are
deployed trackside and then on a
random basis. This is a tiny proportion
of its workforce.
• Citigroup states in employees’ contracts
that they can be tested at any time.(continued)
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health and safety concerns (mentioned by 20 per
cent). Other reasons given for not considering
testing included: costs, lack of knowledge on
how to go about it and a belief that it impinges
on employees’ human rights.
Only 1 per cent of the businesses said they
had been approached by organisations
promoting drug- and/or alcohol-testing
products in the previous year.
The vast majority of businesses interviewed
for this MORI poll were not testing for drugs
and/or alcohol, nor did the majority of
interviewees think that their organisations were
likely to introduce testing in the near future. But
it would be wrong to conclude that this poll
rules out a significant expansion of drug testing
in the UK over the next five to ten years.
In particular, the majority of employers said
that they would be more likely to consider the
introduction of drug testing if certain conditions
were met:
• 78 per cent said that they would be more
likely to test if they believed that the use
of drugs or alcohol was affecting staff
performance/productivity
• 72 per cent if they believed drug and
alcohol use was prevalent within the
workforce
• 61 per cent if they believed it was
prevalent in their sector or industry
• 89 per cent if it affected health and safety
• 94 per cent if it was an insurance
requirement
• 96 per cent if it was a legal requirement
(that is, 100 per cent of companies that
were not already drug testing).
2.2.2 The MORI poll
The IIDTW commissioned a MORI poll in April
2003 to get a better overview of the current
situation and to find out about employers’
attitudes.
MORI conducted telephone interviews with
over 200 UK companies.13 The person with
overall responsibility for human resources
issues was interviewed.
The overall message from the MORI research
was that testing at work remains the exception
in the UK, but that a significant proportion of
businesses would consider drug testing if they
were persuaded of its benefits.
Three-fifths of the businesses interviewed did
not believe that drug and alcohol testing was an
issue for their sector, compared with only one-fifth
who said that it was. The remainder were either
non-committal or unable to give an answer.
The majority of businesses had a drug and
alcohol policy, but:
• only 4 per cent said that they conducted
drug tests
• a further 9 per cent said that they were
likely to introduce testing in the next year
(2 per cent said that this was ‘very likely’
and 7 per cent that it was ‘fairly likely’)
• 87 per cent said that they were unlikely to
consider testing in the coming year (31
per cent said ‘not very likely’ and 56 per
cent ‘not at all likely’).
The most common reason given for not
conducting tests was that employers didn’t
think that drug or alcohol consumption at work
was a problem for their staff (mentioned by 60
per cent) or it was not considered relevant to
their line of work because there were no serious
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It is not, of course, surprising that employers
are concerned about legal requirements; but
these findings also suggest that they are open to
persuasion and that they might change their
minds on testing. If only one in a hundred
businesses had been approached by drug-
testing companies in the previous year, then this
leaves a large potential market of businesses
that would consider drug testing if they were to
be persuaded both that drugs and alcohol abuse
is a problem for them and that drug testing
would enhance their productivity.
2.2.3 The CBI survey
The Confederation of British Industry (CBI)
distributed a questionnaire on behalf of the
IIDTW in 2003, to approximately 100 members
of its Health and Safety Panel (HSP), which was
completed and returned by 50 companies. The
HSP provides strategic direction for CBI staff on
the full range of health and safety issues.
Membership is by invitation only, and will tend
to comprise companies that have a particular
interest in health and safety issues. Over three-
quarters of respondents who completed and
returned the CBI questionnaire were from
safety-critical industries.14 Four out of five of
these organisations (80 per cent) said that they
had a drug and alcohol policy. Nearly a third (30
per cent) tested for drugs and alcohol. A further
12 per cent reported that they intended to
introduce drug testing in the future, but only
one company said that it was planning to
introduce alcohol testing.
Of the 15 companies that tested for drugs:
• all 15 tested pre-employment
• four tested systematically throughout
employment
• eight tested randomly
• seven tested voluntarily.
Of the 15 companies that tested for alcohol:
• ten tested pre-employment
• three tested systematically
• six tested randomly
• six tested voluntarily.
As regards motivation for testing: 15
companies mentioned health and safety, ten
referred to performance at work, two to their
insurance requirements and four to the legal
requirements.
With regard to insurance requirements, the
Association of British Insurers (ABI) told the
IIDTW that there were no insurance companies
with a formal underwriting policy on drug
testing and that a failure to drug test would not
affect the insurance premiums of British
companies. Representatives from the ABI told
the Commissioners that ‘insurers would never
say to the businesses they insure “we would
change your premium if you introduced a drug
and alcohol policy” … premiums go up because
a firm has accidents and claims … [it is]
impossible to link price reductions with the
implementation of a substance misuse policy’.
Pointedly, these witnesses explained that
‘insurers have far more claims that result from
simple and obvious failures on the part of the
employer to manage, train and provide safety
equipment to their workforce than for any other
reason. There is no evidence of a trend of claims
for drug and alcohol abuse’.
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2.2.4 Small business – the dog that didn’t
bark
The IIDTW was advised that small businesses
often had very different attitudes and
experiences to larger organisations, and that this
was likely to be true of drug testing also. The
Inquiry arranged for a questionnaire to be sent
out to all members of the Federation of Small
Businesses (FSB). This elicited no replies. The
FSB reassured the Commissioners that a low
response rate was not unusual because small
businesses tend to be preoccupied with day-to-
day management, and have very little time or
capacity to devote to wider issues like drug
testing. The IIDTW feels that the lack of any
responses to the FSB questionnaire is a
significant finding in its own right. It suggests
that small businesses do not regard drug use
among their employees as a serious problem, or
see drug testing as a priority for them.
2.2.5 Conclusion
Overall,the picture is somewhat confusing.
The 2003 MORI poll for the IIDTW found
that 4 per cent of businesses were testing for
drugs and alcohol. The CBI Survey says 30 per
cent. And research for the Chartered
Management Institute (CMI), also conducted in
2003, found that 16 per cent of organisations
were conducting random testing and 14 per cent
were doing pre-employment testing. To further
confuse matters, no fewer than 41 per cent of
respondents to the MixMag survey said that
they had been tested at work, including 24 per
cent who said that they had been tested as part
of the selection procedure for their current job.
And 48 per cent of respondents to the TUC
online survey said that their employers tested
for drugs or alcohol, with 14 per cent saying
that they – or someone they knew – had lost
their job as a result of a drug test.
The high incidence of testing reported by
respondents to the MixMag and the TUC
surveys is not all that difficult to explain. The
samples were self-selecting, and it is a
reasonable supposition that people with direct
experience of drug testing are much more likely
to take the time to complete a questionnaire. But
these findings should not be dismissed entirely.
First, they confirm that there are significant
numbers of people who have first-hand
experience of drug testing in the workplace.
Second, they suggest that drug testing at work
is a concern for employees – at least, to the
extent that a significant number will take the
time to respond voluntarily to these kind of
survey questions. Nonetheless, it is clear from
looking at these two sets of findings that the
respondents are not representative.
There is also an obvious explanation for the
fact that both the CBI survey and the CMI
research found a significantly higher proportion
of organisations drug testing than the MORI poll
did. Companies that were drug testing – or were
considering doing so – would be more likely to
respond to the CBI survey than those that were
not doing so. In addition, and relatedly, no fewer
than three-quarters of respondents to the CBI
survey were working in safety-critical areas. A
similar point applies to the research by the CMI.
A high proportion of respondents were from the
uniformed, emergency and transport services. In
these safety-critical professions, the incidence of
testing will be much higher than in other
businesses.
All in all, these surveys suggest that a
significant number of UK businesses in safety-
critical sectors are testing for drugs and/or
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alcohol. But overall the proportion might
nonetheless seem quite low – at least on the
MORI poll sample. However, even if only 4 per
cent of all businesses are drug testing, then this
is affecting hundreds of thousands of
employees. Many organisations that are testing
are exceptionally large businesses with lots of
employees. Furthermore, if the 9 per cent of
respondents who told the MORI researchers
that they were likely to introduce drug tests in
the next year were to do so, this would treble the
proportion of businesses conducting tests in a
single 12-month period, bringing the total to
more than one in ten of all businesses.
Ultimately, however, the reality is that there is a
shortage of reliable data on drug testing at
work, and that further research and monitoring
will be needed to measure these trends.
2.3 What kinds of tests are used by UK
employers?
The IIDTW found that, where UK employers do
test for alcohol or drugs, they do so for a variety
of reasons and in a variety of ways. Some test
pre-employment, others ‘for cause’ and others
at random. These different kinds of drug test
can be combined in a variety of ways.
Organisations also differ in the way that drug
testing is implemented – for example, who is
tested – and in their protocols for dealing with
test results. Of particular importance, there is a
distinction between the use of drug testing in
safety-critical industries on the one hand, and
testing in environments in which there are not
the same health and safety concerns on the
other.
The IIDTW was told, for example, that some
organisations that drug test prospective
employees as part of their recruitment
procedures will not inform candidates that
testing for drugs will be part of the pre-
employment medical. But other organisations,
such as Rolls-Royce plc, will inform applicants
that drug testing is part of the recruitment
process in advance, in order to ‘give them an
opportunity to behave responsibly’. Different
organisations may also deal with a positive
result at the pre-employment stage in different
ways. Most organisations will not employ an
applicant who tests positive because of a
general concern about ‘drug users’. But the
IIDTW heard from UK Coal that it allows an
applicant who tests positive to reapply six
months later.
Similarly, the IIDTW heard from a number of
companies that said that they test ‘for cause’ in
cases where an employee’s behaviour gives rise
to a suspicion that they are under the influence
of alcohol or drugs. But other organisations
explained that they regarded unsatisfactory
behaviour or poor performance, whatever its
cause, as a management issue to be dealt with
through normal disciplinary process, rather
than an occasion for drug testing.
The IIDTW talked to companies that test on
a random basis. But, again, this form of testing
is implemented in a variety of ways. An
organisation may decide to test 1 per cent, 5 per
cent or even 25 per cent of its workforce.
Quarrying and some offshore drilling
companies told the IIDTW that they conduct
random drug tests on all staff, regardless of
seniority or the safety-critical nature of their
role.15 But other organisations – for example,
London Underground – test only those who are
involved in ‘safety-critical’ work (as they define
it).
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In addition, different organisations test for
different substances. The IIDTW found that
most organisations that undertake drug testing
will test for cannabis, amphetamines, ecstasy,
cocaine and opiates. But there are important
differences from industry to industry. The bus
and coach operator Stagecoach, for example,
told the Inquiry that it invariably screens for
cannabis, but that every employee is also asked
to take a second test ‘blind’, which screens for
one other commonly used substance. A minority
of organisations – particularly in the transport
industry – also use breathalysers to test for
alcohol. But the IIDTW found that this is
uncommon in other sectors – in part, because
employers feel that they can recognise whether
employees are working under the influence of
alcohol or not, without resorting to testing.
Finally, the IIDTW has revealed some
significant differences in the way that different
organisations respond to those employees who
declare that they have a drug or alcohol
problem. Some larger organisations provided a
range of services to staff who came forward in
this way. Employees with drug or alcohol
problems might, for example, be taken off
safety-critical work and given other things to
do. Some organisations can also arrange for
employees to have a comprehensive needs
assessment and counselling (either in-house or
bought-in), and may even support staff through
treatment, including residential programmes.
Generally speaking, employees who
subsequently come back to work will be
regularly and (relatively) frequently tested for a
period of time.
Typically, the policies of these organisations
state that, if employees come forward, they will
not be victimised. Staff whose drug use is
uncovered as a result of a positive drug test may
be dealt with less sympathetically. But this is not
invariably so. In particular, British Energy told
the IIDTW that an employee who tested positive
would be likely to be removed from safety-
critical work and subjected to close monitoring
with support on an ongoing basis, but would
not necessarily face dismissal.16
It is important, then, to be aware of the wide
variety of drug-testing regimes that are operated
by employers, as well as simply the extent of
drug testing in the UK.
2.4 Pressures for expansion
To conclude this section, the IIDTW believes
that the polling evidence shows that a major
expansion of drug testing at work in the UK –
while far from inevitable – is a genuine
possibility.
The signs are there.
First, while the social and political situation
in the UK today is, of course, very different from
that in the United States back in the 1980s and
1990s, the American experience does show how
rapidly drug testing at work can expand.
Strongly promoted by the Reagan
administration from the mid-1980s as part and
parcel of its ‘war against drugs’ – but also as a
response to a number of high-profile accidents –
workplace testing in the United States has
extended from environments where safety is
paramount to those with low safety concerns.
Pre-employment testing has become routine in
almost every occupational area. Peter Francis,
Senior Lecturer in Criminology and Sociology at
the University of Northumbria, has estimated
that 40 to 50 per cent of all companies in the
United States are now drug testing. A recent
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review suggests that something like 15 million
employees are tested annually in the United
States.17
It is notable in this context that a number of
UK companies that provided evidence to the
IIDTW had introduced drug testing partly
under the influence of developments in the
United States. British Energy, a leading nuclear
energy producer with over 5,000 employees,
told the IIDTW that it had introduced
unannounced testing after employees had
visited and worked on American sites where it
was compulsory. Rolls-Royce plc introduced
drug and alcohol testing in the UK in the early
1990s to enable the company to continue its
work with US Airfreight, because random drug
testing is a requirement of the US Federal
Aviation Authority.
Second, it is evident that more and more UK
employers – including many outside of the
safety-critical sector – are coming to see drug
misuse as a serious issue for them. This is clear,
for example, from evidence provided by senior
figures in the business world to the All-Party
Parliamentary Drug Misuse Group in July 2003.
Third, commercial incentives may also help
to drive an expansion of drug testing in the UK.
In the United States, drug testing is a multi-
billion-dollar-a-year industry.18 In 1993, it was
estimated that the manufacture of equipment
and chemicals alone was worth annually $300
million in the United States (Zwerling, 1993). In
addition, large numbers of Americans are
employed in drug testing – and related –
services providing everything from analysis of
tests, to substance misuse programmes, to ‘beat-
the-test’ services.19 Drug testing is big business.
Unsurprisingly, a growing number of
companies are promoting drug testing at work
to UK businesses. The IIDTW took evidence
from several of these businesses. It was clear
that many of them viewed the supply of drug
and alcohol services in the workplace as a
market with an enormous potential for growth.
The Inquiry’s perception was that the active
marketing efforts of the sector were beginning
to encourage a rapid expansion in workplace
testing.
The sector consists of a very disparate group
of companies and individuals. Many of them
are very responsible, working to high standards.
However, the picture is mixed. On the issue of
marketing, one or two of the companies that
gave evidence to the Inquiry made what
appeared to be inflated claims about both the
extent of alcohol and drug problems in the
workplace and the effectiveness of their own
products. For example, one drug-testing
company quoted the Health and Safety
Executive (HSE) as saying that ‘drug abuse is
responsible for 13 per cent of workplace
accidents and 64 per cent of deteriorating job
performance’. The HSE assured the Inquiry that
it had never produced such findings. The
company which provided a substantial amount
of useful material to the Inquiry, acknowledged
that the figures were incorrect and have assured
the Inquiry that they now give accurate figures.
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If drug or alcohol use is having a significant
impact on performance at work, then there will
be a prima facie case for drug testing as far as
employers are concerned. If testing prevents
accidents at work, then that looks like a good
argument in its favour in certain industries.
Employers could also be favourably inclined to
test if it raised productivity, improved
performance, reduced absenteeism or enhanced
the reputation of their company.
But is drug testing a good way of realising
any of these ends?
How effective is it in reducing workplace
accidents? Does it have a discernible effect on
absenteeism? What about productivity? And
what are the costs for employers?
Surprisingly, perhaps, the IIDTW could find
no conclusive evidence for a link between drug
use and accidents at work, other than for
alcohol. Nor was there any reliable data on the
cost effectiveness of testing. The companies that
gave evidence to the Inquiry did not appear to
have conducted cost-benefit analysis or looked
in detail at the opportunity costs of testing, by
comparing the costs with other potential health
and safety investments. An exception was a
witness from the Engineering Employers’
Federation, who explained to the IIDTW that:
… testing is not high up on the Federation’s
agenda and won’t be without evidence that drug
testing has clear benefits. There is more
detriment than good in pursuing drug testing
rather than more positive drug and alcohol
policies to help give employees a chance and
rehabilitation.
Nor was the IIDTW presented with any
conclusive evidence of the deterrent effect of
testing. The Commissioners heard of three
instances when a follow-up random testing of
the entire workforce on an oil installation in the
North Sea conducted shortly afterwards
produced a drop in positive results compared
with the original testing. Elsewhere, however,
there was a lack of compelling evidence to show
that drug testing is an effective deterrent
(although the Inquiry notes that this is very
difficult to prove one way or another).
3.1 Drug testing and safety-critical
environments
A key rationale for drug and alcohol testing in
the workplace is the danger represented by
intoxicated workers, who may place the
physical safety and even the lives of themselves
and others at risk. If drug testing is an effective
way of reducing the risk of accident in the
workplace, this is an argument in its favour. The
IIDTW has reviewed the evidence on the
relationship between testing and safety in the
workplace. It has also heard testimony from
industries where the safety of employees, and
often the public too, is a matter of day-to-day
concern – including transport, the nuclear
industry, coal mining and quarrying.
The safety point was well made by a
representative from a large quarrying business
in his evidence to the Inquiry.1 The IIDTW was
told that quarrying operations would continue
in all weather conditions – and often in
darkness – using massive equipment and
transportation. This witness told the IIDTW that
‘it is a gut feeling that, not so much drugs, as
alcohol has been one of the main contributing
factors’ to workplace accidents in the quarrying
industry. The Inquiry was told that quarrying
had been one of the most dangerous industries
3 The evidence: costs and benefits
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up until about ten years ago, but a whole raft of
safety features had been initiated, and serious
injury and mortality have steeply declined. This
demonstrates the importance of a holistic
approach to health and safety in these kinds of
industries. Drug testing can have – at most –
only a subsidiary role, and it is extremely
difficult to assess the incremental impact of
testing where it is operating alongside a range
of other health and safety measures.2
3.1.1 The relationship between drugs and
safety at work
Common sense suggests that intoxication
increases the risk of accident at work.
But the reality is more complicated.
Taken as a whole, the available research
suggests that the relationship between drug use
and workplace accident is more complex and
less definite than is widely assumed.
In 1993, a review of the findings of a number
of key research studies on alcohol consumption
and injury at work came to a surprising
conclusion (Zwerling, 1993). Unsurprisingly, the
research found that alcohol use among drivers of
heavy goods vehicles increased the risk of fatal
accident. However, these studies did not show
conclusively that drinking was associated with
more occupational injury overall. Some of the
studies could find little or no general relationship
between drinking and non-fatal accidents.
The same study looked at the research on
illicit drug use and occupational injury.
Unfortunately, there is a shortage of reputable
work in this area. This is partly because standard
tests for drugs cannot show whether or not
somebody was actually intoxicated at the time the
test was conducted. However, the research that
was available in the early 1990s suggested that
the use of illegal drugs was only weakly related
to accidents at work. There was some evidence of
a relationship between the use of stimulants
(such as cocaine and amphetamines) and fatal
accidents in the heavy trucking industry.3 But,
when it came to non-fatal accidents, the author of
this review concluded that ‘there is little evidence
of an association between drug use and non-fatal
injuries’ (Zwerling, 1993).
This conclusion was supported by the US
National Academy of Sciences in 1994 in Under
the Influence? Drugs and the American Workforce.
This report found no ‘clear evidence of the
deleterious effects of drugs other than alcohol on
safety and other job performance indicators’
(Normand et al., 1994).
3.1.2 A note of caution
This is a controversial area and the IIDTW has
found it hard to get clear and definite answers
from witnesses. A literature review by the Health
and Safety Executive (HSE) reports that ‘five
studies have found some association between
drug use and workplace accidents, whereas
seven others have found little or no evidence’.
Because of the paucity of good information, the
HSE commissioned research by academics at
Cardiff University, which was published while
the IIDTW’s report was in draft (see box at the
end of this section). This research suggests only
that ‘recreational drug use may reduce
performance, efficiency and safety at work’.
The evidence is inconclusive (Beswick et al.,
2002). Aside from this, the IIDTW would stress
three key points.
1 It is not acceptable, as a general rule, for
employees in safety-critical roles to be
intoxicated at work. Nor is it acceptable for
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employers to turn a blind eye if this is
happening.
2 Safety concerns do not neatly map onto
wider perceptions of the relative harmfulness
or social acceptability of different psycho-
active substances – or indeed to their legality.
Alcohol may pose more threat to workplace
safety in contemporary Britain than, say,
cannabis or cocaine. Prescription and over-
the-counter drugs may have problematic side
effects too. Companies working in safety-
critical environments need to be aware of the
problems associated with licit drugs, as well
as illicit ones. This point was explicitly made
by Transco’s Senior Medical Officer in his
evidence. For Transco, he explained, any
problems of impairment at work were more
likely to be with alcohol or prescription
drugs given the age profile of its workforce.4
3 Intoxication at work is a source of risk in
safety-critical environments, but it is not the
only source of risk. Policy makers should
not become fixated on intoxication at work
and neglect other factors. As one
commentator argues: ‘many job injuries
stem directly from the workplace itself.
Dangerous working conditions, noise and
dirt on the job, and conflicts at work appear
to be the greatest predictors of job injuries.
Sleeping problems, which may be
exacerbated by shift work, also seem likely
to be another direct cause of job injuries …
Accident-prevention programmes might be
more effective in focusing efforts on
reducing the influence of these factors
rather than illicit drug use’ (MacDonald,
1995).
Drug and alcohol policy is one key aspect of
good employment practice in safety-critical
industries, but it is not the only aspect. As Ross
Coomber explained in his review for the IIDTW:
… one point which most expert commentators,
informed testing protagonists, labour
organisations and unions agree on is that where
drug and alcohol testing programmes are
introduced or already exist they should form part
of a comprehensive drug and alcohol policy or
programme, not exist in isolation.
The latest research
In 2004, the Health and Safety Executive
published a research report on the
relationship between drug use and
accidents in the workplace entitled The
Scale and Impact of Illicit Drug Use by
Workers. The research was conducted in
South Wales and took the form of a
community-based questionnaire survey
and a cohort study of workers carrying out
cognitive performance tasks. Overall,
30,000 individuals in Cardiff and Merthyr
Tydfil were randomly selected to receive
the questionnaire, with 7,979 people
completing the survey, of whom 4,620 (58
per cent) were currently in employment.
Data was also collected from Accident and
Emergency Units across Wales and there
was a survey of college students. In total,
54 people undertook to carry out the
cognitive performance task, 44 participants
had used drugs in the week of the study
and ten had not done so.
(continued overleaf)
46
Drugs testing in the workplace
The principal findings are outlined below.
• Thirteen per cent of working
respondents reported drug use in the
previous year, including 29 per cent of
those under 30.
• Drug use does have an impact on
cognitive performance, but this varies
depending on the type of drug or drugs
used.
• There is an association between drugs
and minor injuries among those who
are also experiencing other minor injury
risk factors.
• There was no association between drug
use and workplace accidents, though
associations did exist between (a)
cannabis only use and work-related
road traffic accidents among those also
reporting higher levels of other
associated risk factors, and (b) drug use
and non-work accidents among those
who are also experiencing high levels of
other risk factors.
• The lack of association with work
accidents may be because: no
association exists; the number of
accidents was too small for a signficant
association to be detected; accidents
were not restricted to those resulting
from the individual’s own error; at
work, individuals are in familiar
situations, doing familiar tasks from
which as much risk as possible has been
eliminated and are less likely to be
experiencing the acute effects of drug
use.
It is concluded that, ‘overall, the present
project has shown that recreational drug
use may reduce performance efficiency
and safety at work’.
(The Scale and Impact of Illegal Drug Use by
Workers, by Andy Smith, Emma
Wadsworth, Susanna Moss and Sharon
Simpson of the Centre for Occupational
and Health Psychology at Cardiff
University, is available from the Health
and Safety Executive, and is at
www.hse.gov.uk/research)
(continued)
3.1.3 The role of testing
Responsible employers should adopt sensible
policies to minimise the risks to health and
safety as a result of intoxication at work.
Employers who gave evidence to the IIDTW
took their duty of care for the health and safety
of their staff very seriously. According to the
MORI poll conducted for the IIDTW, 89 per cent
of employers who were not already testing for
drugs said they would consider doing so if they
believed that this would have a positive impact
on the health and safety of employees. But is
drug testing a good way of detecting and
deterring employees from coming to work in a
state of intoxication? And is this the best way of
addressing this problem?
A literature review prepared for the IIDTW
by Peter Francis and colleagues at Northumbria
University (Francis et al., 2003) stressed that ‘too
few empirical studies on the effectiveness of
workforce alcohol and drug testing exist to
conclude that it reduces employee health and
safety problems’. Another recent review of
evidence on links between drug testing and
47
The evidence: costs and benefits
workplace injury concludes that both
mandatory random and ‘for cause’ testing have
only ‘very limited’ impact on accidents at
work.5 As Peter Francis and colleagues state:
… the majority of research studies fail to take
account of the possible and actual effects of non-
drug-testing factors (such as increased employee
training, superior capital equipment and better
management and supervisory arrangements) in
reducing employee and employer risk.
Furthermore, it is possible that drug testing
may have a negative impact on health and
safety, at least at the margins and in some
circumstances. For example, Southern Water
told the IIDTW that it had found that the
introduction of a strict policy of drug testing
following any incident that resulted in one or
more days off work had the unintended and
perverse consequence that routine and more
minor accidents were not being reported at all
for fear of triggering testing procedures.
Witnesses from Southern Water told the
Commissioners that this had resulted in an
instance of chronic ill-health (a back problem)
not being identified and dealt with. Once this
unexpected effect was identified, Southern
Water changed the testing policy as soon as it
could.
Nor does drug testing measure impairment as
such. To repeat, drug tests – with the notable
exception of alcohol breath tests – reveal only
that a drug or its metabolite is present in an
individual’s body. Tests are unable to show
whether or not someone is actually intoxicated,
or to provide a reliable indication of impairment
levels, or to reveal whether an individual is an
addict or a regular, irregular or one-off user.
This does not mean that drug and alcohol
testing cannot have a useful role in safety-
critical industries. It does mean, however, that
this role will be limited, and that organisations
need to know how to interpret positive results
and how to act appropriately.
It might be concluded that it would be better
for safety purposes if it were possible to test
directly for impairment (that is, fitness for work)
rather than to do this indirectly by testing for the
presence of drugs and metabolites in the human
body – especially as this is a very unreliable
guide to intoxication. Various methods of
impairment testing are being developed (see
box). Potentially, these tests could provide a
more effective measure of impairment at work,
while, at the same time, avoiding the
invasiveness of traditional drug and alcohol
tests. As one commentator has put the point,
impairment testing looks directly at fitness to
work – a legitimate concern for employers – and
not at ‘lifestyle’.
Impairment testing
It was outside the remit of the IIDTW to
assess in any detail the effectiveness of
impairment testing, but the Inquiry
believes, at least in principle, that this
could provide a possible alternative to
drug and alcohol testing with a number of
advantages. Ross Coomber, Principal
Lecturer in Sociology at the University of
Plymouth, provided the IIDTW with
information on a number of approaches to
impairment testing that are being
pioneered elsewhere in the world.
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Daily Skill Test System
Factor 1000 is a new product that is being
marketed in the United States as an
alternative to urine testing and on the
basis of what is perceived to be some
increasingly negative views of drug-
testing programmes. It is produced by
Performance Factors, which argues that
‘many employees and union leaders
believe that it [i.e. traditional drug and
alcohol testing] is inaccurate, costly and an
invasion of privacy’. By comparison, it is
claimed, ‘Factor 1000 tests whether the
worker is impaired at the time he or she is
being asked to perform a job – it doesn’t
judge off-the-job behaviour’, and it ‘is also
effective in detecting impairment from
stress and fatigue’. Essentially, this system
tests an employee’s judgement and
response time by looking at his or her
ability to manipulate a cursor on a
computer screen.
The Drug Impairment Detection System (DIDS)
Air traffic controllers in Oklahoma City in
the United States have been trialling the
DIDS system, which works in the
following way.
1 The individual takes a ‘FIT’ test, when a
controlled dose of normal light is
administered to the eye and a number
of measurements are made of the eye’s
reaction.
2 A baseline is established for each subject
by (a) ensuring he or she is drug-free at
the time that the baseline is set; and (b)
taking multiple tests to establish the
subject’s ‘PassPoint’ profile.
3 With the baseline established, the
measurements from subsequent tests
are compared to the ‘PassPoint’ profile.
4 If impairment is identified, ‘PassPoint’
can recommend a confirmatory test and
suggest which drugs are tested for.
(For a more detailed discussion of DIDS,
see Details on FIT PassPoint Substance Abuse
Monitor at www.pmifit.com [PMI, 2003])
OSPAT
This impairment monitoring system is
being tried out by coal miners in Australia.
Again, workers are required to undertake
a simple exercise on a computer before
starting their shift. A series of exercises are
undertaken by each worker when the
system is installed to establish a base line
against which reactions are subsequently
measured.
(continued)
3.1.4 The evidence of employers to the
IIDTW
The IIDTW heard evidence from a number of
UK employers working in safety-critical
industries. These witnesses enabled the Inquiry
to explore further some of the key themes from
the literature.
Four points that emerged from the evidence
of these employers are of particular relevance in
this context.
First, the majority of employers in safety-
critical industries who provided evidence to the
IIDTW felt that drug misuse at work was not a
serious or widespread problem for their
companies.
For example, Rolls-Royce plc told the
Inquiry that, in the early 1990s, they had
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instituted pre-employment testing of all
prospective employees applying for repair jobs
and extensive random testing of existing
employees involved in the repair of aircraft
engines. This was done for business reasons,
given Rolls-Royce plc’s involvement with US
companies.6 By 1998, Rolls-Royce plc had
conducted approaching 1,000 tests. Not one of
these was positive. It told the IIDTW that
random testing is now only carried out when
this is specifically required by the US Federal
Aviation Authority or the Ministry of Defence. A
witness from Rolls-Royce plc told the IIDTW
‘we felt there wasn’t enough evidence from the
performance, health and safety aspects to
actually say we wanted to introduce random
testing for the whole workforce’.
The United Kingdom Atomic Energy
Authority (UKAEA) had a very similar message
for the IIDTW. A witness explained:
… we’ve now done getting on for three years [of
testing] and we pretty well confirmed that we
don’t have a problem. We’ve done nearly 2,000
tests, 1,300 were pre-employment, and we are
quite surprised at how few of these came up …
out of the 1,300 we’ve only had 11 positives …
and we’ve [also] done 407 tests on UKAEA staff
and we’ve had two positives. All except for one
of all of those has been for cannabis.
Similarly, the quarrying company, Foster
Yeoman, told the Inquiry that it had introduced
a comprehensive drug and alcohol policy in
November 2001, with provision for drug testing
pre-employment, for cause, post-accident,
random and as a follow-up where an employer
has come forward for help. In this time, there
had been only 12 positive tests. Six were found
to be a result of (licit) medication, five detected
cannabis and one detected cannabis and
benzodiazepines.
One or two companies, it should be noted,
were more concerned about drugs, with this
often relating to wider economic, social and
demographic trends. A witness from UK Coal
felt that there was likely to be illicit drug use
among some employees, as some of the mines
were in areas that are renowned for drug
problems. This seems to have been borne out by
the company’s experience of testing. Between
March and November 2003, the Inquiry was
told that UK Coal had carried out 171 pre-
employment tests. Over 5 per cent were positive
even though applicants were told that they
would be screened for drugs and alcohol as part
of the recruitment process. But this appears to
be the exception not the rule.
Second, many of the UK employers in safety-
critical industries who took the time to provide
evidence to the IIDTW stressed the importance
of fairness and transparency.
An obvious issue here is whether or not
testing should be restricted to staff whose role
has a direct and obvious health and safety
aspect or whether it should be carried out more
widely within these industries. For example,
British Energy told the IIDTW that all
employees at every level of seniority within the
organisation are tested as part of the pre-
employment selection process, and could be
subject to random testing as employees. This
was at the request of the trade unions, but it was
also believed to be a good way of demonstrating
to staff that the company took the responsibility
of managers for staff welfare seriously. A
witness from British Energy explained:
‘everyone can be tested, including
administrative staff. Because … they’re all
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contributing to the safety of the whole.’
Third, even in safety-critical environments,
drug testing could be divisive and
counterproductive if it was clumsily handled or
inappropriate.
SeeBoard plc said that it had made the
decision not to introduce random testing for all
staff, in part because it feared that this would
damage industrial relations. A witness from
SeeBoard explained that ‘testing is very
unpleasant, and it’s my job to look after the
health and safety of staff, and not to police
them’.7
Similarly, in its evidence, Southern Water
told the IIDTW that it felt that it would be
unlikely to test widely for drugs or alcohol in
future, as ‘it did that much harm, [we] would
want very good evidence before carrying out
any [further] testing’. The witness explained
that those who had been drug tested by the
company had reacted negatively, that it was
expensive and that there was no added value to
the company. He concluded that he would
prefer to focus on good day-to-day management
of staff than on drug testing.
This point was made by a number of
witnesses from the safety-critical industries who
provided evidence to the IIDTW. For example, a
witness from Transco, the gas supplier, said that
the majority of health and safety incidents were
caused by a general failure of the application of
management systems and that high quality
management made drug testing less of an issue.
‘Managers need to be trained in what testing
can and can’t do’, he concluded.
Fourth, a number of safety-critical
employers who gave evidence emphasised the
need for welfare and support services for staff
with alcohol or drug problems.
For example, London Underground has a
‘tough’ policy on alcohol and drugs, not least
because of concerns about the requirements of
the Transport and Works Act 1992. Its policy is
believed to be one of the most comprehensive
and stringent in the UK.
It states that ‘all employees are required not
to consume or use illegal drugs at any time,
whether on duty or not, so as to ensure they are
not under their influence when reporting for
duty, carrying out work for the company or
when on company premises’. Employees are not
allowed to buy alcohol while in uniform, and
they are responsible for ensuring that their
performance is not impaired by prescribed or
over-the-counter medication.8
But London Underground stressed to the
IIDTW that it has a strong commitment to staff
welfare in this area. If an employee comes
forward with an alcohol or drug problem, then
he or she may be taken off duty, assessed for
treatment and supported ‘within reason’. The
IIDTW spoke to one London Underground
employee who had been taken off duty for nine
months while he underwent a programme of
treatment. (It is a different story if staff declare
that they have a problem only when confronted
with a test or testing positive. In these
circumstances, they can face disciplinary action
which is very likely to lead to immediate
dismissal.)
The President of the Police Superintendents’
Association also stressed the need for a
supportive and welfare-orientated approach in
his evidence to the IIDTW. He commented that
the police force would tend to reflect:
… what goes on in society generally, given the
age group we are recruiting from … if there is
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habitual use of recreational drugs by people
outside the service … [it simply flies in the face of
reality to think that] drugs will suddenly disappear
[inside the police service].
Police officers can be involved in a range of
safety-critical tasks, including driving at high
speeds through built-up areas and handling
firearms. But there is also a special issue about
the use of illegal drugs by police officers. The
public will not have faith in police officers who
are breaking the law, and ‘where an officer … is
buying illegal substances, they … [may be] …
vulnerable to corruption, because they can be
blackmailed’. But, as he also proceeded to
argue, drug and alcohol use among police
officers is about workplace stress and health, as
much as detection and discipline. ‘Police
personnel are put through some pretty stressful
things and they are not given counselling on
every occasion’, he explained, ‘the force has a
responsibility to make sure they are looked
after. It is not just a case of testing them and
convicting them. [We are also proposing that]
there are programmes there to help them and to
treat them.’
These comments raise much wider issues
about society’s attitudes to people who develop
serious substance misuse problems. The IIDTW
heard from a number of employers who were
committed to supporting employees with drug
and alcohol problems. But lawyers working in
the employment field told the Commissioners
that employees could be extremely reluctant to
come forward for help. Some fear that they may
be victimised and some workplaces have a
culture in which admitting to this kind of
problem is regarded as a display of weakness.
The IIDTW was told that, in reality, it is very
rare for employees to come forward on a
voluntary basis. Where they come forward at
all, this is almost always precipitated by a crisis
– often because someone is convinced that their
substance problem is about to be exposed
anyway. This all raises some wider questions
about contemporary working cultures and our
attitudes to those who develop drug and alcohol
problems.
The issues about the quality of management
systems and the role of support and welfare
services are considered in the conclusion to this
chapter. But, first, what about the other
justifications for drug and alcohol testing?
3.2 Other rationales for drug testing: the
evidence
Ten of the 50 companies that took part in the
CBI survey conducted for the IIDTW said that
their principal motivation for drug testing was
to enhance performance at work, compared to
15 who said that their primary concern was
health and safety. Over three-quarters of
businesses responding to the MORI poll said
that their decisions about introducing drug and
alcohol testing would be influenced if they
believed that substance use was affecting staff
performance or productivity.
Some serious questions can be raised about
the effectiveness of drug and alcohol testing as a
way of reducing injury and death in safety-
critical environments. But nobody would
question the legitimacy of these ends in
themselves. In the safety-critical industries,
there is a prima facie case for alcohol and drug
testing, although much of the evidence
presented to the IIDTW throws doubt on how
substantial the real benefits are. Significantly,
however, 50 per cent of employers responding
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to the IIDTW’s MORI Poll did not think that
drug and alcohol testing should apply only to
health-and-safety-critical organisations.9
Obviously, employers have a legitimate
interest in staff performance, beyond health and
safety. But a range of legal, ethical and social
questions now arise about the extent to which
organisations can and should regulate the
private lives of employees. These issues have
been examined in depth elsewhere in this report
(see Chapter 2). This section looks at a number
of more practical questions. Most importantly,
does drug or alcohol use actually have a
significant impact on performance at work?
And, be this as it may, is there any evidence that
drug testing is an effective way of improving
performance?
3.2.1 Absenteeism
A number of empirical studies have found that
problem drinkers and illicit drug users tend to
be absent from work more often than their
colleagues. In their evidence to the IIDTW, Peter
Francis and colleagues at the University of
Northumbria detail the findings of a long
succession of research studies – mainly, but not
exclusively, from the United States – that
conclude that there is a discernible relationship
between drug and alcohol use and absenteeism.
The literature review prepared for the
IIDTW by Ross Coomber, Principal Lecturer in
Sociology at University of Plymouth, casts
doubt on the veracity of these findings.10 In
particular, he points out that the research has
often failed to take account of other relevant
factors that might influence rates of absenteeism
– such as age, gender, ethnicity and
occupational stress.11 He also notes that there
are some other research studies that have
concluded that there is little difference between
drug users and non-drug users in their rates of
absenteeism.12
Coomber proceeds to discuss a major review
that was conducted in the 1990s and found ‘a
small but noticeable proportion of work
problems are associated with alcohol and/or
drug use’, but concluded that it was difficult ‘to
draw firm conclusions about either the extent of
work-related problems associated with
employee substance use or any causal role that
substance use plays in the emergence of those
problems’ (Hanson, 1993). Another –
contemporaneous – review concluded that there
was ‘a weak association between a positive
employment drug screen and the adverse
employment outcomes of absenteeism, injuries,
accidents and turn-over’, adding ‘the evidence
is strongest for absenteeism’ (Zwerling and
Ryan, 1992).
Significantly, some of the research suggests
that rates of absenteeism may be higher for
problem drinkers than for illicit drug users. A
major review, conducted in the mid-1990s,
looked at the international research, including
studies from the United States, France, Sweden,
Australia and the United Kingdom. It
concluded that there was an association
between high rates of absenteeism and alcohol
consumption – and, in particular, that
‘absenteeism seems to be a marked
characteristic of problem drinkers’. The authors
conclude that rates of absence for problem
drinkers are anywhere between two and eight
times as high as for non-problem drinkers, and
argue that this finding is robust cross-nationally
(Martin et al., 1994). This is in line with the
findings of a research study that was conducted
in the 1960s.
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There is reputable evidence that absence
rates are higher among problem drinkers.
Overall, however, the research on the links
between drug use and absenteeism is
inconclusive. Perhaps the most that can be said
is that there is some evidence for a weak
relationship.
3.2.2 Turnover
The IIDTW was told that there is some evidence
from the United States for a relationship
between illicit drug use on the one hand and, on
the other, a higher risk of being dismissed from
or voluntarily leaving a job.13 The Inquiry’s
view is that this evidence should be treated with
caution, particularly given the probable impact
of a range of other demographic variables on
staff turnover. It is likely, for example, that
young employees are more inclined both to use
drugs and to move from job to job.
3.2.3 Performance and productivity
The story on performance is much the same as
for absenteeism.
A report by the Health and Safety
Laboratory at Sheffield explains that there is
‘conflicting evidence about the effect of illicit
drugs on productivity’ (Beswick et al., 2002).
Another major review of the literature
concludes that there is ‘insufficient evidence
that … illicit drug consumption is responsible
for lowering labour productivity and work
performance’.14 And Peter Francis and his
colleagues told the IIDTW that ‘at best it can be
suggested that there is conflicting evidence as to
the relationship between alcohol and illicit drug
use … and performance’.
The recent report for the All-Party
Parliamentary Drug Misuse Group, Drug Testing
on Trial (All-Party Parliamentary Drug Misuse
Group, 2003), cites the 1996 annual survey of the
American Management Association. This
survey asked corporations that had introduced
drug testing about its effectiveness in terms of
absenteesism/illness, disability claims, accident
rates, incidents of employee theft and incidents
of employee violence. The All-Party Group
reports that:
… none of the … indicators had a percentage
increase above single digits answering ‘yes’ and
only eight per cent of companies performed any
cost benefit analysis of their drug testing
programmes.15
To summarise, and as in the case of
absenteeism, the common assumption that drug
and alcohol use will have a major impact on
productivity and performance at work is not
well supported by the evidence.
Furthermore, and yet again, if there are
grounds for concern about performance, they do
not necessarily relate to those drugs that are of
greatest concern to society. For example, an
important review of the literature could find no
evidence that marijuana use has a negative
impact on performance at work.16 But there is
research that suggests that there is a significant
relationship between declining productivity and
alcohol use, especially alcohol abuse.17
3.2.4 Reputation
It is extremely difficult to assess the impact of
drug and alcohol use among employees on a
company’s reputation. A recent review of the
literature highlights the paucity of research on
the impact of drug use on the ‘broader realm of
customer and consumer relations’. From a
different perspective, a representative of the
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entertainment industry told the IIDTW that, even
though a ban on smoking had been instituted, it
could not be talked about because it would
damage the reputation of the organisation, ‘If I
tried to introduce testing, I would probably lose
my job’, he added. Different sectors clearly value
different reputations!
3.2.5 Conclusion
The best available evidence provides little
support for alarmist claims about the impact of
alcohol and drug use on absenteeism, turnover,
productivity and reputation.
The IIDTW heard some inflated claims about
the impact of drug use on performance from
one or two drug-testing companies.
Occupational health professionals have a good
understanding of drug and alcohol issues and
will generally know when the claims that are
being made for drug-testing services are
unreliable or unsubstantiated. But the IIDTW
was concerned that smaller organisations,
without specially trained staff, could be
persuaded to contract for services that they did
not need, might be sub-standard and could
damage relationships with their employees.
Given what is known about the effect of
drugs on cognition,18 it is a reasonable
assumption that intoxication will tend to affect
performance at work.
Anybody who has ever gone to work with a
hangover will know that this can affect
performance. Anyone who has ever not gone to
work with a hangover will know that it can
cause absenteeism. The same will apply to the
after-effects of many illicit drugs.
However, neither the research evidence nor
the testimony of witnesses to the IIDTW
suggests that this is actually a particularly big or
pressing issue for most organisations in the
United Kingdom.
There is evidence of a weak association
between alcohol and drug use and workplace
performance, including absenteeism and
productivity – which is strongest for alcohol.
But, in the view of the IIDTW, this is far from
being a compelling argument for alcohol or
drug testing, for at least four reasons.
1 Effectiveness: there is the issue of whether
drug testing at work works. Does it actually
reduce those forms of drug and alcohol use
that could affect performance? In his
literature review for the IIDTW, Ross
Coomber argues that it is not clear from the
evidence how effective drug testing is when
it comes to reducing drug and alcohol use.
2 Appropriateness: even if drug and alcohol
testing were effective in this sense, there
would be the wider question of its
appropriateness. The evidence suggests, for
example, that problem drinking can have a
greater impact on performance at work than
illicit drug use. But is testing the best and
most appropriate way to identify and engage
staff who are developing serious alcohol
problems?
3 Ethical issues: the leisure activities of
employees can have a negative impact on
performance at work. But employers are not
entitled to expect staff to live in such a way
that they will be maximally productive at
work. As the previous Information
Commissioner Elizabeth France has
commented: ‘employers are not enforcers of
the drug laws and must respect an
individual’s right to a private life’.19 In this
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context, the IIDTW was told that London
Underground (LU) forbids its employees
buying or consuming alcohol outside work
hours if they are in LU uniform or are
wearing any insignia identifying them as its
employees. There is a genuine public
confidence issue here, but this rule shows
the difficulties of drawing appropriate
boundaries between work and private life.
4 Costs: any performance benefits need to be
weighed against costs. As Peter Francis and
colleagues from Northumbria University
point out: ‘the introduction of workforce
drug testing, far from addressing lowered
employee productivity, may well further
negatively affect the performance and
productivity of employees. It may adversely
affect employees’ attitudes towards the
organisation, damage industrial relations
and, as a result, decrease productivity and
cut profits.’ For example, an employee
whose relationship with her employer
involves a high level of surveillance and
control may be less inclined to work
creatively and productively, and less
committed to the organisation. In this way, a
drug-testing regime could result in a
diminution, rather than an enhancement, of
productivity and performance.
The relevance of many of these points will
depend on the particular type of drug testing
that is under consideration.
A hair test as part of a pre-employment
screening may indicate the presence of drugs
that an applicant has used, some months – or
even years – earlier. A breath test could show
that a heavy goods vehicle driver has turned up
for work under the influence of alcohol.
Random testing may be adopted as a general
means of deterring staff from using drugs and
alcohol. Post-accident testing may be more a
matter of having proper procedures in place for
investigating incidents at work and ensuring
that the lessons are learnt. Unless the arguments
are to become impossibly complicated and
convoluted, it is difficult to avoid
generalisations in identifying and evaluating the
rationales for drug and alcohol testing. But it is
important, nonetheless, to keep in mind that
these are generalisations and that the
applicability of many of the arguments varies
from case to case.
3.3 More on costs
Outside of the safety-critical industries, the
benefits of drug and alcohol testing are unclear.
In addition, any benefits will need to be
balanced against a whole range of cost factors.
These include financial costs; impact on staff
morale and industrial relations (including any
negative effect of drug testing itself on
productivity and discipline); and human
resource costs (for example, where well-
qualified and able candidates fail pre-
employment drug tests).
3.3.1 Financial costs
The first, and most obvious, cost of drug testing
at work to organisations is the financial cost.
Drug-testing companies have a legitimate
business interest in seeking to persuade
employers to drug test. In the United States,
workplace testing grew, in the space of two
decades, into a multi-billion-dollar industry.
The IIDTW heard evidence from a number
of drug-testing companies that said that
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workplace testing was a major area of expansion
in the United Kingdom. For example, Tricho-
Tech – a company that specialises in hair testing
– has been conducting drug tests and analysing
the results in the United Kingdom since 1993.
While 80 per cent of Tricho-Tech’s work still
comes from the courts, a representative told the
IIDTW that it had experienced a significant
increase in demand for pre-employment
screening and workplace drug testing. This is
now the fastest growing area of Tricho-Tech’s
business. The IIDTW heard a similar story from
LGC Ltd (formerly known as the Laboratory of
the Government Chemist). Since the LGC was
privatised in 1996, the Inquiry was told, the
company as a whole has expanded from 200 to
600 employees and its total annual turnover is
approximately £50 million. A dedicated team
within the company carried out in excess of
175,000 workplace drug testing samples
annually, with a significant proportion coming
from military testing.
The cost of drug testing at work to
organisations will vary depending on the type of
testing, the numbers of employees who are being
tested and the prices charged by a particular
drug-testing company. For example, the drug
testing company Altrix told the IIDTW that it
charged between £30 and £35 for an initial
screening or test, and an additional £52 for
confirmation of a positive result.
It is important that employers know the full
costs of legally defensible tests. A witness from the
LGC explained to the Inquiry that drug testing
is a more complicated business than many
employers realise. For example, what is called
‘presumptive testing’ – where the initial body
fluid sample shows positive by a change in
colour on a dipstick – may be comparatively
cheap, but it is not legally defensible in
isolation. Samples need to be sent on to a
laboratory for proper scientific analysis
following a positive result and this will add to
the cost. The LGC witness emphasised that it is
extremely important to ensure that drug-testing
companies that are selling ‘presumptive’
products are explaining to prospective
purchasers that they need to follow up on
positive results.
A cognate issue is the accreditation of
laboratories that are carrying out drug tests. The
IIDTW heard evidence from the United
Kingdom Accreditation Service (UKAS), which
is the sole national accreditation body that is
recognised by the Government for the
assessment of laboratories, including those
providing drug testing – and related – services.
Accreditation involves UKAS assessing
adherence to European and International
standards for testing laboratories (ISO 17025).
These standards relate to testing laboratories in
general and are not specific to those carrying
out workplace drug tests. To fill this gap,
Guidelines for Legally Enforceable Workplace
Drug Testing have been developed by a steering
group representing UK analytical laboratories
and other interested parties. Laboratories
undertaking workplace drug testing are advised
to use the Guidelines as a template in applying
for accreditation. The Guidelines go beyond
questions of laboratory practices and quality
assurance to cover matters such as the dignity of
the employee from whom the sample is to be
taken, recommended cut-off levels, below which
the result of a test should be treated as negative,
and a recommendation that tests should be
performed only in the context of an established
policy on drug testing agreed between the
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employer and employees. Adherence to the
Guidelines, however, is not a condition of
accreditation. Although, as a set of rules
voluntarily adhered to, these Guidelines are the
beginning of a self-regulatory system, there is
no mechanism for monitoring or for enforcing
compliance.
In most sectors, adherence to European and
international standards is voluntary, although
legislation sometimes makes it a legal
requirement. Companies that are accredited are
permitted to advertise the fact to potential
buyers of their services with the crown mark.
This acts as a version of the ‘kite mark’. Its
efficacy in driving companies that are not
accredited from the market rests on purchasers
choosing only accredited companies.
Companies are regularly inspected and subject
to reaccreditation every four years.
UKAS has accredited approximately 1,500
laboratories, of which approximately 12 are
involved in drug testing. It told the IIDTW that it
was concerned about the number of non-
accredited bodies that were providing drug-
testing services, and that these concerns were
shared by the Department of Trade and Industry.
‘There are undoubtedly labs that are not
accredited’, the IIDTW was told, ‘they might be
very good but one cannot be sure. That is why
we recommend that people use accredited labs.’
The IIDTW was also told that the financial
cost of accreditation may be a barrier for some
organisations. For a new applicant, the cost of
initial assessment is as much as £750 per day,
with the accreditation process possibly taking
between five and seven days. Achieving
accreditation can therefore cost in the region of
£4,000 to £5,000. If successful, the laboratory is
accredited for four years, with an annual visit to
ensure that it is maintaining its systems
properly. The cost of these annual visits, and of
the reassessment visit every four years, is
charged at £524 per day, with a typical visit
costing in the region of £2,000 to £3,000. The
IIDTW believes that it is unlikely that
laboratories will submit themselves to a
voluntary accreditation process at all unless
they are fairly confident that they will be
successful, but failure to seek accreditation does
not necessarily show that there is a problem
with a laboratory, as this will often be purely a
commercial decision.
However, UKAS told the IIDTW that
customers were increasingly requiring
laboratories to hold the relevant UKAS
accreditation if they were to be awarded
contracts to analyse samples from drug tests. It
was claimed that the demand for accreditation
was increasing as industry became more aware
of the process and its benefits. This is recognised
in the Health and Safety Executive’s guidance
document for employers, which clearly
recommends that analysis should be
subcontracted to UKAS-accredited laboratories.
3.3.2 Staff morale and industrial relations
A number of businesses that gave evidence to
the IIDTW felt that drug testing had damaged
relations with their employees. For example,
Southern Water felt that testing had done ‘more
harm than good’, explaining that staff had
reacted negatively. The United Kingdom Atomic
Energy Authority said that there had been
resistance to testing at some of their sites, as
‘some were more human rights conscious than
others’. The Inquiry also heard from the trade
union representative for Amicus20 at a large
French company operating in Ulster who felt
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that the company’s testing regime had had a
very damaging impact on industrial relations,
largely as a result of the high-handed manner in
which he felt the testing programme had been
implemented. The union was concerned that
employees could be bullied, harassed and
embarrassed by the operation of this policy, and
feared that any accidents might be concealed
from supervisors by staff who were anxious
about drug tests.
As the manager of treatment services at
London Underground explained to the Inquiry,
‘no matter how good the service and the policy,
if you don’t have the buy in from the work
force, it won’t work’. If it doesn’t work, then this
will have significant cost implications for the
organisation. Along similar lines, a witness from
BT explained that it was difficult to reconcile
drug testing with the organisation’s values,
which emphasised ‘trustworthiness’.
‘Trustworthiness goes both ways, so we have to
trust our people – they’re our interface with our
customers’, the witness explained, adding: ‘to
bring in something that shows we don’t trust
them questions their honesty. It would be
counter-cultural for our organisation.’
The potential for tension between employers
and employees is confirmed by the research.
Peter Francis and his colleagues explained to the
IIDTW that:
… the research literature suggests that difference
in perspectives between employers and
employees toward drug-testing programmes can
be expressed as competing interests between
the employer’s right to a drug-free workplace and
the employee’s right to privacy. While employers
who test their respective workforces for
substance use see workforce drug testing as a
reasonable course of action, research indicates
that some employee groups, worker
organisations (including trade unions) and
researchers tend to see workforce drug-testing
programmes as intrusive and unnecessary.
Drug testing can affect the attitudes and
behaviour of employees, producing negative
attitudes towards the company and creating a
climate of suspicion, resentment and mistrust.
This will tend to have a negative impact on
turnover, absenteeism and productivity –
precisely those things that drug testing is
intended to benefit. As London Underground
explained in their evidence all drug testing
systems can be subverted, and this will be a
particular problem where they are resented by
employees.
However, the message from research is that
employees will tend to accept drug testing
where it is introduced in the right way and for
what they recognise as good reasons.
Employees’ attitudes vary significantly
depending on their assessment of the fairness of
particular drug-testing programmes.
In part, this is about procedural fairness and
transparency. Drug-testing programmes are
more likely to be acceptable to employees where
trade unions – and other worker organisations –
have been involved in their development and
implementation. In its evidence to the IIDTW,
for example, British Energy said that its policy
had been generally well received by staff, and
that it felt that this was due to its extensive
consultation with employees over a long period.
Research shows that most employees will
tend to be supportive of drug testing where they
can see that there is a clear justification – and it is
not simply about policing their behaviour. This is
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particularly true for safety-sensitive areas of
work. Reputable studies from the United States
and Canada have shown, for example, that
employees are much more favourably disposed
to ‘for cause’ testing than random testing.21 The
acceptability of testing to employees may also
depend on how extensively it is carried out
across the organisation – for example, if senior
staff are not being tested, or a particular group of
employees feel they are being ‘singled out’, this
may be a source of resentment. (The CBI survey
conducted for the IIDTW received responses
from 15 companies that tested staff for drugs. The
Inquiry was told that none of these companies
had restricted testing to particular grades or
levels of seniority and only five restricted testing
to staff with specific trades or functions.)
Drug testing will be costly for organisations
if it has a negative impact on staff morale,
commitment and motivation. These costs are
likely to be high if testing is introduced without
proper involvement of employees, and
particularly so where there is no clear
justification for testing that is acceptable to staff
themselves. As London Underground told the
IIDTW:
… it is very difficult to do drug testing well … you
have to decide why you are doing it and what you
are going to do with the results … you have to
explain to people what you are doing … where
are your policies? How can you defend what you
are doing?
3.3.3 Recruitment and human resource costs
Pre-employment drug testing is a way of
identifying candidates who have used illicit
drugs, usually with the aim of not offering jobs
to these applicants. Organisations that
randomly test employees often dismiss staff
who fail tests. The assumption that lies behind
the use of drug testing at work in these
circumstances appears to be that organisations
will perform better if they do not employ drug
users.
Is this true?
On the contrary, the exclusion of illicit drug
users may constitute a substantial cost for many
organisations. Many recreational users are
highly educated and trained people, and will
often be put off from applying for jobs if they
anticipate being tested for drugs.
Nearly three-quarters of the young people
who responded to the MixMag survey said that
they had used ecstasy in the last month (69.8 per
cent), almost two-thirds cannabis (63.1 per cent)
and approaching half cocaine (42.7 per cent). Of
this group, 30 per cent said that they had ‘A’
levels, 9.2 per cent had City and Guild
qualifications, 12 per cent diplomas, 21.4 per cent
first degrees and 4.3 per cent a higher degree.
These young people were also asked if they
would be discouraged from applying for a job if
the employer tested them for drugs. Over a
quarter (28.3 per cent) said that they would be and
over half of the remainder (41.2 per cent of the
total) that they might be. Over half of these young
clubbers said that, if their current employer
introduced drug testing, then they would be
more likely to look for work elsewhere.
The MixMag findings are supported by a
body of international research evidence that
shows that drug testing – especially pre-
employment – can have a negative impact on
recruitment. Recent developments in the United
States are salutory for British employers who
are considering testing. In 2000, the American
Civil Liberties Union was openly complaining
that testing made it harder for employers to
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attract qualified candidates.22 This problem has
been so serious in the United States that some
firms are reported to have suspended pre-
employment testing in tight labour markets.23
Employers are within their rights in taking
disciplinary action against staff who are
intoxicated, and they have a legitimate interest
in knowing whether job applicants have serious
alcohol or drug problems that might affect their
work. But, to repeat, drug tests are not an
effective measure of impairment, and people
who have used drugs months, or even years,
earlier may fail pre-employment tests. With over
a quarter of young people in Britain (28 per
cent) telling the British Crime Survey 2002–2003
that they had used illicit drugs in the last year,
the wisdom of adopting expensive testing
procedures in an attempt to exclude these illicit
drug users from employment is doubtful, given
the human resource that this represents for
employers.
3.3.4 Other costs
If businesses are not careful in their approach to
drug testing, they could also face legal action,
and all the costs that this entails for the
organisation – both financially and in terms of
its reputation. As noted in an earlier section of
this report, the application of data protection
principles will have a significant effect on drug
testing by employers who ‘will have to be much
clearer as to the purpose of drug testing and be
able to justify that testing in the light of how it
affects their workers and their right to respect
for private life’.
Other costs were less obvious. For example,
many safety-critical industries test staff after
any incident or accident. This seems reasonable
as part of investigative procedures. But the
The employees
The evidence to the IIDTW from
employees is no more than suggestive, as
the Inquiry did not have the time or
resources to talk to more than a small
number of individual employees about
their views and experiences. It is
interesting, however, that those employees
that the IIDTW did speak to consistently
expressed resentment at what they viewed
as intrusive drug testing that blurred the
established boundaries between their
professional and private lives. (All names
have been changed.)
Janine
Janine is a successful and confident
woman in her late-twenties who is
working in the telecommunications
industry. She told the IIDTW:
As long as you do your work … are good at your
work … that should be the issue … This would
get employers involved in your private life, not
just your work life. Personal recreational
(continued)
IIDTW heard some anecdotal evidence that this
form of testing could be counterproductive, as it
could prevent staff from reporting incidents. If
there is no investigation, then this increases the
risks of more serious accidents later on.
Many of these costs were explicitly
acknowledged by businesses responding to the
IIDTW’s MORI poll. Over a third (37 per cent)
agreed that drug and alcohol testing in the
workplace sent out the wrong messages to staff
and nearly a third (32 per cent) felt that it
impinged on employees’ human rights.24
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3.4 Conclusion
There are organisational costs to drug testing
and – at least, outside of safety-critical
environments – its effectiveness and
appropriateness are far from clear. Employers
have a legitimate interest in knowing whether
members of their staff are turning up for work
unable to perform or regularly taking sick leave
because of alcohol or drug problems. They then
have the options of addressing this as a health
or welfare matter, or as a straightforward
disciplinary issue. But people’s privacy should
be respected by the organisations that employ
them, and it is inappropriate for employers to
arrogate investigative powers for their own sake
and assume a law-enforcement role.
enjoyment shouldn’t have anything to do with the
company … There are already enough rules about
work, without invading my private time …
random testing, in particular, is blurring the line
between work time and private time.
She continued:
If random testing was introduced, I would look
elsewhere. I would definitely choose a job that
did not drug test. If there was pre-employment
testing, I would abstain, then take the test … I
would totally refuse random testing.
Bill
Bill is in his early thirties. He is a doctor
who does not use drugs. He told the
Inquiry that he ‘wouldn’t want to work in
any environment that policed my lifestyle’.
He agreed that his employers had a right
to know if he was intoxicated in work
hours, as he was ‘renting out my body for
so many hours a week’, but thought
testing would be acceptable to him ‘if it
could be only about the “now”, rather than
a lifestyle thing’.
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Over an 18-month period, the IIDTW has heard
extensive evidence from a wide range of
individuals and agencies – including employees
and employers, trade unions and business
organisations, drug-testing companies and
regulatory authorities, scientific experts,
lawyers, philosophers and social scientists.
Drug testing at work is a complex topic, and
evidence heard by the Inquiry has often defied
assumptions and preconceptions. The IIDTW
believes that there can be a limited role for drug
and alcohol testing in some circumstances. But
drug testing at work is not a quick and easy fix.
The Commissioners are deeply concerned about
its unexamined expansion in Britain and about
the potential for further growth in the future.
Overall, the IIDTW concludes that there is no
justification for drug testing as a way of policing
the behaviour of the workforce, nor is it an
appropriate tool for dealing with most
performance issues. Drug testing can have an
important role in safety-critical and other
occupations where the public is entitled to expect
especially high levels of probity, safety and
security. Even here it should be approached with
caution and, if the technology is available, direct
testing of impairment will generally be preferable
to drug testing, and the importance of the culture
of an organisation cannot be overstated. Nor are
drug testing systems infallible. The technology is
imperfect and there are ways of subverting them.
One of the strongest themes to emerge from the
evidence heard by the IIDTW over an 18-month
period is that good all-round management is the
most effective method for achieving higher
productivity, enhanced safety, low absentee rates,
low staff turnover and a reliable and responsible
workforce. For the majority of businesses,
investment in management training and systems
is likely to have more impact on safety,
performance and productivity than the
introduction of drug testing at work.
The principal conclusions and
recommendations of the IIDTW are set out
below.
1 Keeping things in perspective
The use of illicit drugs is widespread in Britain,
as are unhealthy patterns of alcohol
consumption. For example, the latest sweep of
the British Crime Survey reported that over a
quarter (28 per cent) of 16 to 24 year olds had
used illicit drugs in the last year, and recent
Home Office research reports that over a third
(39 per cent) of 18 to 24 year olds could be
classified as ‘binge drinkers’. More recently, in
March 2004, the Government published its long-
awaited Alcohol Harm Reduction Strategy for
England (Prime Minister’s Strategy Unit, 2004),
which claims that alcohol misuse is now costing
£20 billion each year through crime and
disorder, injuries and illness, and lost
productivity in the workplace. There is
legitimate cause for concern at the levels of drug
and alcohol use by the population at large, but
this becomes a problem for employers only if it
is having an adverse effect in the workplace.
There is no conclusive evidence that this is a
significant problem at work.
The survey evidence considered by the
IIDTW was mixed and equivocal. Over half (58
per cent) of nearly 250 respondents to a TUC
questionnaire felt that someone they knew had
performed less effectively at work because of
drugs or drink. Twenty-three per cent of
respondents to a self-responding MixMag
survey said that alcohol had made a difference
4 Conclusion and recommendations
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to their performance at work and 63.9 per cent
that illicit drugs had done so. The IIDTW also
heard evidence that levels of drug and alcohol
use are high in the catering and entertainment
industries – with significant safety implications
in the former case.
However, the majority of employers who
gave evidence to the IIDTW about their
experiences of drug and alcohol testing reported
very low levels of positive results. The IIDTW is
confident that the overwhelming majority of
employees in safety-critical work are
conscientious and behave responsibly.1 The
furthest that a recent research survey from the
Health and Safety Executive (HSE) is prepared
to go is to say that ‘recreational drug use may
reduce performance, efficiency and safety at
work’, and witnesses from the HSE told the
Commissioners that ‘incidents where people act
outside of what would be normally competent
behaviour are very, very, few’ (adding that
‘Health and Safety Inspectors do not find a
massive problem with drug abuse in the
workplace’). Similarly, Ross Coomber, Professor
of Sociology at the University of Plymouth,
concludes his literature review for the IIDTW by
saying that:
… the evidence for clear-cut deleterious effects
of drug use on business is equivocal. What is less
so is the belief by the business sector of the
harm that drug use, and alcohol consumption in
particular, causes to British industry’.
Overall, there is a lack of evidence to suggest
that drug and alcohol use is in fact having a
serious and widespread effect on the workplace
in modern Britain.
The IIDTW has not been able to determine to
its own satisfaction the impact of drug use in
the workplace or trends in the development of
drug testing as a practice among British
employers, although it has considered evidence
that gives a good indication of the current state
of affairs. The IIDTW concludes that there is a
need for continuing monitoring and analysis of
trends, located within the Health and Safety
Executive, and with the close involvement of the
Confederation of British Industry, Federation of
Small Businesses and Trade Union Congress.
The IIDTW would welcome the regular
publication of an official statistical and research
bulletin on health and safety at work that
monitors the impact of drugs and alcohol in the
workplace, the reporting of adverse events and
the use of drug testing by employers, alongside
other factors that can affect performance and
safety. This work could be led by the Department
of Health, working closely with other relevant
government departments, including the
Department of Trade and Industry.
The IIDTW notes that the Government is
currently consulting on a strategy for public
health that ‘will involve working with a number
of organisations within industry on how they
can improve employees’ health’, and that a
White Paper on Public Health is anticipated
later this year. This provides an ideal
opportunity to promote best practice in dealing
with alcohol and drug issues in the workplace,
and to ensure that this comes to be seen as a
mainstream health and welfare matter, linked to
other work-related public health issues (such as
excessive hours and stress).
The IIDTW believes that a fruitful line of
inquiry for future research is the relationship
between drug and alcohol problems among
employees and different management
philosophies within organisations.
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2 Performance at work
The IIDTW notes that a wide range of things can
affect an individual’s performance at work –
including prescription drugs, moderate alcohol
consumption, poor diet, late nights, tiredness and
stress, child-care responsibilities, divorce and
bereavement. Employees should not be required
to live their lives in such a way as to be maximally
productive at work. However, if an employee’s
private activities or problems have a sufficiently
serious impact on work performance, then what
are ordinarily private matters can become a
legitimate concern for employers. The relevant
thresholds are difficult to specify with precision
and depend on both the intensity and frequency of
the effect on performance. Paradoxically, if these
thresholds are being exceeded then it is likely that
the employee’s problems will be sufficiently
evident that there will be no need to resort to drug
or alcohol testing.
The IIDTW concludes that employers have a
legitimate interest in drug and alcohol use among
their employees in a restricted set of circumstances
only. These circumstances are where:
1 employees are engaging in illegal activities
in the workplace
2 employees are actually intoxicated in work
hours
3 drug or alcohol use is (otherwise) having a
demonstrable impact on employees’
performance that goes beyond a threshold
of acceptability
4 the nature of the work is such that any
responsible employer would be expected to
take all reasonable steps to minimise the
risk of accident
5 the nature of the work is such that the
public is entitled to expect a higher than
average standard of behaviour from
employees and/or there is a risk of
vulnerability to corruption (for example, in
the police or prison service).
3 Employment and private life
Employers therefore have a legitimate interest
in the private behaviour of their employees only
where it is having a serious impact on their
capacity to work, and then only in a limited and
specific set of circumstances. A distinction
between professional and private life is a
fundamental value of our society and the
IIDTW would be extremely concerned about
any erosion of this boundary. The IIDTW is
concerned that drug and alcohol testing at work
could potentially transform businesses into
quasi-law enforcement agencies and agents of a
particularly virulent form of ‘nanny statism’.
There is a danger of slipping inadvertently into
a situation where employers are routinely
investigating the private lives of employees
(and potential employees), and effectively
imposing extra-judicial penalties for illegal – or
undesirable – behaviour. The IIDTW found that
the overwhelming majority of British employers
who gave evidence have no desire to police the
private lives of their staff.
The IIDTW concludes that employers have
no direct interest in the private behavour of
employees and prospective employees as such
and that investigation of an employee’s private
life simply for its own sake is a serious invasion
of personal liberty.
This means that drug and alcohol testing can
never be justified as a means of policing the
65
Conclusions and recommendations
private behaviour of employees or potential
employees and in the absence of legitimate
safety or performance concerns (which include
concerns about ‘reputation’ and ‘probity’ in
some professions). This means, for example,
that organisations should not be conducting
pre-employment tests simply as a way of
investigating the ‘character’ of applicants. Nor
should people be turned down for jobs,
dismissed or disciplined as a form of
extrajudicial punishment for using drugs, and
independently of any impact on performance at
work.
The IIDTW notes that many drug tests do
not measure current impairment or intoxication
at all, but that they do reveal that somebody
used drugs days, weeks or months previously.
This information is unlikely to have a direct
bearing on performance or safety at work and
this sort of testing is therefore rarely
appropriate.
4 Legality is not the key issue
It is natural to assume that the legal status of
different drugs will have an important bearing
on arguments about drug testing at work.
Employers have a legitimate interest in whether
their staff are breaking the law in the workplace,
and this is a particular concern in professions
that have a law-enforcement role. More
generally, where staff are using illicit drugs at
work, their employers could face criminal
proceedings if they were to turn a blind eye.
This aside, however, the distinction between
licit and illicit substances is largely beside the
point for the debate about drug testing at work.
What matters is impairment, performance and
safety. The Code from the Information
Commissioner (who oversees the
implementation of the Data Protection Act),
published in November 2003, states that testing
should be used only to ‘detect impairment at
work rather than illegal use of substances in a
worker’s private life’.
Relatedly, the experience of the IIDTW was
that many witnesses with managerial and
occupational health responsibilities accepted
that alcohol was more of a problem than drugs
if the question was explicitly posed by the
Commissioners. However, most of these
witnesses proceeded to focus on illicit drugs in
presenting their evidence. Aside from its legal
status, what appears to be a more tolerant
attitude to alcohol probably reflects the fact that
managers are more familiar with, and therefore
less anxious about, alcohol use, and that they
are confident in their ability to recognise and
respond to alcohol-related problems without
recourse to drug testing or to formal
disciplinary procedures. As a witness from the
company NORCAS, which provides a range of
drug and alcohol services to organisations,
explained:
… employers can be of an older generation and,
whereas they think they can deal with alcohol as
an issue, because they know the effects of
alcohol for themselves, they don’t know how to
deal with drugs.
Some of the evidence presented to the
IIDTW suggests that alcohol consumption is a
greater cause for concern than illicit drug use.
The Commissioners also note that the Alcohol
Harm Reduction Strategy, published in March
2004, claims that alcohol misuse is a cause of
increased absenteeism, early retirement and
premature death that costs the UK economy up
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to £6.4 billion a year in lost earnings for
individuals, lost profit for employers and lost
productivity for the country. The IIDTW
believes that there should be further
investigation of public behaviour and attitudes
with regard to drinking at work as part of the
Alcohol Harm Reduction Strategy.
5 A private matter
It has been suggested by some people that the
use of drug testing at work is a private,
contractual matter between employee and
employer, and is not the state’s business. The
IIDTW rejects this argument for two reasons.
First, the inequality in the bargaining positions
of employers and employees will often mean
that ‘consent’ to drug testing at work is merely
nominal. Second, the IIDTW has been
impressed by the evidence that a significant
expansion of drug testing at work could have
profound economic and social costs for the
community at large (for example, by effectively
barring people from productive employment).
Drug testing by business is everybody’s
business.
The IIDTW is persuaded that drug testing at
work cannot be dismissed as a ‘private’,
contractual matter between individuals and
organisations, but should be viewed as a public
policy issue and subject to a full public debate
and to appropriate regulation by the state.
6 Drug testing and the law
The IIDTW found the legal position on drug
testing at work somewhat confused, largely
because there is no direct legislation, and
important legal questions hinge on interpretation
of a whole range of legal provisions in health and
safety, employment, human rights and data
protection law. If the IIDTW found the legal
situation unclear, despite the considerable legal
expertise at its disposal, it is unlikely that the law
is well understood by many employers,
employees or the public at large.
The principles behind the legal or self-
regulatory provisions that exist appear to be as
follows:
• that people are entitled to a private life
• that employers are required to look to the
safety of those affected by the work of
their employees, both other employees
and members of the public
• that people are entitled to dignity
• that people are entitled to proper quality
standards for evidence used against them
in court or disciplinary proceedings.
We heard that recent developments in data
protection law appear to have created a more
secure framework to ensure these rights. Thus
the combination of the first three data protection
principles and the draft guidelines issued by the
Information Commissioner (Part 4 of the
Employment Practices Data Protection Code on
health information of employees) cover the right
to private life and the right to safety at work. In
addition, the guidelines lay down procedural
requirements to ensure proper standards of
evidence where testing is justified.
The Information Commissioner’s guidance,
however, while welcome, remains just that. The
final result of the consultation on the draft
guidelines is due out in July 2004. We do not
know that it will remain as drafted. If, after its
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publication, there remained any ambiguity, the
IIDTW would welcome greater certainty about
the law and in particular a confirmation from
the Government that drug testing outside
safety-critical occupations and those where
there are other special confidence issues is not
legal. In addition, the IIDTW believes it should
be made clear that data processed in breach of
the requirements of the Act (as interpreted by
the Information Commissioner’s guidelines) is
not admissible in disciplinary proceedings or
court proceedings for dismissal.
In respect of ensuring the quality of
evidence, the Information Commissioner’s
guidelines appear to overlap with the
safeguards provided by the use of an accredited
laboratory that also abides by the Guidelines on
Legally Enforceable Workplace Drug Testing.
However, the accreditation system that applies
to drug laboratories covers only a very small
part of the industry. Only around a dozen
laboratories are accredited. And the Guidelines
for Legally Defensible Workplace Drug Testing
is an unsatisfactory attempt at self-regulation.
Although the IIDTW welcomes the rules in the
Guidelines themselves, which flesh out the
Information Commissioner’s guidelines, there
are no monitoring or enforcement mechanisms.
The IIDTW does not believe that this
situation is satisfactory. Since the results of tests
can have a significant effect on the rights of
individuals whose results are found positive
(refusal or loss of employment or disciplinary
proceedings), substandard laboratories are not
acceptable. Those laboratories that are not
accredited should be given three years either to
bring themselves up to UKAS-accredited
standards or to form an equivalent self-
regulatory system that ensures: adherence to the
requirement that tests are based on reliable
scientific evidence; that specimens are collected
and kept under proper conditions; and that test
results are interpreted only by qualified and
experienced staff.
The effectiveness of such a scheme should be
reviewed after three years and, if it is not
working satisfactorily to ensure employers and
employees are protected from unscrupulous or
substandard service providers, the Government
should act to introduce a legal requirement that
all laboratories and testing systems meet the
standards set by the UKAS accreditation system
and equivalent standards to those set by the
Guidelines for Legally Enforceable Workplace
Drug Testing.
In the meantime, the Steering Group that
developed the Guidelines for Legally
Enforceable Drug Testing should consider the
feasibility of setting up an inspection system for
laboratories that claim to adhere to the
Guidelines or means of incorporating them
within a European and/or international
accreditation system.
The IIDTW also calls on the Government to
produce clear and definitive guidance on the
legal and other issues around drug testing at
work, and to finance a major communication
initiative to ensure that this information is
accessible to all employers and employees. This
information should include a recommendation
that companies that carry out drug testing that
is justified under the Data Protection Act should
ensure that workplace tests that are relied on in
disciplinary or dismissal proceedings are robust
in quality and should promote the use of
accredited laboratories.
In addition, the Commissioners strongly
support the call from the All-Party Parliamentary
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Drug Misuse Group for more general
government guidance for employers on drug and
alcohol policies backed up by a new National
Support Service. The IIDTW notes that official
guidance is not always accessible or fit for
purpose, and would welcome the production of a
set of user-friendly resources for organisations,
including a decision tree for employers who are
contemplating the use of drug testing.
The IIDTW notes that the recently published
Alcohol Harm Reduction Strategy for England
(Prime Minister’s Strategy Unit, 2004) states that
the Department of Health will set up by the first
quarter of 2005 a website for employers to
provide advice on the warning signs of alcohol
misuse and how to handle employees with an
alcohol problem. The IIDTW feels that this site
would be a natural vehicle for providing
employers with balanced information on both
drug and alcohol testing.
The IIDTW also welcomes the pledge in the
Alcohol Harm Reduction Strategy to extend the
Home Office’s National Workplace Initiative,
which trains company representatives on
handling drug use in the workplace, to include
alcohol. However, the IIDTW is concerned
about mixed messages if this initiative is led by
the Home Office, as there is a danger that this
will result in the issue being seen as a law
enforcement and not a health and safety matter.
7 Safety-critical industries
The role of drug and alcohol testing in safety-
critical industries is rarely questioned. In fact,
the evidence presented to the IIDTW by
representatives from safety-critical industries
often raised some genuine questions about the
usefulness or appropriateness of testing even in
these environments. In most industries, accident
rates were ‘virtually zero’ and – with one or two
exceptions – those organisations that were drug
testing their employees reported very low
numbers of positive results.
Drug and alcohol testing is not a quick fix.
But the IIDTW was nonetheless satisfied that it
can have a role to play in safety-critical
enviroments. First, it is apparent, from what we
know about the psychological effects of various
drugs, that intoxication can impair performance,
with serious health and safety implications, and
it is also a reasonable supposition that testing
could deter and detect drug use in some
circumstances. Second, even if this deterrent
effect is extremely marginal, the IIDTW is
acutely conscious that, in some occupations, the
consequences of a single error could be very
grave indeed. Third, the IIDTW has been
advised that it is difficult – if not impossible – to
prove a deterrent effect anyway due to the very
wide range of variables acting on a situation (so,
it is unlikely that any deterrent affect will ever
be conclusively established one way or another
by the research evidence).2 And, finally, while
some of the evidence presented to the IIDTW
suggests that drug testing in safety-critical
industries is more about maintaining public
confidence than having a demonstrable impact
on behaviour, the Commissioners recognise that
the confidence of the public is an entirely valid
consideration in its own right.
The IIDTW accepts that there is a case for
drug testing in safety-critical industries. But
direct testing of impairment is better suited to
health and safety purposes than drug testing –
which is an indirect and unreliable measure of
impairment. The further development of
impairment-testing techniques – and, in
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particular, testing that can target only those
forms of impairment that are relevant to a
particular task or job – could potentially
undermine the arguments for drug testing in
safety-critical occupations. The IIDTW heard
that there is ongoing research into impairment
testing, but no conclusive evidence that it will
necessarily improve sufficiently. If this form of
testing is successfully developed, a review
conducted in five or ten years may struggle to
make a case for drug testing even for safety-
critical workers.
The IIDTW also notes that testing in safety-
critical industries should be one part of a
comprehensive drug and alcohol policy.
Furthermore, a focus on drugs and alcohol
should not divert attention or investment from
other health and safety priorities – for example,
poor working practice, communication failures,
stress and excessive tiredness. Any guidance or
advice for employers should also present
alternatives to drug testing and provide objective
criteria for assessing their relative merits.
8 Implementation issues
If the benefits of drug testing are uncertain, then
the costs should not be underestimated either.
Some employers from safety-critical industries
who provided evidence to the IIDTW said that
testing had been divisive and damaging to
industrial relations. There can also be a large
disparity between the good intentions behind a
drug-testing policy and the implementational
reality on the ground. The IIDTW heard of cases
where testing procedures that appeared to be
more or less foolproof had been subverted. In
particular, the IIDTW heard evidence of
managers and staff colluding to subvert testing
systems out of friendship or a sense of loyalty to
colleagues, to avoid losing a trained employee
or because a positive test could reflect badly on
their team or part of the business. The Inquiry
also heard of cases where employees had not
reported incidents, with possibly serious health
and safety implications, for fear of triggering
drug testing and disciplinary procedures
against themselves or colleagues.
The majority of witnesses to the IIDTW saw
drug and alcohol issues as a health and welfare
matter, and not simply – or primarily – as a
disciplinary issue. This is surely right. It follows
that organisations should not be drug testing
unless they have appropriate systems to deal
with staff identified as having drug or alcohol
problems.
Thus, BT explained to the IIDTW that ‘as
with any problem, [we] … support the
individual in dealing with it’ (i.e. a drug or
alcohol problem). And Rolls-Royce plc told the
IIDTW that it had issued all its managers with a
guide to mental health that clearly stated that
alcohol and drug abuse should be treated as a
health problem, and addressed by providing
appropriate support and counselling to
employees. As noted earlier, while London
Underground takes a ‘tough’ line when staff test
positive for drugs and alcohol, it also offers
plenty of support to staff who proactively come
forward with problems.
The arguments for treating drug and alcohol
misuse as essentially a health and welfare issue
are not only ethical ones, there is also a strong
business case for supporting staff who develop
problems. Failure to do so can mean losing
trained and able staff, it can be divisive, may be
open to legal challenge and could have a
negative impact on the company’s reputation
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with employees, potential employees and
customers.
The IIDTW believes that the key to
successful implementation of a drug and alcohol
policy is that it is conceived as an aspect of
health and welfare policy and not exclusively as
a disciplinary matter. A drug and alcohol policy
will be effective only if it is accepted and owned
by staff across the organisation (although the
IIDTW acknowledges that, in some occupations,
working while intoxicated by drugs or alcohol is
highly irresponsible behaviour and is a serious
disciplinary matter).
The IIDTW concludes that drug testing at
work should be introduced only in specific
circumstances where there is a demonstrable
benefit, and should not be introduced in the
absence of proper consultation and involvement
of trade unions and/or other staff
representatives.
The acceptability of testing is also about the
approach that is taken to alcohol and drug
problems among staff.
The IIDTW believes that, where staff in
safety-critical roles are found to have drug or
alcohol problems, this is a health and welfare
issue and should not be a basis for automatic
dismissal or for automatically triggering
disciplinary procedures. Wherever possible,
employees with safety-critical functions should
be redeployed in other roles and given
appropriate help and support. Aside from the
welfare arguments, if a drug policy including
testing is clearly a health and welfare initiative,
it is far less likely to be undermined and
subverted, and will fulfil its safety function far
more effectively.
The IIDTW accepts that, if companies do
drug test staff, there is a good case for restricting
testing to staff in safety-critical industries who
have a direct safety-critical role, but notes that
this is a very difficult line to draw. The IIDTW
also notes that many individuals will have
safety-critical jobs although they are not
employed in safety-critical industries, and this
needs to be recognised in developing policy and
guidance.
The IIDTW is concerned that responsibility
for safety in the workplace is not ‘downwardly
delegated’. The decisions of senior staff can
have as great a consequence for public safety as
the actions of, say, a train driver or a miner.
Drug and alcohol policy should not be
something that is imposed on employees by
managers – for example, through unnecessarily
invasive testing regimes – but must be even-
handed and non-discriminatory. The IIDTW
believes that it is unacceptable, for example, if
an organisation is drug testing junior staff
where senior management are themselves
involved in a culture of drinking in working
hours. All those affected by drug policy need to
be involved in its formation. If policy is not seen
to be fair, then drug testing will be a source of
conflict and an ‘us’ and ‘them’ mentality, which
will undermine the effectiveness of any
workplace drug and alcohol policy.
9 Drug testing in its place
The IIDTW would emphasise that management
structures should routinely pick up on staff who
are not performing at work or are frequently on
sick leave anyway. For the most part, it is unclear
that anything can be achieved through drug and
alcohol testing that could not be done better




Precisely this point was made by a number
of businesses that gave evidence to the IIDTW.
Southern Water told us that drug testing had
added little value, and that, in future, they
would deal with drug and alcohol issues by
good routine management. Transco told us that
good, high quality management made drug
testing less of an issue. And a representative
from the Engineering Employers’ Federation
said that drug and alcohol use was a basic
management issue:
… do you raise the fact that someone is under-
performing and instead of dealing with it in a
sensible ‘people management skill’ way – by
asking questions such as ‘what is happening?’,
‘how are you doing?’ – go down the route of drug
testing and just say ‘we are thinking of drug
testing you’.
This point was made with force and clarity
in a personal written submission to the Inquiry
from Andrew May, Chair of the Chartered
Management Institute Working Party on Drug
and Alcohol Abuse in the Workplace. He
commented:
… a relationship based on trust and open
communication between managers and staff is
essential to identify and cope with abuse
problems. It is equally important for dealing with
staff problems arising from family problems
(illness, divorce) or other addiction problems
(gambling, eating disorders). It is not just drug
abuse that affects performance, and over-
emphasising this abuse risks ignoring others with
equally serious consequences … Early
recognition and supportive policies minimise the
adverse effects of abuse to the benefit of
individuals and the organisation.
The Commissioners fully endorse these
comments.3 Where testing is carried out in
house, it will generally be the responsibility of
occupational health departments. The London
Chamber of Commerce convened a round-table
discussion for the IIDTW in 2003 at which it was
made clear to Commissioners that some
occupational health managers fear that the
relationship of trust with staff may be damaged
by their involvement in drug testing.
The IIDTW finds that drug testing is no
alternative to good management practice, and, if
not sensitively handled, can damage relations of
trust between managers and staff.
The IIDTW notes that an unhealthy and/or
excessively stressful work environment can
contribute to substance problems, and that all
organisations have a responsibility to address
the causes as well as the consequences of drug
use.
10 The responsibilities of employees
While the evidence presented to the IIDTW
suggests that the majority of staff behave
responsibly in Britain, it would be wrong to
conclude this report without a reference to the
responsibilities of employees. It is unacceptable
for anyone to arrive at work in a state of
intoxication that could place their colleagues,
members of the public or the reputations of
organisations at risk, or – in general – means
they are unfit to do the work that they have
been employed to do.
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accept random drug testing in the service,
because of their role as enforcers of drug
laws. He commented: ‘we owe it to the
public to show it quite clearly and
categorically that the police do not take




for police’, The Guardian, 6 September 2003).
More recently, it was reported in the
magazine DrugLink that ‘In October, Home
Secretary David Blunkett was handed
guidance by the Police Advisory Board
(PAB) recommending drug tests for all new
recruits, for those entering specialist jobs
and as a response to specific incidents and
behaviour. Already four forces –
Merseyside, Greater Manchester, West
Midlands and Grampian – have tested
officers. But this could be the thin end of the
wedge which some experts predict would
have a disastrous effect on recruitment and
officers’ morale and health. The PAB wants
the Home Secretary to consider random
testing of all Britain’s 130,000 officers in late
2005, a policy which has the strong backing
of the Association of Chief Police Officers
(ACPO) and the Police Superintendents’
Association (PSA)’ (Max Daly, ‘Passing out
parade’, DrugLink, Vol. 19, No. 1, January/
February 2004).
3 ‘Chain of custody is a legal term that refers
to the ability to guarantee the identity and
integrity of the specimen from collection
through to reporting of the test results. It is
a process used to maintain and document
the chronological history of the specimen.
(Documents should include name or initials
of the individual collecting the specimen,
each person or entity subsequently having
custody of it, the date the specimen was
collected or transferred, employer or
agency, specimen number, patient’s or
employee’s name and a brief description of
the specimen.) A secure chain of custody,
together with the analytical techniques used
by the Regional Laboratory for Toxicology
to confirm the identity of drugs present in a
specimen, leads to the production of a
legally defensible report’
(www.toxlab.co.uk/coc.htm).
4 Indeed, one witness pointed out to the
Inquiry that for some drug users – including
those being treated with substitutes like
methadone – not using drugs could impair
performance (this would obviously apply to
many prescription drugs too, and –
arguably – to nicotine).
5 In sport, this issue is further complicated by
the fact that some of the substances that
athletes are prohibited from taking are
derivatives of substances that are produced
naturally in the human body and the extent
to which the body produces these
substances varies significantly from one
person to another. Paradoxically, the
exertion of sporting activity itself can push
naturally produced testosterone and
nandrolone levels up close to – or
sometimes beyond – prohibited levels.
6 For example, skier Alain Baxter had an
Olympic bronze medal from the 2002 Salt
Lake City Winter Olympics withheld when
he failed a drugs test. He later explained
‘they had found traces of what appeared to
be the banned substance methamphetamine
in my urine sample, so were going to take
my medal away. Eventually, we worked out
that the positive test was caused by a Vicks
Nasal Inhaler I had bought in the US and
was using to clear my sinuses. I had always
used the same decongestant in the UK and
assumed it was safe. But the American
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version contained a tiny amount of
levamfetamine, a mild form of the banned
substance’ (‘Triumph and despair’, The
Observer, 18 January 2004).
7 In what follows, the IIDTW is particularly
grateful for the detailed, considered and
illuminating discussion of the legal issues
provided in ‘An expert legal opinion for
leading barrister Michael Ford’, which was
submitted to the IIDTW in November 2003
and a report entitled ‘Drug testing at work:
a legal perspective’, which was prepared for
the Inquiry by Gillian Ferguson LLB (Hons),
LLM (Cantab.) of Matrix Chambers. These
reports will be made available to the public
in due course. The Commission would also
like to thank the practising lawyers with
particular expertise in employment law
from legal practices across England and
Wales who gave evidence to the Inquiry,
and participants in the Plenary Session at
the Industrial Law Society on 12 September
2003 on ‘Drug testing at work: legal and
ethical issues’.
8 To be more precise, there is an implied term
in every relationship that an employer will
not ‘without reasonable and proper cause,
conduct itself in a manner calculated or
likely to destroy or seriously damage the
relationship of trust and confidence
between employer and employee’. As
Michael Ford pointed out to the IIDTW,
leaving aside the interpretation of this
implied term ‘[it] will not override express
terms … including, in the present context,
express terms of contract which give the
employer the right to require its employees
to undertake drug testing’.
9 If a case for unfair dismissal is successful,
then an employee is entitled to an award to
compensate for financial loss (the maximum
award is currently set at £52,600).
Significantly, this award may be reduced if
the ‘blameworthy conduct’ of the employee
is judged to have caused or contributed to
his or her dismissal.
10 But, if adopting a fair procedure would
have led to dismissal in any event, the
compensatory award is likely to be
restricted to the period it would have taken
for a fair procedure to take its course –
normally no more than a few weeks.
11 Where the use of illicit drugs has given rise
to a criminal record, the disclosure of this
information is subject to a set of statutory
rules, notably under the Rehabilitation of
Offenders Act 1974.
12 See, in particular, Section 2 and Section 3(1)
of the Health and Safety at Work Act.
13 The Management of Health and Safety at
Work Regulations are SI 1999/3242. See, in
particular, Regulation 3.
14 See Sections 27 and 28, Transport and Works
Act.
15 Concerns about compliance with the
Transport and Works Act apparently played
an important part in London
Underground’s decision to include drug
testing provisions in its substance abuse
policy. For an illuminating discussion, see
Palmer, M., ‘Workplace monitoring: taking
the drink and drugs high ground?’,




16 Sex Discrimination Act 1975, Race Relations
Act 1976 and Disability Discrimination Act
1995. The prohibition on discrimination on
the basis of trade union membership is
contained in the Trade Union and Labour
Relations (Consolidation) Act 1992.
17 The fact that drugs may mask or remove the
disability is not relevant to assessing
whether someone is disabled or not. The
effects of any treatment are factored out in
assessing disability.
18 The exclusion of drug and alcohol
dependency in the Disability Discrimination
Act 1996 obviously does not apply to health
problems that are the result of past
substance use – for example, where heavy
alcohol use has resulted in liver damage.
19 On this matter, see X v. Commission of the
European Communities [1995] IRLR 320.
20 In his evidence, leading barrister Michael
Ford notes, for example, that the adoption
of a ‘reasonable expectation of privacy’ test
in the USA ‘has largely left management
prerogative unscathed in the sphere of drug
use and testing’. By contrast, in France,
where there is a right to private life at work,
the courts have required much more
stringent justification of drug and alcohol
testing – holding, for example, that only
health and safety reasons are sufficient to
justify tests.
21 It is worth noting that a recent Employment
Appeal Tribunal ruling, while rejecting an
argument based on Article 8, did express
concerns that a company’s drug policy
effectively meant that ‘no drugs having
certain persistent detectable characteristics
could be taken by employees in their
private time without probably jeopardising
employment’ (O’Flynn v. Airlinks, EAT/
0269/01).
22 He continues: ‘For what they are worth, my
views are that O’Flynn and Whitefield
(Whitefield v GMC [2003] IRLR 62) accord too
little importance to the impact of drug testing
on private life; that testing for prescription
drugs which therefore reveals information
about an individual’s health will require
particularly compelling justifications; and
that in future tribunals are likely to demand
a clearer link between off-duty drug use and
performance at work than the traditional
approach has demanded (though they will
probably tend to find a link more readily if
drugs are criminalised)’.
23 In her evidence to the Inquiry, Gillian
Ferguson of Matrix Chambers explains: ‘it is
clear that certain public sector employers,
such as government departments or the
police, are public authorities. These types of
bodies are pure public authorities and all
acts of such bodies, including workplace
drug testing, are caught by the Human
Rights Act. However, the position is less
clear in relation to bodies that have a
combination of public and private
functions, such as a privatised utility with
mixed commercial and regulatory functions
or a professional association with a
regulatory role. These types of bodies are
sometimes termed “hybrid public
authorities”. It is only those acts of hybrid
public authorities that are of a public nature,
which are caught by the Human Rights Act.
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Since drug testing is arguably a private act
within the inherently private employment
relationship, workplace drug testing by a
hybrid public authority is likely to fall
outside the scope of the Human Rights Act.
However, where the functions that render
an employer a “public authority” relate to
health and safety, drug testing is arguably a
public act and therefore covered by the
Human Rights Act.’
24 See the ILO Inter-regional Tripartite Experts’
Meeting on Drugs and Alcohol Testing in the
Workplace, 10–14 May 1993, Oslo.
25 This is because the principal remedies of the
Act are administrative, not criminal.
26 Information Commissioner, The Employment
Practices Data Protection Code: Part 4:
Information about Workers’ Health, 2003, at
para. 3.4.1.
27 Information Commissioner, The Employment
Practices Data Protection Code: Part 4:
Information about Workers’ Health, 2003, at
para. 3.4.4.
28 Information Commissioner, The Employment
Practices Data Protection Code: Part 4:
Information about Workers’ Health, 2003, at
para. 3.4.4.
29 Information Commissioner, The Employment
Practices Data Protection Code: Part 4:
Information about Workers’ Health, 2003, at
para. 3.4.6.
30 Information Commissioner, The Employment
Practices Data Protection Code: Part 4:
Information about Workers’ Health.
Supplementary Guidance, 2003, para. 3.4.1.
31 Information Commissioner, The Employment
Practices Data Protection Code: Part 4:
Information about Workers’ Health.
Supplementary Guidance, 2003, para. 3.4.2.
32 Amicus-AEEU told the IIDTW that an
action was being pursued in the civil court.
33 The Fortune magazine ranks the largest
companies in the United States in an annual
Fortune 500 list. Essentially, Fortune
magazine lists the US-based corporations
with the largest revenue in the past year.
Fortune 500 companies are among the
biggest, most profitable and most powerful
companies in America.
34 One of the employees who spoke to the
IIDTW – a young woman working in the
telecommunications field – made the point
about the distinction between private and
work life with particular force and clarity.
‘As long as you do your work … that
should be the issue’, she argued. ‘Drug
testing would get employers involved in
your private life. Personal recreational
enjoyment shouldn’t have anything to do
with the company … random testing, in
particular, is blurring the line between work
time and private time … if they insist on
random testing, I’d query their motives. It is
just too invasive. I’m contracted to work
between 9.00 and 5.30 – that is the time I put
in. Any other time is my own.’
35 Miller, D. (ed.), The Blackwell Encyclopedia
of Political Thought, Blackwell, Oxford, 2004.
36 Although, incidentally, as a matter of fact, it
is the possession of drugs and not their use as
such that is legally prohibited under the




1 Martin, P., ‘Tackling drug related crime –
from warfare to welfare’, interview in Safer
Society, No. 14, Autumn 2002.
2 Parker, H., Williams, L. and Aldridge, J., ‘The
normalisation of “sensible” recreational drug
use: further evidence from the North West
England longitudinal study’, Sociology Vol.
36, No. 4, 2002. See also, Parker, H., Aldridge,
J. and Measham, F., Illegal Leisure: The
Normalisation of Adolescent Recreational Drug
Use, Routledge, London, 1998.
3 See, in particular, Goulden, C. and Sondhi,
A., At the Margins: Drug Use by Vulnerable
Young People in the 1998/1999 Youth Lifestyles
Survey, Research Study 228, Home Office,
London, 2001.
4 Altrix is a drug-testing service that was
established in 1998. The Altrix laboratories
analyse approximately 200,000 samples a
year, involving over 1,000,000 individual
tests. Altrix is now the largest specialist oral
fluid drug-testing laboratory in Europe,
providing services mainly to the drug
rehabilitation and criminal justice sectors
and also to a number of commercial
organisations. It told the IIDTW that
workplace testing was as an area for future
expansion.
5 See DrugScope (2001), ‘Charity launches
service to ease industry’s £2.8 billion drug
and drink habit’ (press release), which is
available at www.drugscope.org.uk.
6 Chartered Management Institute, Managing
the Effects of Drugs and Alcohol in the
Workplace, CMI, London, 2003.
7 There have been some illuminating studies
of specific industries. For example, the
Caterer and Hotelkeeping Magazine published
the results of a survey of catering workers
on 9 October 2003. While the results of this
survey should be treated with caution, its
findings are striking nonetheless: over 97
per cent of those workers who participated
in the survey considered drug and alcohol
use at work to be a problem; 24 per cent
reported having personally drunk to excess
at work; 12 per cent admitted using illegal
drugs at work; 59 per cent said they had
witnessed other employees drinking to
excess during working hours; and 40 per
cent had witnessed other employees taking
illegal drugs during working hours
(Catering and Hotel Magazine, 9 October
2003).
8 The questionnaire was included in Hazard
magazine, No. 100, 5 April 2004 and the
results were analysed by the TUC on behalf
of the Independent Inquiry.
9 In 1986, President Reagan issued an
Executive Order requiring federal agencies
to introduce urine testing in order to create
‘drug free federal workplaces’. The Drug
Free Workplace Act 1988 prohibits the
manufacture, distribution, possession and
use of controlled substances in the
workplace.
10 Greenburg, E.R., Canzoneri, C. and Straker,
T., 1994 AMA Survey on Workplace Drug
Testing and Drug Abuse Policies, American
Management Association, New York, 1994.
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11 Dalen, P., Beck, O., Bkorklov, P., Finer, D.,
Garle, M. and Sjoqvist, F., ‘Workplace drug
testing likely to increase in Europe’,
European Journal of Clinical Pharmacology, Vol.
56, 2000, p. 103.
12 Chartered Management Institute, Managing
the Effects of Drugs and Alcohol in the
Workplace, CMI, London, 2003.
13 The study was restricted to companies with
at least ten employees.
14 The breakdown of the number of
respondents to the CBI questionnaire by
industry is as follows: finance (3), chemical
(11), gas (2), utility (10), engineering (11)
postal/courier (2), education/research (2),
mining/quarrying (2), communications (2),
retail (2) and transport (2).
15 The Inquiry was told that some offshore
drilling companies conduct random tests on
all staff, while others reserve random testing
for safety-critical workers only.
16 Although it was a different story for
contractors, who were viewed as a source of
a greater potential substance misuse
problem, and would generally face
immediate dismissal.
17 All-Party Parliamentary Drug Misuse
Group, Drug Testing on Trial, July 2003.
Williams, J., ‘Tinker, tailor, soldier,
smackhead: doctors on heroin, nurses on
pills, executives on coke. How serious is
drug taking at work’, The Big Issue, 9–15
February 1998.
18 Williams, J., ‘Tinker, tailor, soldier,
smackhead: doctors on heroin, nurses on
pills, executives on coke. How serious is
drug taking at work’, The Big Issue, 9–15
February 1998.
19 Discussed in Moore, D. and Haggerty, K.,
‘Bring it on home: home drug testing and
the relocation of the war on drugs’, Social
and Legal Studies, Vol. 10, No. 3, 2001,
pp. 377–95.
Chapter 3
1 Until recently, the quarrying industry had
the highest rates of industrial accident in the
UK. Disturbingly, the IIDTW was told that,
if somebody worked for 40 years as a
quarryman, they would have a one in ten
chance of being killed or seriously injured.
This is a working environment that is
potentially very dangerous and totally
unforgiving of carelessness and mistakes.
2 This witness told us that this ‘gut feeling’
could not be backed up by solid evidence,
as, in the past, the industry had not had
effective alcohol and drug policies, which
would have ensured that workplace
accidents and their causes were properly
investigated and monitored.
3 Although, in such cases, it was difficult to
separate out impairment caused by the drug
use from impairment due to the underlying
fatigue.
4 Also, in its evidence, London Underground
told the Inquiry that its drug and alcohol
policy stated that, if employees were taking
medication, then they had a responsibility
to find out about side effects that might
impair their work performance.
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5 Kraus, J.F., ‘The effects of certain drug-
testing programs on injury reduction in the
workplace: an evidence-based review’,
International Journal of Occupational
Environmental Health, Vol. 7, No. 2, 2001,
pp. 103–8.
6 ‘If we wanted the business’, it explained to
the Inquiry, ‘we had to have the policy’.
7 Of two young applicants for jobs who tested
positive for cannabis, this witness
commented that ‘it was really quite
upsetting … [and I] … would not want to
go through that again’.
8 The wording of the London Underground
policy on medication is, as follows: ‘all
employees are required: when requiring
medication, to find out if there may be side
effects likely to impair their work
performance and safety from the drug or
other medication concerned, whether
prescribed or available without
prescription, and, where this is the case, to
seek advice regarding alternatives;
additionally to advise their manager when
reporting for work’.
9 Compared to 30 per cent who did support
such a restriction.
10 It was pointed out to the IIDTW that testing
could even be a cause of absenteeism.
People might not turn up for work if there
was a risk that they would be drug tested
and they had used a drug that could be
detected. For example, someone who had
taken cocaine at the weekend might not
come to work on Monday morning.
11 It may be, for example, that young men are
more likely to take days off work and more
likely to be drug users than middle-aged
women, and this will distort the results if all
that is considered is the relationship
between drug use and absenteeism.
12 See, for example, Register, C.A. and
Williams, D.R., ‘Labor market effects of
marijuana and cocaine use among young
men’, Industrial and Labour Relations Review,
Vol. 45, No. 3, 1992, pp. 419–34.
13 See, for example, Zwerling, C., Ryan, J. and
Orav, E.J., ‘The efficacy of pre-employment
drug screening for marijuana and cocaine in
predicting employment outcome’, Journal of
the American Medical Association, Vol. 264, 1990.
14 Francis, P. and Wynarczyk, P., ‘Regulating
the invisible? The case of workplace illicit
drug use’, in P. Davies, P. Francis and V.
Jupp (eds), Invisible Crimes: Their Victims and
their Regulation, Macmillan, London, 1999.
15 For further details of this survey, see ‘Drug
testing: a bad investment?’, American Civil
Liberties Online Archive, www.aclu.org/
library/pbp5.html
16 Kaestner, R., ‘New estimates on the effects
of marijuana and cocaine use on wages’,
Industrial and Labor Relations Review, No. 47,
1994, pp. 454–70.
17 See, for example, Trice, H. and Roman, P.,
Spirits and Demons at Work (Second Edition),
Cornwell University, New York, 1978.
18 Which will, of course, vary depending on
the type of drug under consideration and an
individual’s pattern of drug use.
80
Drugs testing in the workplace
19 In her evidence to the All-Parliamentary
Drug Misuse Group.
20 Amicus-AEEU is the UK’s largest
manufacturing union, with 730,000
members in the public and private sectors.
21 The key references are Gilliom, J.,
Surveillance, Privacy and the Law: Employee
Drug Testing and the Politics of Social Control,
University of Michigan Press, 1994 and
Butler, B., Alcohol and Drug Testing in the
Workplace, Butterworths, Toronto, 1993.
22 Sullum, J., ‘Pissing contest’, Reason, January
2000.
23 See, for example, Spell, C.S. and Blum, T.C.,
‘Organisational adoption of pre-
employment drug testing’, Journal of
Occupational Health Psychology, Vol. 6, No. 2,
2001, pp. 114–26.
24 In contrast, 49 per cent did not think it sent
out the wrong message to staff and 50 per
cent did not think it impinged on human
rights.
Chapter 4
1 The IIDTW was able to speak directly only
to a small number of employees who used
drugs, and they will not necessarily be the
best judges of the effects on their
performance. However, it is interesting that
these witnesses did not feel that their drug
use had a significant impact on their work
and that some believed that they had
worked harder than otherwise to cover up
their drug use. In addition, the IIDTW heard
evidence from employers that the level of
positive results was extremely low, and
there was no discernible relationship
between the introduction of drug testing
and a reduction in accident rates.
2 The IIDTW also notes that it has been
demonstrated in other contexts that
deterrence is linked to the perceived
likelihood of discovery. Drug testing might
have to be conducted on a regular and
frequent basis (maybe weekly or daily) if it
is to have any kind of deterrent effect.
3 Andrew May further commented:
‘Managers have legal responsibilities for
managing people, as well as commercial
duties to their organisation. Penalties faced
by managers who fail go far beyond loss of
office, with imprisonment for corporate
manslaughter now a reality. Techniques in
risk assessment have been refined to help
identify what constitutes risk, and one
significant area of risk is employees who
behave irrationally. A good “man-manager”
minimises risk by knowing their staff and
through monitoring their actions. Detecting
change in behaviour or performance will
spark enquiry into the cause. A manager
will need to be able to pinpoint a cause
through an awareness of the external signs
of behaviour, which, of course, may have no
connection with drug abuse.’
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Appendix
Organisations and individuals who gave evidence to the
Inquiry
Transport
June Ashton, Human Resources Manager for UK Bus Division, Stagecoach
Lynne Beale, Group Risk Manager, Arriva Group
Dr Olivia Carlton, Head of Occupational Health, London Underground
Nigel Radcliffe, Senior Drug and Alcohol Counsellor, London Underground Support Services
Other Industries
Dr Ian Almond, Senior Medical Advisor, TRANSCO (utility company gas distributor)
John Corden, Head of Health, Safety, Emergency Planning and Security, Southern Water (utility
company, water supply and waste)
Dr N.F. Davies, chief Medical Officer, Nuclear Power Generator, British Energy
Liz Eades, Occupational Health Advisor, Seeboard Plc (utility company, electricity distribution)
Paul Fairlamb, Group Safety Manager, UK Coal (independently owned coal mining company)
Rory Graham, Director, Health, Safety & Training, Foster Yeoman (quarrying industry)
Alison Jackson, Safety, Health and Environment Division, UKAEA (decommissioning of nuclear
reactors, and other radioactive facilities)
Dr Sayeed Khan, Chief Medical Advisor, Engineering Employers’ Federation
Dr I.J. Lawson, Chief Medical Officer, Rolls-Royce Plc (multinational, engineering production for
civil aerospace, defence aerospace, the marine and energy sectors)
Dr Paul Litchfield, chief Medical Officer, and Head of Health and Safety, BT Group
(telecommunications services)
Andrew May, (personal submission) Chair, Chartered Management Institute Working Party on
Drugs and Alcohol in the Workplace
Jane McCourt, Occupational Health Advisor, Citigroup (banking/financial services)
Name withheld, Group Health and Safety Manager, Entertainment Industry
Name withheld, head chef and author, Catering Industry
Statutory Sector
Rob Bettinson, Development Manager, UKAS (United Kingdom Accreditation Service)
Iain Bourne, Strategic Policy Officer, Information Commissioner
Paul McCormack, Psychosocial Issues Unit, HSE (Health and Safety Executive)
Chris Rowe, Head of Psychosocial Issues, Policy Unit, HSE (Health and Safety Executive)
David Smith, Assistant Commissioner, Information Commissioner
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Insurance
Phil Grace, Risk Manager, Casualty, Norwich Union (insurance company)
Tim Humphreys, Manager for Liability Department for GI, ABI (Association of British Insurers)
Lawyers
Richard Arthur, Employment Rights Unit, Thompsons Solicitors
James Davies, Partner, Employment Law, Lewis Silkin Solicitors
Gillian Ferguson, Research Panel, Matrix Chambers
Michael Ford, Senior Council, Old Square Chambers
Gillian Leach, Employment Law specialist, Blake Lapthorn Linnell
Daniel Naftalin, Mishcon de Reya Solicitors
Katie Swaine, Head of Legal Services, Release
Gabriella Wright, Employment & Pension Unit, Charles & Russell
Fraser Younson, Head of Labour and Employment Group, London, Mcdermott Will and Emory
Laboratories/testing companies/policy providers/service providers
Matthew J. Atha, Principal Consultant IDMU (Independent Drug Monitoring Unit)
Keith Burns, Employment, Assistant Director, Promis Recovery Centre
Dr David Caughey, Senior Occupational Physician, Aon Health Solutions (Occupational Health Providers)
Julian Coe, CEO, Altrix Healthcare plc
Simon Floyd, Training and Consultancy, NORCAS
John Franklin-Webb, Principal Director, GSI Grosvenor International Services
Karl Graham, Business Unit Manager Workplace and Prison, Altrix Healthcare plc
Patricia Grant-Wilson, Centre Manager, GSI Grosvenor International Services
Lindsay Hadfield, Policy & Education Services, Medscreen Ltd
Alec Horner, Risk Management Consultant, ‘Minimise Your Risk’ (education and policy)
Steve Nurdin, Market Sector Manager, Altrix Healthcare plc
Roger Singer, Director, AVOIDD, DDE (drink driver education)
Chris Wakeham, Managing Director and Consultant, Hampton Knight
John Wicks, Managing Director, Tricho-Tech Ltd
Dr Keith Williams, Team Leader, Bioanalysis and Toxicology, LGC (Laboratory of the Government Chemist)
Police
Chief Superintendent Mike McAndrew, ‘E’ district Secretary, Police Superintendents’ Association




Ross Coomber, Principal Lecturer in Sociology, University of Plymouth
Peter Francis, Sociology and Criminology division, University of Northumbria
Natalia Hanley, University of Northumbria
Neil Hunt, Lecturer in Addictive Behaviour, University of Kent at Canterbury
David Wray, University of Northumbria
Trinh Thu, Associate Director, MORI Social Research Institute
Roundtable – health issues
Dr Maureen Baker, Honorary Secretary, RCGP (Royal College of General Practitioners)
Dr Rosemary Field, Director of Primary Care, National Clinical Assessment Authority
David Harding-Price, Chair of Mental Health Practice, Royal College of Nursing
Lady Anne Parkinson, Changing Minds Campaign, D & A Misuse Working Group
Hugh Robertson, Head of Health and Safety Unit, UNISON
Dr David Saunders, Senior Member of College Counsel, RCA (Royal College of Anaesthetists)
Roundtable – occupational health
Bev Cornish, occupational health consultant
Jane McCourt, Occupational Health Advisor, Citigroup
Pauline Lepine, Occupational Health Advisor, John Lewis
Sheila Nursimbula, Occupational Health Advisor, Metropolitan Police
Hilary Philpot, Group Health and Safety Manager, Universal Music Operations Ltd
Mike J. Roberts, Occupational Health Advisor, Department of Transport
Jane Stanton-Humphreys, Corporate Health Services Manager, Citigroup
Roundtable – Industrial Law Society
Membership of the Industrial Law Society Conference, 12 September 2003
Trade Unions
Jim Doneghy, Union Official AMICUS-AEEU
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Employees
Ben Goldacre, Journalist, Doctor, DJ
‘James’, Management Consultant
‘Ian’, London Underground employee




Dr Blair Chritchon, Deputy Head of Occupational Health, London Underground
Linda Harwood, Human Resources Policy Manager, London Underground
Dr Tim Norman, Policy Advisor, Department of Transport
Dr Lilley Read, Research Manager, Department of Transport
Mike Stallard, Business Services Manager, London Underground
Les Warneford, Managing Director, Stagecoach Bus and Coach Company
Statutory Sector
Dermot Breem, HSENI (Health and Safety Executive, Northern Ireland)
Adam Brett, Chairman, Northern Ireland Employment Lawyers Group
Trish Newton, Deputy Head of Job Seekers’ Division, Jobcentre plus
Dr Delia Skan, Senior Employment Medical Advisor, HSENI (Health and Safety Executive, Northern
Ireland)
Prison and Probation Service
Steve Limpkin, Head of Probation Service, National Probation Directorate
John Marsh, Head of Personnel Management Group, Prison Service
Clive Peckover, Head of Personnel Policies, Custody to Work
Research, information and service providers
Dr Angela Gorta, Research Consultant, Police Integrity Commission (Sydney, Australia)
Christine Hayhurst, Director, Public and Professional Affairs, Chartered Management Institute
Anusha Kurunathan, Sales, Frost and Sullivan (international market consultant on emerging high-
technology and industrial markets)
William Shone, Head of Marketing, Euromed Limited (diagnostic services provider)
Tony Wallwork, Grendonstar, (training and drug and alcohol policies)
Helen Vangikar, Toxicology Manager, Quest Diagnostic
Alex Wong, Research Analyst, Healthcare, Frost and Sullivan
